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In the context of pharmacogenomics, whole genome sequencing provides a powerful approach for identifying 
correlations between response variability to specific drugs and genomic polymorphisms in a population, in an 
unbiased manner. In this study, we employed whole genome sequencing of DNA samples from patients showing 
extreme response (n=72) and non-response (n=27) to the antiepileptic drug levetiracetam, in order to identify 
genomic variants that underlie response to the drug. Although no common SNP (MAF>5%) crossed the conven-
tional genome-wide significance threshold of 5×10-8, we found common polymorphisms in genes SPNS3, HDC, 
MDGA2, NSG1 and RASGEF1C, which collectively predict clinical response to levetiracetam in our cohort with 
~91% predictive accuracy (~94% positive predictive value, ~85% negative predictive value). Among these genes, 
HDC, NSG1, MDGA2 and RASGEF1C are potentially implicated in synaptic neurotransmission, while SPNS3 is 
an atypical solute carrier transporter homologous to SV2A, the known molecular target of levetiracetam. Further-
more, we performed gene- and pathway-based statistical analysis on sets of rare and low-frequency variants 
(MAF<5%) and we identified associations between genes or pathways and response to levetiracetam. Our findings 
include a) the genes PRKCB and DLG2, which are involved in glutamatergic neurotransmission, a known target 
of anticonvulsants, including levetiracetam; b) the genes FILIP1 and SEMA6D, which are involved in axon guid-
ance and modelling of neural connections; and c) pathways with a role in synaptic neurotransmission, such as 
WNT5A-dependent internalization of FZD4 and disinhibition of SNARE formation. Targeted analysis of genes 
involved in neurotransmitter release and transport further supports the possibility of association between drug 
response and genes NSG1 and DLG2. In summary, our approach to utilise whole genome sequencing on subjects 
with extreme response phenotypes is a feasible route to generate plausible hypotheses for investigating the genetic 
factors underlying drug response variability in cases of pharmaco-resistant epilepsy.  
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The advent of next-generation sequencing (NGS) has made possible the routine reconstruction of an individual’s 
genetic variation profile across their whole genome1,2, while the introduction of NGS to clinical practice brings 
closer the promise of personalised medicine for diagnostic sensitivity and therapeutic precision3,4. In the context 
of pharmacogenomics, whole exome and genome sequencing combined with appropriate bioinformatics and sta-
tistical analysis has the potential to identify variants that correlate with clinical response to specific drugs, in a 
comprehensive, high-resolution and unbiased manner5–12, i.e. without the need for a prior hypothesis regarding 
the type (e.g. common or rare), location or distribution of genomic polymorphisms across the whole extent of the 
genome. We employed whole genome sequencing to better understand response variability to the antiepileptic 
drug levetiracetam (LEV), a third-generation first-line drug for the treatment of both focal and generalised epi-
lepsies, for which high variability of clinical response is observed. 
 
Experiments in mice show that SV2A, but not its paralogs SV2B and SV2C, is the molecular target of LEV13. SV2A 
is a synaptic glycoprotein with widespread distribution in the brain14 and a crucial role in synaptic vesicle exocy-
tosis15. Mice deficient in SV2 functionality exhibit severe seizures with a concomitant reduction in (inhibitory) 
GABAergic neurotransmission16 and an abnormal presynaptic accumulation of calcium leading to increased neu-
rotransmitter release17. LEV inhibits presynaptic calcium channels18 and calcium-dependent vesicle exocytosis19, 
and it reverses synaptic deficits due to overexpression of SV2A20. However, its exact mechanism of action as an 
antiepileptic drug is not understood.  
 
It is natural to hypothesize that LEV may act by modifying deregulated SV2A-dependent neurotransmission and 
that variability in SV2A functionality may explain differential responsiveness to treatment with LEV. This view 
is supported by reports showing that partial loss of SV2A functionality is linked to decreased LEV efficacy in 
several mice seizure models21, or that levels of SV2A expression in tumour and peri-tumoral tissue predicts clin-
ical response to LEV in patients with glioma22. However, neither common nor rare polymorphisms in SV2A (in-
cluding polymorphisms overlapping its binding site with LEV) are associated with clinical response to the drug, 
based on targeted sequencing approaches23,24. Any role of genetic variation (either rare or common) in other ge-
nomic loci as potential predictors of LEV efficacy remains to be elucidated. 
 
We analysed whole genome sequencing (WGS) data from 99 people with epilepsy, classified as extreme respond-
ers (n=72) or non-responders to LEV (n=27), aiming to explore the genetic differences between the two groups 
and to identify rare or common polymorphisms that may be predictive of the response/non response phenotype. 
Using whole genome sequencing (instead of targeted sequencing or genome-wide SNP arrays) facilitates the 
search for genetic predictors to LEV in a complete, high-resolution and unbiased manner. At the same time, a 
targeted search for genomic features associated with response to LEV is still possible. Here, we identified common 
polymorphisms which collectively predict a substantial fraction of clinical response to the drug in our cohort of 
patients with epilepsy. Furthermore, analysis of groups of low-frequency variants highlights significant associa-
tions between response to LEV and genes involved in synaptic neurotransmission, axon guidance and modelling 




Sample acquisition and whole genome sequencing 
The study was approved by the relevant local ethics committee. Patients provided written informed consent, or in 
the case of people unable to provide consent, assent was obtained from parents or guardians as permitted within 
the approved protocol.  
 
Ninety-nine unrelated adults with a range of types of epilepsy were recruited from the National Hospital for Neu-
rology and Neurosurgery. Non-responders (n=27; ~27%) were defined as patients who had failed to respond to at 
least two of the currently established epilepsy treatments and had not responded to maximum tolerated doses of 
levetiracetam used for at least 12 months. Extreme responders were defined as patients who became seizure-free 
for at least 12 months after initiation of levetiracetam and who had not previously responded to at least three 
appropriately chosen and used antiepileptic drugs (AEDs; n=72; ~73%).  
 
Samples from the above subjects were sequenced at the Oxford Genomics Centre using the HiSeq2500 platform, 
v3 chemistry and the 100bp paired-end read format (Illumina, San Diego, CA). Sequencing was performed across 
2.3 lanes per sample at depth 30X (Figure 1).  
 
Bioinformatics analysis 
Reads were mapped to hs37d5 using BWA25 and duplicate reads were removed using the MarkDuplicates option 
from the Picard toolkit26 all with default options. Variants were called simultaneously across all 99 samples with 
Platypus27 v0.7.9.3 resulting in a multi-sample VCF file. Read alignments were checked visually using the Inte-
grative Genomics Viewer v2.3.528. 
 
In total, ~20M variants were called across all samples (Figure 1). We excluded variants in multi-allelic loci or in 
sex chromosomes, variants with FILTER flag other than PASS, and variants in homopolymers with running length 
larger than 8 base pairs (HP>8). We excluded genotypes of low quality (PHRED score GQ<20), and with less 
than 10 reads covering the variant location (DP<10). We also excluded variants not in Hardy-Weinberg Equilib-
rium29 (p-value less than 10-6) and with missing genotypes in more than 2 individuals (~2%). Furthermore, we 
excluded variants in low complexity regions30, in poor mappability regions31, in segmental duplications32 and in 
the top 1% most variable genes according to Ingenuity IVA33. On the remaining ~8.4M variants, we conducted 
principal component analysis using the prcomp function in R34 and we identified 7 outlier samples, which were 
excluded from further analysis (Figure 2A,B). We did not find evidence of association between clinical response 
and sex in the remaining 92 patients (Figure 2C). The filtered data were annotated using the Ensembl Variant 
Effect Predictor35 software v90.5 with allele frequency annotations provided by gnomAD r2.0.136 and variant IDs 
provided by dbSNP37 build 150. Overall, we reviewed ~3.9M common variants (MAF>5%), and ~4M low-fre-




We conducted single-variant tests on common variants, and gene- and pathway-based tests on low-frequency and 
rare variants (Figure 1). In the case of common variants, we calculated SNP-specific p-values by applying a two-
tailed Fisher’s exact test on each common variant (Figure 3A). In a pre-specified second stage, we selected a small 
subset of variants by using all variants with p-value less than the conventional suggestive genome-wide signifi-
cance threshold of 10-5 (n=23 variants; Table S1 and Figure 3A, white dots) as predictors (along with sex) in a 
penalised logistic regression model38 (known as the LASSO; Figure 3B). An optimal penalisation parameter was 
estimated using leave-one-out cross-validation. This resulted in the selection of 10 out of 23 variants with maximal 
predictive power (Figure 3B, red dots). An additional selection step was applied by filtering out all variants 
(among those selected by the LASSO in the previous step) that had non-protein-coding gene annotation or were 
annotated as intergenic. This resulted in the final selection of 5 variants with protein-coding gene annotations 
(Table S1). The reason for this final selection step was to avoid overfitting during the downstream analyses de-
scribed below and because the selection of variants in protein-coding genes (instead of non-protein coding or 
intergenic variants) facilitates the subsequent investigation of their possible biological relevance. After variant 
selection, we conducted an analysis of deviance by examining a series of logistic regression models using response 
to LEV as the dependent variable (Table S2). The BASIC model includes, besides the intercept, a single predictor, 
sex. The FULL model includes in addition the genotypes of the previously selected variants. A number of inter-
mediate models are simple extensions of the BASIC model through the inclusion of just one of these variants. 
Finally, we calculated the predictive power of the FULL model using leave-one-out cross-validation and the ac-
curacy (ACC), sensitivity (TPR), specificity (TNR), positive (PPV) and negative (NPV) predictive values, and 
Matthews correlation coefficient (MCC) as metrics of predictive power. For completeness, we also conducted 
auxiliary statistical analyses, which included a genome-wide Bayesian analysis and calculation of bespoke ge-
nome-wide significance thresholds (see Supplementary Material for more details). 
 
In the case of rare and low-frequency variants, we first calculated a variant-specific p-value by applying a two-
tailed Fisher’s exact test, as in the case of the common variants. Subsequently, we aggregated all variant-specific 
p-values in a gene- or pathway-specific statistic using an appropriately corrected Fisher’s product method39 (see 
Supplementary Material), which takes into account the effective number of independent variants in a group of 
variants, thus correcting for correlations between variants in the same gene or pathway. The resulting statistic was 
used to calculate a gene- (Table S3) or pathway-specific (Table S4) p-value for testing the null hypothesis that 
none of the variants in the gene/pathway are associated with response to LEV, against the alternative hypothesis 
that at least one variant in the set is associated with response to LEV. P-values were corrected for multiple hy-
pothesis testing across all genes or pathways using Sidak’s method. 
 
Finally, we conducted a targeted analysis of common and rare variants in a set of genes implicated in neurotrans-
mitter transport and release and in a set of genes associated with epilepsy (Table S5). For the common variants, 
we tested each variant individually using a two-tailed Fisher’s exact test of independence, as above. We used 
Sidak’s method for multiplicity correction across all genes in each of the two sets. The effective number of inde-
pendent variants was estimated by first calculating a gene-specific estimate of the number of independent variants 
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using four alternative methods39–43, followed by summing these estimates over all genes. All four methods re-
turned consistent results. For the rare variants, we calculated gene-specific p-values followed by multiplicity cor-
rection using the Sidak method, as before. 
 
More details on the statistical analysis are given in the Supplementary Material. 
 
RESULTS 
Common polymorphisms in genes SPNS3, HDC, NSG1, MDGA2 and RASGEF1C predict clinical 
response to LEV in our cohort with overall accuracy ~91% 
We constructed a statistical model that utilises common genomic variation to predict response to LEV in our 
cohort. Towards this aim, we first assessed the significance of association between each SNP and response to 
LEV (Figure 3A). The smallest SNP-specific p-value calculated at this stage was 1.6×10-7, i.e. no p-value crossed 
the conventional genome-wide significance threshold of 5×10-8 (Table S1). This was followed by a principled 
SNP selection process (see Methods) to identify a minimal set of highly predictive variants (n=5 variants). These 
are located in the protein-coding genes SPNS3, HDC, NSG1, MDGA2 and RASGEF1C, as indicated by the non-
zero coefficients in Figure 1B. Variants with non-zero coefficients in the non-coding genes RP11-284F21.8, 
RP11-446J8.1 and RP11-650J17.1, as well as two intergenic variants in chromosome 15, were not included, in 
order to keep the model small and avoid overfitting (see Methods for rationale). All these variants are listed in 
Supplementary Table S1.  
 
At the next stage, we conducted an analysis of deviance on the polymorphisms identified in the previous step (see 
Methods and Table S2). We found that the inclusion of these SNPs in a logistic regression model reduces the 
residual deviance from ~107 (BASIC model) to ~28 (FULL model), thus significantly improving the goodness of 
fit (p-value=1.15×10-15 based on a χ2 test) of the model to the data. The fraction of explained deviance in the data 
was assessed using a pseudo-R2 metric, the adjusted D2, as described in Guisan & Zimmermann44. The BASIC 
and FULL models have an adjusted D2 equal to 1% and 73%, respectively, which implies that the identified 
variants in genes SPNS3, HDC, NSG1, MDGA2 and RASGEF1C collectively explain ~72% of the total deviance 
(Table S2). When considering just a single gene as predictor (as in any of the intermediate models between BASIC 
and FULL), the improvement in model fit is significant (as indicated by the low p-values). Furthermore, the pro-
portion of explained deviance by SNPs in each gene ranges between 10% (HDC) and 21% (SPNS3), as inferred 
by comparing the adjusted D2 value for each of the intermediate models to the adjusted D2 value of the BASIC 
model.  
 
Subsequently, we assessed the predictive power of the FULL model using leave-one-out cross-validation. In brief, 
this involves fitting the FULL model in all but one subjects and predicting the response phenotype of the held-out 
subject using the fitted model. This process of model fitting and prediction is repeated until all 92 subjects have 
been used for prediction. We found that the FULL model correctly predicts clinical response to LEV in 62 re-
sponders and 22 non-responders, which corresponds to ~94% sensitivity (TPR) and positive predictive value 
(PPV), ~85% specificity (TNR) and negative predictive value (NPV), and ~91% overall predictive accuracy 
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(ACC). The Matthews correlation coefficient (MCC), a balanced performance metric for binary classifiers even 
when the two classes are of very different size, was equal to ~79%.  
 
Local genomic structure near the identified variants and possible biological relevance 
For gene NSG1 on chromosome 4, three highly correlated SNPs (rs7695197, rs3981 and rs12641832) are located 
~5kb upstream of the gene, less than 3kb upstream or downstream of transcription factor binding sites (TFBS) 
and DNaseI hypersensitivity sites (DHS), and less than 5kb upstream of a small cluster of conserved elements 
(CE; Figure 4A). The odds ratio for a recessive model (with respect to the ALT allele) is ~23 times in favour of 
the non-responders, while the corresponding odds ratio for a dominant model is ~2.7 (see Table S1 for the number 
of homozygous/heterozygous cases in each group). In other words, non-responders to LEV are ~23 times more 
likely to be homozygous for the alternative allele than responders. NSG1 (Neuronal Vesicle Trafficking Associ-
ated 1) is abundantly expressed in the brain45,46 and it plays a role in synaptic neurotransmission and plasticity due 
to its involvement in recycling and trafficking of receptors, such as the glutamate receptor AMPA, the amyloid 
precursor protein (APP), and the L1 cell adhesion molecule (L1CAM)47. 
 
The intronic variant rs34570575 in gene RASGEF1C on chromosome 5 overlaps a DHS and it is located ~5kb 
upstream of a TFBS and a cluster of CE (Figure 4B). The odds ratio for a dominant model of inheritance (with 
respect to the ALT allele) is slightly higher than that of a recessive model (~9.5 and ~8, respectively; Table S1). 
RASGEF1C (RAS guanyl-nucleotide exchange factor domain family member 1C) is abundantly expressed in the 
brain45,46. It belongs to a family of proteins containing the RASGEF domain, which regulates the GTPase activity 
of RAS-like proteins. These comprise a superfamily of membrane-associated signalling molecules involved in a 
variety of essential cellular processes, including vesicle trafficking and synaptic function48–50.  
 
In gene MDGA2 on chromosome 14, rs1952220 is an intronic variant, less than ~4kb from CE, TFBS and DHS 
(Figure 4C). The odds ratios for recessive and dominant models (with respect to the ALT allele) are 0.11 and 0.61 
in favour of the non-responders, respectively, suggesting a recessive model where non-responders to LEV are ~9 
times less likely to be homozygous for the alternative allele than responders (Table S1). The MDGA2 (MAM 
Domain Containing Glycosylphosphatidylinositol Anchor 2) mRNA is expressed in the cerebral cortex45,46. 
MDGAs are Ig superfamily cell adhesion molecules that contribute to the radial migration of cortical neurons 
during early neural development. They play an important, neuroglin-2-dependent role in controlling the function 
of inhibitory synapses, and they have been associated with autism spectrum disorders and schizophrenia51,52.  
  
In gene HDC on chromosome 15, rs7182203 is an intronic variant that overlaps a TFBS and a DHS, and it is 
within 5kb of upstream or downstream CE (Figure 4D). From Table S1, the odds ratios for recessive and dominant 
models (with respect to the ALT allele) are 1.1 and 0.12 in favour of the non-responders, respectively. This implies 
that patients that respond to LEV are ~8 times more likely to be homozygous or heterozygous for the alternative 
allele in comparison to non-responders. HDC (histidine decarboxylase) is expressed in the brain45,46, and it catal-
yses the synthesis of histamine, which is implicated, among others, in neurotransmission and smooth muscle tone. 
Elevated levels of histamine in the brain appear to suppress seizures and confer neuroprotection, thus antiepileptic 
agents that boost the levels of histamine in the brain may act by increasing HDC activity53. Furthermore, HDC 
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has been linked to the pathogenesis of Tourette’s syndrome54. Interestingly, LEV has been used for the treatment 
of Tourette’s syndrome, although its efficacy has not been established55–57. 
 
Finally, in gene SPNS3 on chromosome 17, the intronic variants rs2047231, rs2047232 and rs2047233 overlap a 
DHS and a cluster of CE, and they are located within 5kb of upstream or downstream TFBS (Figure 4E). From 
Table S1, the odds ratio for a recessive model (with respect to the ALT allele) ranges among these three SNPs 
between 0.07 and 0.09 in favour of non-responders. This implies that patients responding to LEV are between 
~11 and ~14 times more likely to be homozygous for the alternative allele than non-responders. SPNS3 (a putative 
sphingolipid transporter 3) is expressed in the cerebral cortex45,46. Both SPNS3 and SV2A, the known target of 
LEV, are atypical solute carrier (SLC) transporters. They belong to the Major Facilitator Superfamily (MFS) of 
membrane transporters, and they share a common structure consisting of 12 transmembrane segments, which is 
necessary for optimal transporter activity58,59. 
 
Tests on sets of low frequency variants (MAF<5%) 
Next, we studied variants with MAF<5%, i.e. low-frequency and rare variants. Among the approximately 4M 
variants with MAF<5%, we focused on the top 5% genotypically most variable variants across all 92 samples in 
our cohort. These included ~182K variants with MAF between 0.003% and 5%. A common strategy for increasing 
statistical power when studying low-frequency and rare variants is to analyse sets of variants, instead of individual 
variants. Therefore, we examined gene- and pathway-based sets of variants (see Methods).  
 
Gene-based tests indicate that low-frequency variants in genes PRKCB, DLG2, FILIP1, SEMA6D and 
LINC01090 are associated with response to LEV 
We conducted 19,824 gene-based tests, which is the number of genes harbouring at least one of the ~182K low-
frequency and rare variants in our data. We found that four protein-coding genes (PRKCB, DLG2, FILIP1 and 
SEMA6D) and a long intergenic non-protein-coding RNA (LINC1090) had a Family-Wise Error Rate (FWER) 
less than 10%, and they were kept for further study (Table S3 and Figure 5). 
 
The top hit, PRKCB, encodes a protein kinase C, a family of serine- and threonine-specific protein kinases, which 
can be activated by calcium and second messenger diacylglycerol47. There are 78 variants in PRKCB with MAF 
between 2.2% and 4.9%. Forty-five of them have p-values less than 0.05 and they aggregate towards the 5’ end 
of the gene (Figure 5A). Associated Reactome pathways are glutamate binding, activation of AMPA receptors 
and synaptic plasticity60. PRKCB is implicated in the trafficking of GluR2-containing AMPA receptors60. It is 
known that fast synaptic excitation relevant to epilepsy is mediated mainly by AMPA receptors, thus rendering 
the latter potential targets of antiepileptic treatment61. There is evidence suggesting that LEV interacts with AMPA 
receptors62 and that its antiepileptic action is mediated by inhibiting glutamatergic neurotransmission through 
presynaptic calcium channels63, but the precise molecular mechanism that mediates its action remains unclear. 
 
A second hit of interest, DLG2, encodes a membrane-associated guanylate kinase, which is implicated in the 
clustering of receptors (including NMDARs), ion channels, and associated signalling proteins at postsynaptic sites 
of excitatory synapses47. We found 208 variants in this gene with MAF between 0.96% and 4.97%, 53 of which 
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have p-values less than 0.05 (Figure 5B). A related Reactome pathway is protein-protein interactions at synap-
ses60. There is evidence supporting the role of NMDARs in epilepsy, and as a potential therapeutic target of 
antiepileptic drugs, including LEV64. It is possible that LEV blocks epileptiform bursting induced by NMDA in 
vitro without affecting normal synaptic transmission65 and that it inhibits NMDA-dependent excitatory postsyn-
aptic currents63, although its precise molecular mechanism of action remains unclear. 
 
Among the remaining three hits (Figure 5C-E), FILIP1 includes 12 variants (11 with p-values less than 0.01) with 
MAF between 1.8% and 5%, SEMA6D has 41 variants (17 with p-values less than 0.05) with MAF between 1.9% 
and 5% and LINC01090 harbours 35 variants (18 with p-values less than 0.01) with MAF between 1.7% and 5%. 
FILIP1 encodes a protein that stimulates filamin A degradation, which may regulate cortical neuron migration, 
dendritic spine morphology, and normal excitatory signalling47. SEMA6D encodes a transmembrane semaphorin, 
a class of proteins involved in axon guidance, and maintenance and remodelling of neural connections47. Finally, 
LINC01090 is transcribed into a long intergenic non-protein-coding RNA47, which is associated with post-trau-
matic stress disorder66. 
 
Pathway-based tests indicate that associations between response to LEV and Reactome pathways are driven 
mainly by low-frequency variants in gene PRKCB  
We conducted tests using gene sets, instead of single genes, as the organisational unit for grouping individual 
variants together. We have used all pathways from Reactome, a curated, peer-reviewed database of interacting 
signalling and metabolic molecules, which are organised into groups of higher order structures (pathways) with 
well-defined biological relevance60. In total, we considered 2,028 pathways, of which 1,979 harboured at least 
one of the ~182K low-frequency highly-variable variants in our data. Among these, we identified six pathways 
with FWER<5% and one pathway with FWER<10% (Table S4). 
 
The top hit is activation of NF-kappaB (nuclear factor kappaB) in B cells. NF-kappaB is a ubiquitous transcription 
factor, which is instrumental in gene regulation relevant to cell death and survival and to the immune system’s 
response to inflammation. The next hit is WNT5A-dependent internalization of FZD4. WNT5A regulates multiple 
intracellular signalling cascades via internalisation of its receptors. These include FZD4, a member of the frizzled 
gene family, which encode seven-transmembrane domain proteins47. Importantly, the WNT5A-dependent uptake 
of FZD4 occurs in a clathrin-dependent manner67. Clathrins are adaptor proteins, which are essential in the for-
mations of synaptic vesicles, and which are known to interact with SV2A, the molecular target of LEV68.  
 
Another interesting pathway is disinhibition of SNARE formation. SNARE is a family of proteins, which are 
important components of the mechanism responsible for membrane fusion, thus playing an important role in 
docking of synaptic vesicles with the presynaptic membrane, and neurotransmitter release. It is known that SV2A, 
the target of LEV, regulates the formation of SNARE complexes: kindling epileptogenesis triggers the long-term 
accumulation of both SNARE and SV2A in the ipsilateral hippocampus, a molecular process which is reversed 
by LEV69.  
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Next, we asked which genes underlie these findings. In total, in these pathways, there are 108 genes harbouring 
low-frequency mutations (Table S4). In Figure 6, we illustrate these genes, as well as their pathway membership. 
PRKCB is mutated in all but the least significant pathway with FWER<10%, followed by its paralog, PRCKA, 
which is mutated in three pathways (central panel). The remaining genes are mutated in only 1 or 2 pathways. 
Furthermore, PRKCB and PRKCA harbour the largest number of low-frequency mutations, along with RUNX1 
(top panel). However, in PRKCB, more than half of these mutations have p-values less than 0.05 (see also Table 
S3) leading to a low gene- and pathway-based p-value (Tables S3 and S4), while only a very small proportion of 
mutations in PRKCA and RUNX1 have p-values less than 0.05. Among the other highly mutated genes, LPR6 and 
IKBKB also harbour a large proportion of mutations with low p-values, but they participate in only 1 and 2 path-
ways, respectively. We conclude that the significant associations in Table S4 are driven mainly by PRKCB in all 
but the least significant pathway with FWER<10%. Associations in this last pathway (disassembly of the destruc-
tion complex and recruitment of AXIN to the membrane) are driven mainly by LRP6, a transmembrane low density 
lipoprotein (LDL) receptor47. Neuronal LRP6-mediated Wnt signalling is critical for synaptic function and cogni-
tion70,71. 
 
Targeted analysis of genes implicated in neurotransmitter transport and release highlights the 
previously identified genes NSG1 and DLG2, but not SV2A, SV2B or SV2C  
Whole genome sequencing permits focused analysis of identified sets of variants, in addition to unbiased analysis 
over the whole genome. Furthermore, by testing only a small subset of variants, we can ameliorate the effect of 
multiple hypothesis testing, thus increasing the power of statistical analysis. We conducted targeted analysis of 
common and rare variants on a set of 294 genes implicated in neurotransmitter transport and release (Table S5). 
These genes (SYNAPTIC) were identified based on their Gene Ontology72 terms and they included SV2A and its 
paralogs, SV2B and SV2C. In addition, we tested all 402 high-confidence (i.e. “green”) genes (EPILEPSY) in the 
genetic epilepsy syndromes panel v1.35 provided by Genomics England73 (Table S5).  
 
In the case of SYNAPTIC genes, which harboured ~51K common variants, we found evidence of association 
with response to LEV in the previously identified gene NSG1 at a FWER<5% or <10%, depending on the meth-
odology used for calculating the effective number of independent tests (Table S5). Furthermore, when examining 
the ~2.6K rare variants found in SYNAPTIC genes, DLG2 was found associated with response to LEV at a 
FWER<0.1% (Table S5). This is not surprising, since DLG2 was also found associated with LEV response in the 
previously conducted gene-based tests. We did not find any evidence of association between LEV response and 
SV2A or its paralogs, SV2B and SV2C, using either SNP- or gene-based tests. Furthermore, we did not find any 
evidence of association between ~66K common variants in EPILEPSY genes and response to LEV or between 
~3.7K rare variants in the same genes and response to LEV at a FWER<10% (Table S5). 
 
DISCUSSION 
Although the anticonvulsant properties of the prominent antiepileptic drug LEV have been linked to the activity 
levels of its molecular target, the synaptic glycoprotein SV2A21,22, targeted sequencing did not reveal any associ-
ations between common24 or rare23 variation in this gene and LEV efficacy. This leaves open the question as to 
whether genetic variation is a component of response variability and, if so, the identity of the genomic variants 
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underlying clinical response to LEV. In the present study, we followed a whole genome sequencing approach in 
an unbiased search of genomic polymorphisms that underlie clinical response to this drug. 
 
According to one possible hypothesis for explaining variability in drug response, one or more common polymor-
phisms occur with different frequencies between responders and non-responders. Our analysis indicates that com-
mon polymorphisms in genes NSG1, HDC, MDGA2, RASGEF1C and SPNS3 collectively predict clinical response 
to LEV in our cohort with overall accuracy ~91%. These genes are attractive candidates, since the first four are 
potentially implicated in synaptic neurotransmission, while the fourth is a transmembrane transporter protein ho-
mologous to SV2A. 
 
A second hypothesis asserts that multiple rare variants act synergistically to influence a patient’s response to the 
drug. Our analysis showed that groups of low-frequency variants in genes PRKCB, DLG2, FILIP1 and SEMA6D, 
and in pathways involving PRKCB (and LRP6) demonstrate significant associations with the response/non-re-
sponse phenotype.  
 
From a neurophysiological perspective, there are three major, not mutually exclusive hypotheses for explaining 
pharmaco-resistant epilepsy74. First, the drug target hypothesis postulates that alterations in the activity of the 
molecular target of the drug (e.g. due to genomic polymorphisms coding for the drug-target binding site) result in 
reduced drug efficacy. Our analysis did not provide any evidence that SV2A or its paralogs (SV2B and SV2C) are 
associated with response to LEV, in agreement with previous studies23,24 
 
Second, the drug transporter hypothesis states that reduced efficacy of antiepileptic drugs are due to low concen-
tration of the drug at its target site due to over-active efflux drug transporters. A common intronic polymorphism 
in SPNS3, a gene homologous to SV2A, may be of interest in relation to this hypothesis. Both SPNS3 and SV2A 
(and its paralogs) are structurally similar to the solute carrier family 22 (SLC22), a large family of transmembrane 
drug transporters. It should, however, be emphasised that homology (as established through structural similarity) 
is not definitive proof of biological relevance.  
 
Finally, the intrinsic severity hypothesis postulates that severe epilepsy (manifested, for example, as high-fre-
quency seizures) is linked to reduced response to antiepileptic drugs. Neurophysiological processes that are pro-
posed to underlie the severity of epilepsy include neuroinflammation, aberrations in synaptic neurotransmission, 
and restructuring of neural networks75. Our analysis has identified common and low-frequency polymorphisms in 
genes and pathways, which are putatively related to these processes; for example, genes HDC, NSG1, MDGA2, 
RASGEF1C, PRKCB and DLG2 (synaptic neurotransmission) and genes FILIP1 and SEMA6D (restructuring of 
neural networks). 
 
Whilst highlighting the approaches now available through the advent of NGS technologies, the findings in the 
present study need independent replication and potentially functional validation to confirm their role in determin-
ing response to LEV. Furthermore, we expect that the rapidly decreasing cost of WGS will allow conducting 
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similar studies with a larger sample size in the near future. Nevertheless, our approach of using extremes of re-
sponse is a pragmatic way to derive hypotheses for experimental testing. It is interesting to postulate what the 
remaining factors are that determine response to LEV. Drug response is likely to be a complex interaction of many 
factors, including interacting genetic factors, which should be explored through polygenic risk score analysis and 
integrative analysis of multiple data modalities utilizing machine learning approaches. 
 
In summary, we have identified common and low-frequency variants in genes and pathways, which may influence 
clinical response to LEV in a cohort of 99 patients with epilepsy. We conclude that whole genome sequencing 




1. Goodwin, S., McPherson, J. D. & McCombie, W. R. Coming of age: ten years of next-generation sequencing technologies. Nat Rev 
Genet 17, 333–351 (2016). 
2. Metzker, M. L. Sequencing technologies - the next generation. Nat Rev Genet 11, 31–46 (2010). 
3. Taylor, J. C. et al. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat. Genet. 47, 717–
726 (2015). 
4. Ashley, E. A. Towards precision medicine. Nat Rev Genet 17, 507–522 (2016). 
5. Choi, J., Tantisira, K. G. & Duan, Q. L. Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic 
genes. Pharmacogenomics J (2018). 
6. Chua, E. W. et al. Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopu-
rine producers. Pharmacogenomics J 15, 414–421 (2015). 
7. Katsila, T. & Patrinos, G. P. Whole genome sequencing in pharmacogenomics. Front Pharmacol 6, 61 (2015). 
8. Mak, A. C. Y. et al. Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. Am J 
Respir Crit Care Med 197, 1552–1564 (2018). 
9. Mizzi, C. et al. Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics 15, 1223–1234 (2014). 
10. Price, M. J. et al. FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL 
GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION 
AND FUNCTIONAL TESTING (GIFT) EXOME STUDY. J Am Coll Cardiol 59, E9 (2018). 
11. Weeke, P. et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long 
QT interval syndrome. J Am Coll Cardiol 63, 1430–1437 (2014). 
12. Yang, G. et al. SIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association 
Analysis. J Bone Min. Res 33, 91–98 (2018). 
13. Lynch, B. A. et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U 
A 101, 9861–9866 (2004). 
14. Bajjalieh, S. M., Frantz, G. D., Weimann, J. M., McConnell, S. K. & Scheller, R. H. Differential expression of synaptic vesicle protein 2 
(SV2) isoforms. J Neurosci 14, 5223–5235 (1994). 
15. Chang, W.-P. & Südhof, T. C. SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. J Neurosci 29, 883–897 
(2009). 
16. Crowder, K. M. et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U A 96, 
15268–15273 (1999). 
17. Janz, R., Goda, Y., Geppert, M., Missler, M. & Südhof, T. C. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmit-
ter release. Neuron 24, 1003–1016 (1999). 
18. Vogl, C., Mochida, S., Wolff, C., Whalley, B. J. & Stephens, G. J. The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits 
presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol 82, 199–208 (2012). 
19. Harada, S. et al. Inhibition of Ca(2+)-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs. 
Eur J Pharmacol 721, 185–192 (2013). 
20. Nowack, A. et al. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS One 6, e29560 (2011). 
 13 
21. Kaminski, R. M. et al. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetirace-
tam. Epilepsia 50, 1729–1740 (2009). 
22. de Groot, M., Aronica, E., Heimans, J. J. & Reijneveld, J. C. Synaptic vesicle protein 2A predicts response to levetiracetam in patients 
with glioma. Neurology 77, 532–539 (2011). 
23. Dibbens, L. M. et al. Rare protein sequence variation in SV2A gene does not affect response to levetiracetam. Epilepsy Res 101, 277–
279 (2012). 
24. Lynch, J. M. et al. No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Res 83, 
44–51 (2009). 
25. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinforma. Oxf. Engl. 26, 589–595 
(2010). 
26. Picard Tools - By Broad Institute. Available at: https://broadinstitute.github.io/picard/. (Accessed: 5th April 2019) 
27. Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applica-
tions. Nat. Genet. 46, 912–918 (2014). 
28. Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualiza-
tion and exploration. Brief. Bioinform. 14, 178–192 (2013). 
29. Wigginton, J. E., Cutler, D. J. & Abecasis, G. R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76, 887–893 
(2005). 
30. Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics 30, 2843–2851 (2014). 
31. ARGOS. Available at: http://www.cibiv.at/~niko/argos/#tracks. (Accessed: 31st May 2019) 
32. UCSC Genome Browser Home. Available at: https://genome.ucsc.edu/index.html. (Accessed: 31st May 2019) 
33. Ingenuity Variant Analysis. QIAGEN Bioinformatics 
34. R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2019). 
35. McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016). 
36. Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance 
across human protein-coding genes. bioRxiv 531210 (2019). doi:10.1101/531210 
37. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311 (2001). 
38. Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw 33, 
1–22 (2010). 
39. Galwey, N. W. A new measure of the effective number of tests, a practical tool for comparing families of non-independent significance 
tests. Genet Epidemiol 33, 559–568 (2009). 
40. Cheverud, J. M. A simple correction for multiple comparisons in interval mapping genome scans. Heredity 87, 52–58 (2001). 
41. Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. 
Am J Hum Genet 74, 765–769 (2004). 
42. Li, J. & Ji, L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221–227 
(2005). 
43. Gao, X., Starmer, J. & Martin, E. R. A multiple testing correction method for genetic association studies using correlated single nucleo-
tide polymorphisms. Genet Epidemiol 32, 361–369 (2008). 
44. Guisan, A. & Zimmermann, N. E. Predictive habitat distribution models in ecology. Ecol Modell 135, 147–186 (2000). 
 14 
45. Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015). 
46. The Human Protein Atlas. Available at: https://www.proteinatlas.org/. (Accessed: 3rd April 2019) 
47. Stelzer, G. et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr. Protoc. Bioinforma. 54, 
1.30.1-1.30.33 (2016). 
48. Brambilla, R. et al. A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 390, 281–286 (1997). 
49. Ye, B. et al. GRASP-1: A Neuronal RasGEF Associated with the AMPA Receptor/GRIP Complex. Neuron 26, 603–617 (2000). 
50. Stornetta, R. L. & Zhu, J. J. Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders. Neurosci. Rev. J. Bringing Neurobiol. 
Neurol. Psychiatry 17, 54–78 (2011). 
51. Pettem, K. L., Yokomaku, D., Takahashi, H., Ge, Y. & Craig, A. M. Interaction between autism-linked MDGAs and neuroligins sup-
presses inhibitory synapse development. J Cell Biol 200, 321–336 (2013). 
52. Lee, K. et al. MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development. Proc. 
Natl. Acad. Sci. 110, 336–341 (2013). 
53. Bhowmik, M., Khanam, R. & Vohora, D. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic 
consideration of recent progress and perspectives. Br J Pharmacol 167, 1398–1414 (2012). 
54. Baldan, L. C. et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 81, 77–
90 (2014). 
55. Awaad, Y., Michon, A. M. & Minarik, S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov 
Disord 20, 714–718 (2005). 
56. Hedderick, E. F., Morris, C. M. & Singer, H. S. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. 
Pediatr Neurol 40, 420–425 (2009). 
57. Martínez-Granero, M. A., García-Pérez, A. & Montañes, F. Levetiracetam as an alternative therapy for Tourette syndrome. Neuropsy-
chiatr Treat 6, 309–316 (2010). 
58. Jacobsson, J. A., Haitina, T., Lindblom, J. & Fredriksson, R. Identification of six putative human transporters with structural similarity 
to the drug transporter SLC22 family. Genomics 90, 595–609 (2007). 
59. Perland, E., Bagchi, S., Klaesson, A. & Fredriksson, R. Characteristics of 29 novel atypical solute carriers of major facilitator superfam-
ily type: evolutionary conservation, predicted structure and neuronal co-expression. Open Biol 7, (2017). 
60. Fabregat, A. et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res 46, D649–D655 (2018). 
61. Rogawski, M. A. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl 9–18 (2013). 
62. Carunchio, I., Pieri, M., Ciotti, M. T., Albo, F. & Zona, C. Modulation of AMPA receptors in cultured cortical neurons induced by the 
antiepileptic drug levetiracetam. Epilepsia 48, 654–662 (2007). 
63. Lee, C.-Y., Chen, C.-C. & Liou, H.-H. Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on 
the granule cells of the dentate gyrus. Br J Pharmacol 158, 1753–1762 (2009). 
64. Ghasemi, M. & Schachter, S. C. The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav 22, 617–640 
(2011). 
65. Birnstiel, S., Wülfert, E. & Beck, S. G. Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without 
altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356, 611–618 (1997). 
66. Rappaport, N. et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and struc-
tured search. Nucleic Acids Res. 45, D877–D887 (2017). 
 15 
67. Yu, A. et al. Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity sig-
naling. Dev Cell 12, 129–141 (2007). 
68. Yao, J., Nowack, A., Kensel-Hammes, P., Gardner, R. G. & Bajjalieh, S. M. Cotrafficking of SV2 and synaptotagmin at the synapse. J 
Neurosci 30, 5569–5578 (2010). 
69. Matveeva, E. A., Vanaman, T. C., Whiteheart, S. W. & Slevin, J. T. Levetiracetam prevents kindling-induced asymmetric accumulation 
of hippocampal 7S SNARE complexes. Epilepsia 49, 1749–1758 (2008). 
70. Liu, C.-C. et al. Deficiency in LRP6-mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alz-
heimer’s Disease. Neuron 84, 63–77 (2014). 
71. Zhou, C.-J., Borello, U., Rubenstein, J. L. R. & Pleasure, S. J. Neuronal production and precursor proliferation defects in the neocortex 
of mice with loss of function in the canonical Wnt signaling pathway. Neuroscience 142, 1119–1131 (2006). 
72. The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330–D338 
(2019). 
73. Genetic epilepsy syndromes (Version 1.35). Available at: https://panelapp.genomicsengland.co.uk/panels/402/. (Accessed: 8th April 
2019) 
74. Schmidt, D. & Löscher, W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 9, 47–52 (2009). 
75. Mirza, N., Vasieva, O., Marson, A. G. & Pirmohamed, M. Exploring the genomic basis of pharmacoresistance in epilepsy: an integra-









Figure 1: Overview of the study. We recruited 99 patients with epilepsy (72 extreme responders and 27 extreme 
non-responders to LEV). After performing WGS, alignment and variant calling, we identified ~20M unfiltered 
variants. After filtering across variants and samples, we ended up with ~3.9M common (MAF>5%) variants and 
~4M low-frequency and rare (MAF<5%) variants across 92 patients. Subsequently, we calculated p-values for 
each common variant using a two-tailed Fisher’s exact test. In the next step, we performed penalised logistic 
regression (LASSO) on all common variants with p-value less than the suggestive genome-wide significance 
threshold of 10-5 (n=23 variants; Supplementary Table S1). This was followed by further selecting variants with 
protein-coding gene annotation. In the last step, we performed analysis of deviance on the finally selected variants 
(n=5 variants) and we calculated their collective predictive accuracy using a cross-validation approach. For com-
pleteness, we also conducted additional auxiliary statistical analyses on the common variants (see Supplementary 
Material). In the case of low-frequency and rare variants, we focused on the top 5% most variable variants in our 
cohort and, by performing gene- and pathway-based tests on these, we identified associations between several 
genes or pathways and clinical response to LEV. Finally, for both common and low-frequency/rare variants, we 
conducted targeted analysis on a panel of epilepsy genes and on genes related to neurotransmitter transport and 
release. 
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Do WGS at 30x1) Align with BWA 
2) Dedup with Picard tools 
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Figure 2: Overview of the WGS data from 99 extreme responders and non-responders to LEV. A) Principal 
component analysis (PCA) of the matrix of genotypes across all samples and variants. The first two principal 
components are illustrated. Seven samples appear as outliers. B) Repeating the PCA after removing the seven 
outliers identified in (A) indicates lack of any stratification (e.g. due to population structure) in the data. C) Num-
ber of male and female subjects among responders and non-responders to LEV. There are almost twice as many 
non-responders among 49 males (n=17), as among 43 females (n=9) in the data. A two-tailed Fisher’s exact test 
of independence indicates that this difference is not statistically significant (odds ratio: 1.99; 95% CI: 0.72-5.86; 
p-value: 0.17). D) Consequences of all variants identified by WGS. Most variants are intronic, intergenic, or 
located immediately upstream or downstream of protein-coding genes. E) Minor allele frequencies (MAF) of all 
variants identified by WGS. A cut-off of 5% was chosen to discriminate between common and low-frequency or 



























































































































































































































































Figure 3: Genome-wide selection of a minimal set of common (MAF>5%) variants with maximal predictive 
power. A) Manhattan plot summarising SNP-based tests using a two-tailed Fisher’s exact test of independence. 
All variants with p-values below a suggestive significance threshold of 10-5 are indicated with white circles 
(n=23). B) Summary of variable selection using penalised logistic regression (LASSO). All SNPs crossing the 
suggestive genome-wide significance threshold in (A) were used as predictors. Variants selected through this 
process have non-zero regression coefficients (red dots). Among these, the variants with protein-coding gene 






Figure 4: Local genomic structure near the most significant SNPs in genes NSG1, RASGEF1C, MDGA2, HDC 
and SPNS3. Common variants in these genes are strong predictors of clinical response to LEV in our cohort. SNPs 
crossing the suggestive genome-wide significance threshold of 10-5 are indicated in red.  
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Figure 5: Distribution of rare variants along genes PRKCB, LINC01090, FILIP1, DLG2 and SEMA6D. Based on 
gene-based tests, these genes are significantly associated with response to LEV at a FWER<10%. Rare variants 



































































Figure 6: Summary of the results from Reactome pathway-based tests. In the left panel, pathways are as follows: 
1-Activation of NF-kappaB in B cells; 2-WNT5A-dependent internalization of FZD4; 3-RUNX1 regulates tran-
scription of genes involved in differentiation of myeloid cells; 4-Downstream signalling events of B Cell Receptor 
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destruction complex and recruitment of AXIN to the membrane. Among all genes harbouring the highest number 
of rare variants (RUNX1, PRKCA, PRKCB, LRP6), PRKCB and LRP6 have the highest proportion of rare variants 
with p-values less than 5% (right panel). PRKCB is participating in all but one pathway, with the remaining genes 
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Statistical tests on single variants 
For each common variant (and without assuming a particular genetic model), we constructed a 2x3 contingency 
table of counts, where the rows correspond to responders and non-responders (i.e. controls and cases, respec-
tively), and the columns correspond to Ref/Ref, Ref/Alt and Alt/Alt genotypes. We analysed each such SNP-
specific table using a two-sided Fisher’s exact test of independence, which unlike the χ2 test or the Cohran-
Armitage test for trend under an additive genetic model, is applicable even when the counts in any cell of the 
contingency matrix become very small (e.g. <5).  
 
Auxiliary statistical analysis of single variants 
The genome-wide significance threshold for Type 1 error control due to multiple hypothesis testing is usually set 
at 5×10-8, although it has been suggested1 that this can be relaxed to the less stringent value of 10-7. In this study, 
we have calculated a bespoke significance threshold using the Sidak correction2, in order to keep the family-wise 
error rate (FWER) below α=10%. Specifically, we calculated the significance threshold as !"#$ =
1 − (1 − ))+/-.//, where Neff is the effective number of independent tests. For the calculation of Neff, we split 
each chromosome in a large number of blocks each containing 1000 variants, we calculate Neff in each block, and 
we sum the block-specific Neff values across all chromosomes to obtain a genome-wide estimate of Neff. For the 
actual calculation of Neff in each block, we applied four different methods3–7, all of which operate on the eigen-
values of the correlation matrix of the SNP allele counts. Depending on which method is used, the estimated 
effective number of independent tests/SNPs was approximately equal to 3.6M3,4, 358K5, 259K6 or 161K7, leading 
to genome-wide significance thresholds equal to 3.0×10-8, 3.0×10-7, 4.1×10-7 and 6.6×10-7, respectively (Figure 
S1A; Table S1). Two SNPs (rs7182203 in gene HDC and rs2047231 in gene SPNS3, with p-values 2.43×10-7 and 
1.60×10-7, respectively) are above the three least conservative thresholds5–7, while 21 additional SNPs are above 
a suggestive significance threshold of 10-5 (Figure S1A; Table S6). 
 
We have also applied a Bayesian approach to single-variant association testing, as previously described8 (Figure 
S1B; Table S6). Specifically, we calculated the retrospective posterior probability of association (rPPA) for each 
SNP, which can be directly interpreted as the probability (given the data) that a particular SNP genotype is 
 2 
associated with the phenotype8. For each variant, we write: 0112 = 13 × (1 − 13)5+, where 13 =
67 × 8 × (1 − 8)5+. In the previous expression, PO are the posterior odds, BF is the Bayes factor, and π is the 
prior probability of association for the variant. This prior probability typically falls between 10-4 and 10-6, accord-
ing to Stephens & Balding8. The Bayes factor is equal to: 
67 =
9:0;<=>(?-@, ?-+, ?-B|D, E, F) × 9:0;<=>(?G@, ?G+, ?GB|D, E, F)
9:0;<=>(?@, ?+, ?B|D, E, F)
 
where DirMult(...) is the Dirichlet-Multinomial distribution; nX0, nX1, nX2 are the number of responders (X=R) and 
non-responders (X=N) with Ref/Ref, Ref/Alt and Alt/Alt genotypes, respectively; n0, n1, n2 are the total number 
of patients in each of the above genotype categories; and a, b, c are the prior values of the concentration parameters 
of the Dirichlet-Multinomial distribution. 
 
Although Bayesian approaches are, in principle, applicable regardless of the sample size or the number of variants 
entering the analysis, the calculation of rPPA requires an explicit choice of priors π, a, b and c. Here, we have 
assumed that π=10-4, i.e. we expect a priori that 1 out of every 10K SNPs is truly associated with the phenotype 
(values of rPPA for π equal to 10-5 or 10-6 are also given in Table S6). The priors a, b and c were set either equal 








P, where n=n0+n1+n2 is the total number of 
patients. Both options return similar results, although the empirical prior is less conservative (see Table S6). 
 
Under these explicit prior assumptions, we see that the previously identified variants rs7182203 (HDC) and 
rs2047231 (SPNS3) have rPPA values above 50%, i.e. they are more likely than not to be associated with drug 
response (Figure S1B; Table S6). In addition, the following variants also have an rPPA of more than 50%: 
rs7683388 (HTRA3), rs7695197 (NSG1), rs3981 (NSG1) and rs12641832 (NSG1). 
 
Statistical tests on groups of low-frequency and rare variants 
There are various approaches for testing groups of low-frequency and rare variants9–11. In this study, we followed 
a two-stage approach to group-based tests: a) first, we calculated for each variant in a group a p-value using a 
two-sided Fisher’s exact test, as we did for the common variants, and b) we combined all variant-specific p-values 
in the same group into a group-specific statistic using an appropriately scaled Fisher’s product method, which 








where M is the total number of variants in the group, Meff is the effective number of uncorrelated variants in the 
group, and pi is the variant-specific p-value from Fisher’s test. This statistic can be used to measure the strength 
of evidence that a particular group is associated with the response phenotype, and its distribution is approximated 
by a χ2 distribution with 2×Meff degrees of freedom7, which is used to derive a group-specific p-value, pj. Assum-
ing N total groups, we use the Sidak correction to calculate an adjusted-for-multiplicity p-value, !\]^,^ =
1 − (1 − !^)
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Figure S1: Auxiliary statistical analysis of common (MAF>5%) variants across the whole genome. A) Manhattan 
plot summarising SNP-based tests using a two-tailed Fisher’s exact test of independence. Genome-wide signifi-
cance thresholds (calculated using four different methodologies) are indicated, including a suggestive significance 
threshold of 10-5. Two variants (in red) cross the three least conservative thresholds and they could be considered 
statistically significant with respect to these thresholds. B) Manhattan plot summarising the Bayesian analysis of 
single SNPs. We assumed a prior retrospective probability of association (rPPA) equal to π=10-4. Variants with 




Table S1: Summary of all common variants with p-values less than a suggestive genome-wide significance 
threshold of 10-5 (n=23). Among these, those selected by the LASSO are indicated in green and orange (n=10; 
also see Figure 3B). The variants indicated in green (n=5) have protein-coding genes annotations and they were 
selected for further analysis. Those indicated in orange (n=5) have non-protein-coding gene annotations or are 
annotated as intergenic and they were not selected for further analysis. In order to avoid division by zero in the 
calculation of odds ratios, the matrix of counts for each variant was pre-processed using Lidstone smoothing with 
pseudo-count parameter equal to 1 (i.e. add-one smoothing).  
 
Table S2: Analysis of deviance using seven different logistic regression models of increasing complexity. The 
BASIC model includes only sex and the intercept as predictors. The FULL model includes in addition five SNPs 
from genes SPNS3, HDC, NSG1, RASGEF1C and MDGA2, which were previously selected using penalised lo-
gistic regression. Intermediate models include only sex, the intercept and the SNP harboured by the indicated 
gene. DF: degrees of freedom 
 
Table S3: Summary of gene-based tests. Only genes with FWER<10% are shown. The low-frequency variants 
harboured by these genes are listed in the second spreadsheet. 
 
Table S4: Summary of Reactome pathway-based tests. Only pathways with FWER<10% are shown. The rare 
variants harboured by genes in these pathways are listed in the second spreadsheet. 
 
Table S5: Summary of results from the targeted analysis. We list the results from SNP- and gene-based tests on 
SYNAPTIC and EPILEPSY genes. A complete list of genes in each of these two groups is also provided in the 
last spreadsheet. 
 
Table S6: Summary of results from the auxiliary statistical analysis on common variants. Only variants with a p-
value below a suggestive genome-wide significance threshold of 10-5 are presented. P-values were corrected for 
multiplicity using Sidak’s method and four different estimates of the effective number of independent tests, as 
indicated. The results of Bayesian analysis for different choices of the priors π (10-4, 10-5 and 10-6) and (a, b, c) 
(flat or empirical) are also given. rPPA: retrospective probability of association. FWER: family-wise error rate. 
 
 
Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Dominant model Recessive model
17 4350407 G C G rs2047231 intronic 0.82 0.18 SPNS3 1.60E-07 1 4 60 0 15 10 2.94 7.35 89.71 3.57 57.14 39.29 0.82 0.07
15 50553000 G A A rs7182203 intronic 0.26 0.26 HDC 2.43E-07 21 35 10 22 0 4 31.88 52.17 15.94 79.31 3.45 17.24 0.12 1.10
4 8291102 C T T rs7683388 intronic 0.39 0.39 HTRA3 1.52E-06 26 40 0 13 5 8 39.13 59.42 1.45 48.28 20.69 31.03 0.69 30.60
17 4350182 T C T rs2047233 intronic 0.88 0.12 SPNS3 1.58E-06 0 3 63 0 13 13 1.45 5.80 92.75 3.45 48.28 48.28 0.41 0.07
5 179619074 T C C rs34570575 intronic 0.10 0.10 RASGEF1C 2.87E-06 57 9 0 9 14 2 84.06 14.49 1.45 35.71 53.57 10.71 9.49 8.16
3 37604012 T G G rs9825420 intronic 0.18 0.18 ITGA9 3.32E-06 58 6 2 11 15 0 85.51 10.14 4.35 41.38 55.17 3.45 8.36 0.79
4 4345379 T C C rs7695197 upstream 0.31 0.31 NSG1 3.55E-06 34 31 1 7 8 11 50.72 46.38 2.90 27.59 31.03 41.38 2.70 23.65
4 4346427 G A A rs3981 upstream 0.32 0.32 NSG1 3.84E-06 34 30 1 7 8 11 51.47 45.59 2.94 27.59 31.03 41.38 2.78 23.29
4 4346465 T C C rs12641832 upstream 0.33 0.33 NSG1 3.84E-06 34 30 1 7 8 11 51.47 45.59 2.94 27.59 31.03 41.38 2.78 23.29
4 113961039 G T G rs10015551 intronic, non-coding transcript 0.57 0.43 RP11-650J17.1 4.72E-06 6 29 31 2 23 0 10.14 43.48 46.38 10.71 85.71 3.57 0.94 0.04
15 99100580 A G A rs2311753 intergenic 0.79 0.21 5.49E-06 0 24 42 9 8 9 1.45 36.23 62.32 34.48 31.03 34.48 0.03 0.32
15 99101462 A G A rs2871859 intergenic 0.79 0.21 5.49E-06 0 24 42 9 8 9 1.45 36.23 62.32 34.48 31.03 34.48 0.03 0.32
17 4350367 A G A rs2047232 intronic 0.88 0.12 SPNS3 5.64E-06 0 4 62 0 13 13 1.45 7.25 91.30 3.45 48.28 48.28 0.41 0.09
2 156765630 T C C rs16839725 intergenic 0.29 0.29 5.90E-06 40 15 11 3 19 4 59.42 23.19 17.39 13.79 68.97 17.24 9.15 0.99
14 47620548 C T C rs1952220 intronic 0.87 0.13 MDGA2 6.25E-06 2 17 47 1 20 5 4.35 26.09 69.57 6.90 72.41 20.69 0.61 0.11
15 99102128 A G A rs11853887 intergenic 0.76 0.24 6.52E-06 0 25 41 9 8 9 1.45 37.68 60.87 34.48 31.03 34.48 0.03 0.34
4 113961811 C T C rs10433900 intronic, non-coding transcript 0.52 0.48 RP11-650J17.1 6.81E-06 9 27 30 3 22 0 14.49 40.58 44.93 14.29 82.14 3.57 1.02 0.05
3 37603952 T A A rs9825270 intronic 0.19 0.19 ITGA9 7.07E-06 58 7 1 11 15 0 85.51 11.59 2.90 41.38 55.17 3.45 8.36 1.20
4 16428073 G A A rs73224601 intronic, non-coding transcript 0.10 0.10 RP11-446J8.1 7.46E-06 64 1 0 16 9 1 95.59 2.94 1.47 58.62 34.48 6.90 15.29 4.96
3 72015276 C A A rs2036594 intergenic 0.17 0.17 8.48E-06 61 2 3 15 11 0 89.86 4.35 5.80 55.17 41.38 3.45 7.20 0.58
19 46569619 A G A rs713409 intronic 0.53 0.47 IGFL4 8.91E-06 18 24 23 3 22 0 27.94 36.76 35.29 14.29 82.14 3.57 2.33 0.07
19 46569630 A G A rs713411 intronic 0.53 0.47 IGFL4 8.91E-06 18 24 23 3 22 0 27.94 36.76 35.29 14.29 82.14 3.57 2.33 0.07
1 156486009 G A G rs6685228 downstream 0.76 0.24 RP11-284F21.8 9.82E-06 1 9 56 0 16 10 2.90 14.49 82.61 3.45 58.62 37.93 0.84 0.13
CHROM POS REF ALT MINOR ALLELE P VALUEID CONSEQUENCE AF MAF SYMBOL
ODDS RATIO% RESPONDERS % NON-RESPONDERS# RESPONDERS # NON-RESPONDERS
Residual Null Residual Null
BASIC 90 91 107.38 109.55 - 0.02 0.01
BASIC + HDC 89 91 95.43 109.55 5.44E-04 0.13 0.11
BASIC + NSG1 89 91 91.83 109.55 8.03E-05 0.16 0.14
BASIC + MDGA2 89 91 89.68 109.55 2.58E-05 0.18 0.16
BASIC + RASGEF1C 89 91 84.62 109.55 1.84E-06 0.23 0.21
BASIC + SPNS3 89 91 83.49 109.55 1.02E-06 0.24 0.22
FULL 86 91 28.04 109.55 1.15E-15 0.74 0.73
D2 (adj.)DEVIANCEDFMODEL P VALUE D2
All p value < 0.05
PRKCB 78 45 8.24E-08 0.0016
transferase activity, transferring phosphorus-
containing groups, protein tyrosine kinase 
activity
glutamate binding, activation of AMPA 
receptors, synaptic plasticity
LINC01090 35 18 1.45E-07 0.0029 - -
DLG2 208 53 6.25E-07 0.0123 kinase binding, guanylate kinase activity protein-protein interactions at synapses
FILIP1 12 11 7.79E-07 0.0153 cytoplasm, nucleolus, plasma membrane, actin 
cytoskeleton
-
SEMA6D 41 17 4.87E-06 0.0921 semaphorin receptor binding axon guidance, semaphorin interactions
SYMBOL P VALUE (GENE-BASED) FWER GENE ONTOLOGY REACTOME# MUTATIONS
Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt
2 188581504 C T T rs10497687 intronic,non_coding_transcript 0.0495 0.0495 LINC01090 0.46031 60 6 0 22 4 0
2 188663115 C G G rs116771909 intronic,non_coding_transcript 0.0371 0.0371 LINC01090 0.72009 57 8 0 23 2 0
2 188721064 T C C rs7557550 intronic,non_coding_transcript 0.0361 0.0361 LINC01090 0.74016 57 9 0 20 4 0
2 188762907 A T T rs116655447 intronic,non_coding_transcript 0.0293 0.0293 LINC01090 0.16792 55 11 0 25 1 0
2 188776942 T C C rs75411057 intronic,non_coding_transcript 0.0254 0.0254 LINC01090 0.30238 58 7 0 20 5 0
2 188816239 C G G rs112295437 intronic,non_coding_transcript 0.0367 0.0367 LINC01090 1.00000 58 8 0 23 3 0
2 188833988 C A A rs115319205 intronic,non_coding_transcript 0.0176 0.0176 LINC01090 0.30912 59 7 0 21 5 0
2 188855089 C T T rs17262471 intronic,non_coding_transcript 0.0277 0.0277 LINC01090 0.72009 57 8 0 23 2 0
2 188943459 A C C rs77663937 intronic,non_coding_transcript 0.0499 0.0499 LINC01090 0.26662 53 13 0 17 8 0
2 188959003 T C C rs7349373 intronic,non_coding_transcript 0.0434 0.0434 LINC01090 1.00000 58 8 0 22 2 0
2 188966511 C T T rs76695614 intronic,non_coding_transcript 0.0174 0.0174 LINC01090 0.29927 59 7 0 20 5 0
2 189002372 G A A rs77231981 intronic,non_coding_transcript 0.0404 0.0404 LINC01090 0.27341 58 7 1 20 6 0
2 189016852 A G G rs1439880 intronic,non_coding_transcript 0.0387 0.0387 LINC01090 0.34130 57 9 0 19 6 0
2 189028697 A G G rs62181870 intronic,non_coding_transcript 0.0386 0.0386 LINC01090 0.21415 57 9 0 18 6 0
2 189044856 A C C rs75344621 intronic,non_coding_transcript 0.0231 0.0231 LINC01090 0.30912 59 7 0 21 5 0
2 189070772 C T T rs73041656 intronic,non_coding_transcript 0.0370 0.0370 LINC01090 0.00353 62 4 0 18 8 0
2 189080123 A G G rs72897997 intronic,non_coding_transcript 0.0295 0.0295 LINC01090 0.78552 59 6 1 22 3 0
2 189084759 T G G rs73043732 intronic,non_coding_transcript 0.0377 0.0377 LINC01090 0.00279 62 4 0 17 8 0
2 189084858 G A A rs16829913 intronic,non_coding_transcript 0.0311 0.0311 LINC01090 0.00146 63 3 0 18 8 0
2 189085132 T C C rs16829916 intronic,non_coding_transcript 0.0421 0.0421 LINC01090 0.00279 62 4 0 17 8 0
2 189086909 A G G rs17235639 intronic,non_coding_transcript 0.0486 0.0486 LINC01090 0.77339 53 13 0 19 6 0
2 189093576 A G G rs139110719 intronic,non_coding_transcript 0.0345 0.0345 LINC01090 0.00353 62 4 0 18 8 0
2 189098538 T C C rs77518981 intronic,non_coding_transcript 0.0346 0.0346 LINC01090 0.00353 62 4 0 18 8 0
2 189106416 C T T rs4536617 intronic,non_coding_transcript 0.0346 0.0346 LINC01090 0.00382 61 4 0 18 8 0
2 189108567 A G G rs34477786 intronic,non_coding_transcript 0.0489 0.0489 LINC01090 0.00195 61 5 0 16 9 0
2 189110995 A C C rs72903517 intronic,non_coding_transcript 0.0493 0.0493 LINC01090 0.00195 61 5 0 16 9 0
2 189112992 A G G rs76427030 intronic,non_coding_transcript 0.0304 0.0304 LINC01090 0.00114 63 3 0 17 8 0
2 189117009 A G G rs74596536 intronic,non_coding_transcript 0.0380 0.0380 LINC01090 0.00279 62 4 0 17 8 0
2 189129357 G A A rs79376882 intronic,non_coding_transcript 0.0339 0.0339 LINC01090 0.00353 62 4 0 18 8 0
2 189130332 T A A rs78784062 intronic,non_coding_transcript 0.0306 0.0306 LINC01090 0.00124 62 3 0 17 8 0
2 189137825 G T T rs78533331 intronic,non_coding_transcript 0.0305 0.0305 LINC01090 0.00114 63 3 0 17 8 0
2 189138858 A T T rs76319142 intronic,non_coding_transcript 0.0339 0.0339 LINC01090 0.00279 62 4 0 17 8 0
2 189142943 A T T rs60688387 intronic,non_coding_transcript 0.0378 0.0378 LINC01090 0.00353 62 4 0 18 8 0
2 189147226 C T T rs75927445 intronic,non_coding_transcript 0.0377 0.0377 LINC01090 0.00279 62 4 0 17 8 0
2 189149922 C T T rs4490147 intronic,non_coding_transcript 0.0311 0.0311 LINC01090 0.00114 63 3 0 17 8 0
6 76019039 G A A rs13217015 intronic 0.0499 0.0499 FILIP1 0.00082 61 5 0 16 9 1
6 76019395 C G G rs13217241 intronic 0.0495 0.0495 FILIP1 0.00082 61 5 0 16 9 1
6 76019584 A T T rs13217398 intronic 0.0495 0.0495 FILIP1 0.00060 61 5 0 15 9 1
IDCHROM POS REF ALT MINOR ALLELE P VALUE # RESPONDERS # NON-RESPONDERSCONSEQUENCE AF MAF SYMBOL
6 76024704 G A A rs62415695 missense 0.0184 0.0184 FILIP1 0.00181 65 1 0 20 5 1
6 76027221 A G G rs13198000 intronic 0.0485 0.0485 FILIP1 0.00082 61 5 0 16 9 1
6 76038587 G C C rs13193201 intronic 0.0490 0.0490 FILIP1 0.00082 61 5 0 16 9 1
6 76048681 G T T rs78980779 intronic 0.0192 0.0192 FILIP1 0.00181 65 1 0 20 5 1
6 76086411 G A A rs13203246 intronic 0.0499 0.0499 FILIP1 0.00033 62 4 0 16 9 1
6 76088207 A C C rs13211248 intronic 0.0499 0.0499 FILIP1 0.00033 62 4 0 16 9 1
6 76156294 G A A rs34747139 intronic 0.0454 0.0454 FILIP1 0.00085 62 4 0 16 8 1
6 76170874 C A A rs9443176 intronic 0.0416 0.0416 FILIP1 0.00085 62 4 0 16 8 1
6 76183844 G A A rs72877517 intronic 0.0447 0.0447 FILIP1 0.21916 52 13 0 23 2 0
11 83232915 G A A rs114513645 intronic 0.0474 0.0474 DLG2 0.73157 57 8 0 21 4 0
11 83237817 C G G rs1155272 intronic 0.0455 0.0455 DLG2 1.00000 57 9 0 22 4 0
11 83242900 G A A rs117159938 intronic 0.0424 0.0424 DLG2 0.73017 58 8 0 21 4 0
11 83244370 T C C rs996925 intronic 0.0456 0.0456 DLG2 0.74690 57 9 0 21 4 0
11 83255284 T C C rs116983205 intronic 0.0428 0.0428 DLG2 0.73017 58 8 0 21 4 0
11 83259388 A C C rs118015302 intronic 0.0464 0.0464 DLG2 0.74690 57 9 0 21 4 0
11 83264917 A G G rs17463588 intronic 0.0256 0.0256 DLG2 0.74690 57 9 0 21 4 0
11 83375180 A T T rs12791719 intronic 0.0398 0.0398 DLG2 0.06279 58 8 0 18 8 0
11 83377015 C A A rs977822 intronic 0.0335 0.0335 DLG2 0.17547 59 7 0 19 6 0
11 83380474 G A A rs34718216 intronic 0.0336 0.0336 DLG2 0.17547 59 7 0 19 6 0
11 83387738 C T T rs76751610 intronic 0.0333 0.0333 DLG2 0.10333 59 7 0 19 5 1
11 83389547 A T T rs12803579 intronic 0.0343 0.0343 DLG2 0.06500 58 8 0 18 6 1
11 83389577 C A A rs34839973 intronic 0.0398 0.0398 DLG2 0.06500 58 8 0 18 6 1
11 83400031 C T T rs34843650 intronic 0.0345 0.0345 DLG2 0.06500 58 8 0 18 6 1
11 83405196 A G G rs12806068 intronic 0.0319 0.0319 DLG2 0.08178 59 7 0 19 6 1
11 83413022 A G G rs1892949 intronic 0.0320 0.0320 DLG2 0.10333 59 7 0 19 5 1
11 83417779 C T T rs71465553 intronic 0.0317 0.0317 DLG2 0.10333 59 7 0 19 5 1
11 83418812 C T T rs12787861 intronic 0.0329 0.0329 DLG2 0.08178 59 7 0 19 6 1
11 83424657 A G G rs34514322 intronic 0.0320 0.0320 DLG2 0.10333 59 7 0 19 5 1
11 83424825 T C C rs34994208 intronic 0.0330 0.0330 DLG2 0.10333 59 7 0 19 5 1
11 83427143 A C C rs35954003 intronic 0.0327 0.0327 DLG2 0.08178 59 7 0 19 6 1
11 83427549 C T T rs118106162 intronic 0.0327 0.0327 DLG2 0.10333 59 7 0 19 5 1
11 83427586 G A A rs117792962 intronic 0.0326 0.0326 DLG2 0.10333 59 7 0 19 5 1
11 83429731 G A A rs71465554 intronic 0.0317 0.0317 DLG2 0.17547 59 7 0 19 6 0
11 83430048 G A A rs116872257 intronic 0.0316 0.0316 DLG2 0.08178 59 7 0 19 6 1
11 83436606 G T T rs35301519 intronic 0.0327 0.0327 DLG2 0.07030 58 8 0 19 6 1
11 83436879 C T T rs17481934 intronic 0.0328 0.0328 DLG2 0.11742 58 8 0 19 5 1
11 83451753 T C C rs36110284 intronic 0.0344 0.0344 DLG2 0.11742 58 8 0 19 5 1
11 83454878 G A A rs12792825 intronic 0.0331 0.0331 DLG2 0.07030 58 8 0 19 6 1
11 83460859 T C C rs12786565 intronic 0.0405 0.0405 DLG2 0.05388 57 8 0 18 7 1
11 83461366 T C C rs71465556 intronic 0.0345 0.0345 DLG2 0.07030 58 8 0 19 6 1
11 83462110 A C C rs71465557 intronic 0.0344 0.0344 DLG2 0.11742 58 8 0 19 5 1
11 83462245 T C C rs34873133 intronic 0.0403 0.0403 DLG2 0.10134 57 9 0 18 6 1
11 83469530 C T T rs4456272 intronic 0.0342 0.0342 DLG2 0.11742 58 8 0 19 5 1
11 83469764 A T T rs71465559 intronic 0.0365 0.0365 DLG2 0.11742 58 8 0 19 5 1
11 83471488 C G G rs148662532 intronic 0.0124 0.0124 DLG2 0.13742 62 3 0 22 3 1
11 83473103 C A A rs34520201 intronic 0.0445 0.0445 DLG2 0.06038 57 9 0 18 7 1
11 83473291 C T T rs35047639 intronic 0.0441 0.0441 DLG2 0.06038 57 9 0 18 7 1
11 83478153 C T T rs76663974 intronic 0.0409 0.0409 DLG2 0.79699 57 8 1 23 2 0
11 83481286 G A A rs79417402 intronic 0.0346 0.0346 DLG2 0.20777 58 8 0 20 6 0
11 83482085 C T T rs61900028 intronic 0.0374 0.0374 DLG2 0.49988 56 10 0 23 2 0
11 83482647 A C C rs12802155 intronic 0.0322 0.0322 DLG2 0.34130 57 9 0 19 6 0
11 83485395 T C C rs71468352 intronic 0.0307 0.0307 DLG2 0.19653 58 8 0 19 6 0
11 83499391 C T T rs77713322 intronic 0.0304 0.0304 DLG2 0.79699 57 8 1 23 2 0
11 83510016 G A A rs80098460 intronic 0.0215 0.0215 DLG2 1.00000 57 9 0 22 3 0
11 83524658 C T T rs12362201 intronic 0.0449 0.0449 DLG2 0.33478 54 12 0 23 2 0
11 83529668 A T T rs78005836 intronic 0.0224 0.0224 DLG2 0.49839 59 7 0 22 4 0
11 83530139 T C C rs117322638 intronic 0.0227 0.0227 DLG2 0.72340 57 7 0 22 4 0
11 83543747 C T T rs80100935 intronic 0.0355 0.0355 DLG2 0.52285 62 3 1 22 3 0
11 83555201 C A A rs76144509 intronic 0.0461 0.0461 DLG2 0.75217 56 10 0 23 3 0
11 83558415 C T T rs72958255 intronic 0.0260 0.0260 DLG2 0.72086 57 9 0 23 2 0
11 83589911 C T T rs17146314 intronic 0.0462 0.0462 DLG2 0.52280 54 11 1 24 2 0
11 83636021 C T T rs11233813 intronic 0.0453 0.0453 DLG2 0.70191 60 6 0 22 3 0
11 83664354 G A A rs79392602 intronic 0.0490 0.0490 DLG2 0.54308 54 12 0 23 3 0
11 83677047 T C C rs34747709 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83677711 A G G rs34310426 intronic 0.0462 0.0462 DLG2 0.00633 52 14 0 24 0 1
11 83677783 T G G rs34826061 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83678621 C G G rs35494684 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83678640 C A A rs34197413 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83678730 T C C rs12282675 intronic 0.0484 0.0484 DLG2 0.75015 55 11 0 22 3 0
11 83678734 T A A rs71465567 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83678887 T C C rs4133461 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83678920 A C C rs963090 intronic 0.0464 0.0464 DLG2 0.00657 51 14 0 24 0 1
11 83679015 A C C rs12290311 intronic 0.0497 0.0497 DLG2 0.75015 55 11 0 22 3 0
11 83679413 T C C rs7482523 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83679979 T C C rs71465568 intronic 0.0464 0.0464 DLG2 0.00460 52 14 0 25 0 1
11 83680070 G A A rs71465569 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83680280 A G G rs35693607 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83680391 G C C rs12796172 intronic 0.0464 0.0464 DLG2 0.00460 52 14 0 25 0 1
11 83680397 T C C rs11233866 intronic 0.0373 0.0373 DLG2 1.00000 56 9 1 23 3 0
11 83680596 T C C rs34716185 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83680906 A G G rs35240755 intronic 0.0461 0.0461 DLG2 0.00460 52 14 0 25 0 1
11 83681204 C T T rs12790276 intronic 0.0463 0.0463 DLG2 0.00460 52 14 0 25 0 1
11 83681379 C T T rs35307147 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83681457 G C C rs35268360 intronic 0.0462 0.0462 DLG2 0.00460 52 14 0 25 0 1
11 83681470 G A A rs34655432 intronic 0.0462 0.0462 DLG2 0.00633 52 14 0 24 0 1
11 83681548 G A A rs34949067 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83682356 A G G rs35540097 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83683244 G T T rs71465571 intronic 0.0473 0.0473 DLG2 0.00633 52 14 0 24 0 1
11 83683312 A G G rs71465572 intronic 0.0474 0.0474 DLG2 0.00633 52 14 0 24 0 1
11 83683445 G A A rs12804617 intronic 0.0474 0.0474 DLG2 0.00633 52 14 0 24 0 1
11 83683640 A G G rs12804532 intronic 0.0473 0.0473 DLG2 0.00633 52 14 0 24 0 1
11 83683790 G C C rs12805402 intronic 0.0473 0.0473 DLG2 0.00633 52 14 0 24 0 1
11 83683815 T A A rs34912232 intronic 0.0474 0.0474 DLG2 0.00633 52 14 0 24 0 1
11 83683854 C T T rs35024645 intronic 0.0474 0.0474 DLG2 0.00633 52 14 0 24 0 1
11 83683932 G A A rs36114419 intronic 0.0473 0.0473 DLG2 0.00633 52 14 0 24 0 1
11 83684393 G C C rs34272592 intronic 0.0474 0.0474 DLG2 0.00633 52 14 0 24 0 1
11 83684792 A T T rs35812794 intronic 0.0470 0.0470 DLG2 0.00633 52 14 0 24 0 1
11 83684934 A G G rs71468355 intronic 0.0471 0.0471 DLG2 0.00633 52 14 0 24 0 1
11 83684949 C T T rs71468356 intronic 0.0472 0.0472 DLG2 0.00633 52 14 0 24 0 1
11 83685111 T C C rs77093335 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83685208 A T T rs77985485 intronic 0.0463 0.0463 DLG2 0.00657 51 14 0 24 0 1
11 83685270 A G G rs80349643 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83685317 G A A rs79892044 intronic 0.0464 0.0464 DLG2 0.00657 51 14 0 24 0 1
11 83685451 T G G rs71465573 intronic 0.0462 0.0462 DLG2 0.00657 51 14 0 24 0 1
11 83685540 T G G rs71465574 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83685725 A C C rs12794213 intronic 0.0462 0.0462 DLG2 0.00633 52 14 0 24 0 1
11 83685924 C T T rs34436974 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83686159 T C C rs71465575 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83686254 A G G rs71465576 intronic 0.0463 0.0463 DLG2 0.00633 52 14 0 24 0 1
11 83686428 A G G rs71465577 intronic 0.0462 0.0462 DLG2 0.00657 51 14 0 24 0 1
11 83686440 A T T rs71465578 intronic 0.0464 0.0464 DLG2 0.00657 51 14 0 24 0 1
11 83686572 A G G rs71465579 intronic 0.0463 0.0463 DLG2 0.00657 51 14 0 24 0 1
11 83686609 A G G rs71465580 intronic 0.0463 0.0463 DLG2 0.00657 51 14 0 24 0 1
11 83686635 A G G rs71465581 intronic 0.0463 0.0463 DLG2 0.00657 51 14 0 24 0 1
11 83692232 T G G rs34756786 intronic 0.0464 0.0464 DLG2 0.00633 52 14 0 24 0 1
11 83735515 G A A rs80196056 intronic 0.0475 0.0475 DLG2 0.75015 55 11 0 22 3 0
11 83737618 G A A rs17146592 intronic 0.0491 0.0491 DLG2 0.74966 55 11 0 23 3 0
11 83767440 G A A rs11233892 intronic 0.0480 0.0480 DLG2 0.74966 55 11 0 23 3 0
11 83778678 A G G rs35239124 intronic 0.0441 0.0441 DLG2 0.47692 55 10 1 24 1 0
11 83786559 T C C rs34012933 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83791441 T C C rs17561231 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83796163 T C C rs2187553 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83798382 G A A rs34309181 intronic 0.0389 0.0389 DLG2 0.16792 55 11 0 25 1 0
11 83798496 T C C rs34846175 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83798802 T C C rs34045362 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83802683 G T T rs34899787 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83803464 A G G rs71469619 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83807535 T C C rs17495791 intronic 0.0142 0.0142 DLG2 0.43524 58 7 0 24 1 0
11 83813177 T C C rs75925390 intronic 0.0387 0.0387 DLG2 0.16792 55 11 0 25 1 0
11 83814433 G C C rs71469623 intronic 0.0387 0.0387 DLG2 0.16784 54 11 0 25 1 0
11 83821405 C T T rs12808867 intronic 0.0387 0.0387 DLG2 0.16792 55 11 0 25 1 0
11 83821870 C A A rs12785867 intronic 0.0386 0.0386 DLG2 0.16812 55 11 0 24 1 0
11 83827128 G T T rs75687645 intronic 0.0439 0.0439 DLG2 1.00000 55 9 2 21 4 0
11 83828197 G C C rs12808314 intronic 0.0378 0.0378 DLG2 0.16792 55 11 0 25 1 0
11 83828665 T C C rs71469624 intronic 0.0379 0.0379 DLG2 0.16792 55 11 0 25 1 0
11 83830087 C T T rs35992468 intronic 0.0378 0.0378 DLG2 0.16812 55 11 0 24 1 0
11 83839007 G A A rs116913890 intronic 0.0445 0.0445 DLG2 1.00000 55 9 2 21 4 0
11 83839703 C A A rs71469625 intronic 0.0387 0.0387 DLG2 0.16812 55 11 0 24 1 0
11 83844499 T C C rs34770791 intronic 0.0388 0.0388 DLG2 0.16812 55 11 0 24 1 0
11 83846946 G A A rs35615041 intronic 0.0388 0.0388 DLG2 0.16792 55 11 0 25 1 0
11 83850610 T C C rs71469626 intronic 0.0387 0.0387 DLG2 0.16812 55 11 0 24 1 0
11 83851228 G A A rs71469627 intronic 0.0387 0.0387 DLG2 0.16812 55 11 0 24 1 0
11 83855558 A C C rs12788130 intronic 0.0385 0.0385 DLG2 0.16792 55 11 0 25 1 0
11 83856459 T C C rs34337231 intronic 0.0385 0.0385 DLG2 0.16812 55 11 0 24 1 0
11 83857766 T C C rs35969270 intronic 0.0385 0.0385 DLG2 0.16733 54 11 0 24 1 0
11 83860894 G A A rs71469629 intronic 0.0386 0.0386 DLG2 0.16812 55 11 0 24 1 0
11 83862352 T G G rs71469630 intronic 0.0384 0.0384 DLG2 0.16812 55 11 0 24 1 0
11 83866720 A T T rs11233929 intronic 0.0467 0.0467 DLG2 1.00000 55 9 2 21 4 0
11 83867612 T C C rs71469631 intronic 0.0385 0.0385 DLG2 0.16812 55 11 0 24 1 0
11 83875056 A C C rs35910823 intronic 0.0385 0.0385 DLG2 0.16812 55 11 0 24 1 0
11 83878183 T C C rs12801364 intronic 0.0381 0.0381 DLG2 0.16812 55 11 0 24 1 0
11 83880139 A T T rs373152600 intronic 0.0378 0.0378 DLG2 0.17020 55 11 0 23 1 0
11 83882227 C T T rs78328809 intronic 0.0450 0.0450 DLG2 1.00000 55 9 2 22 4 0
11 83888454 C G G rs12808048 intronic 0.0381 0.0381 DLG2 0.16812 55 11 0 24 1 0
11 83890296 T C C rs12799079 intronic 0.0409 0.0409 DLG2 0.10154 53 13 0 23 1 0
11 83892801 C T T rs34386657 intronic 0.0360 0.0360 DLG2 0.16812 55 11 0 24 1 0
11 83899234 A G G rs11233934 intronic 0.0486 0.0486 DLG2 0.75113 55 9 2 20 5 0
11 83900060 A G G rs34042104 intronic 0.0407 0.0407 DLG2 0.10130 53 13 0 24 1 0
11 83903212 A T T rs73517787 intronic 0.0439 0.0439 DLG2 0.10130 53 13 0 24 1 0
11 83903240 A G G rs74448633 intronic 0.0406 0.0406 DLG2 0.10130 53 13 0 24 1 0
11 83903511 C T T rs35502448 intronic 0.0403 0.0403 DLG2 0.10282 53 13 0 25 1 0
11 83905317 G A A rs73517792 intronic 0.0491 0.0491 DLG2 0.21764 53 13 0 24 2 0
11 83906010 C G G rs12800271 intronic 0.0402 0.0402 DLG2 0.06055 52 13 0 25 1 0
11 83907441 G A A rs77892201 intronic 0.0482 0.0482 DLG2 0.10130 53 13 0 24 1 0
11 83907455 C T T rs79602990 intronic 0.0408 0.0408 DLG2 0.10130 53 13 0 24 1 0
11 83908287 T C C rs59681368 intronic 0.0474 0.0474 DLG2 0.10130 53 13 0 24 1 0
11 83908345 G A A rs75344440 intronic 0.0407 0.0407 DLG2 0.10121 52 13 0 24 1 0
11 83922479 G C C rs71469640 intronic 0.0409 0.0409 DLG2 0.10130 53 13 0 24 1 0
11 83924357 T C C rs75384284 intronic 0.0425 0.0425 DLG2 0.10130 53 13 0 24 1 0
11 83926691 A G G rs34664733 intronic 0.0427 0.0427 DLG2 0.10130 53 13 0 24 1 0
11 83942171 T C C rs11233957 intronic 0.0324 0.0324 DLG2 1.00000 56 9 1 22 3 0
11 83954261 T C C rs74818442 intronic 0.0199 0.0199 DLG2 1.00000 60 5 1 22 2 0
11 83961660 C G G rs17159833 intronic 0.0290 0.0290 DLG2 0.49839 59 7 0 22 4 0
11 83965933 A T T rs11233966 intronic 0.0402 0.0402 DLG2 1.00000 55 10 1 22 4 0
11 83979308 C A A rs11233971 intronic 0.0214 0.0214 DLG2 0.75945 61 4 1 23 2 0
11 83985299 C G G rs17500125 intronic 0.0475 0.0475 DLG2 0.27806 56 10 0 24 1 0
11 83987664 C T T rs80140888 intronic 0.0442 0.0442 DLG2 0.54181 53 13 0 22 3 0
11 84037134 C T T rs72959544 intronic 0.0356 0.0356 DLG2 0.00907 60 4 1 18 7 0
11 84051729 G A A rs61899215 intronic 0.0246 0.0246 DLG2 0.59212 58 7 1 25 1 0
11 84073212 A G G rs116901444 intronic 0.0215 0.0215 DLG2 0.75945 61 4 1 23 2 0
11 84124557 A T T rs11234016 intronic 0.0224 0.0224 DLG2 1.00000 60 5 1 23 2 0
11 84148078 C T T rs12793229 intronic 0.0264 0.0264 DLG2 0.76318 60 5 1 25 1 0
11 84157083 A G G rs71468372 intronic 0.0382 0.0382 DLG2 0.16938 62 3 1 21 4 0
11 84161506 A C C rs79104196 intronic 0.0439 0.0439 DLG2 0.50269 55 11 0 23 2 0
11 84168666 C T T rs11234035 intronic 0.0493 0.0493 DLG2 1.00000 53 11 2 21 4 0
11 84203688 C T T rs11234045 intronic 0.0406 0.0406 DLG2 0.16812 55 11 0 24 1 0
11 84216892 T C C rs17808372 intronic 0.0481 0.0481 DLG2 0.37817 51 15 0 22 3 0
11 84238326 T C C rs1367538 intronic 0.0237 0.0237 DLG2 1.00000 59 6 1 24 2 0
11 84257549 C T T rs11234071 intronic 0.0237 0.0237 DLG2 1.00000 59 6 1 23 2 0
11 84265771 G A A rs111685275 intronic 0.0452 0.0452 DLG2 0.77969 54 9 3 21 4 0
11 84298759 G A A rs77693614 intronic 0.0238 0.0238 DLG2 1.00000 59 6 1 23 2 0
11 84378128 T C C rs71469652 intronic 0.0463 0.0463 DLG2 0.29927 59 7 0 20 5 0
11 84395708 C A A rs118128180 intronic 0.0434 0.0434 DLG2 1.00000 56 10 0 22 4 0
11 84557455 T G G rs113083358 intronic 0.0281 0.0281 DLG2 0.39891 58 8 0 21 3 1
11 84561099 T G G rs117287296 intronic 0.0452 0.0452 DLG2 0.10783 62 4 0 20 5 0
11 84565540 C A A rs1943717 intronic 0.0408 0.0408 DLG2 0.11105 62 4 0 21 5 0
11 84580040 A C C rs76074207 intronic 0.0387 0.0387 DLG2 1.00000 57 9 0 23 3 0
11 84581522 T C C rs7125471 intronic 0.0493 0.0493 DLG2 0.10783 62 4 0 20 5 0
11 84598257 T G G rs76429934 intronic 0.0278 0.0278 DLG2 0.37598 58 7 0 21 3 1
11 84639183 G C C rs72955531 intronic 0.0437 0.0437 DLG2 1.00000 62 3 1 24 1 0
11 84749449 C T T rs74775461 intronic 0.0437 0.0437 DLG2 0.29927 59 7 0 20 5 0
11 84789864 A G G rs111410955 intronic 0.0255 0.0255 DLG2 0.72086 57 9 0 23 2 0
11 84837883 G A A rs35003694 intronic 0.0397 0.0397 DLG2 0.73017 58 8 0 21 4 0
11 84918461 T C C rs112844595 intronic 0.0206 0.0206 DLG2 1.00000 57 9 0 22 3 0
11 84991145 C T T rs189136848 intronic 0.0096 0.0096 DLG2 0.40582 59 6 1 25 0 0
11 84991169 C A A rs192808445 intronic 0.0096 0.0096 DLG2 0.40582 59 6 1 25 0 0
11 84996976 A G G rs35695258 intronic 0.0145 0.0145 DLG2 1.00000 58 7 0 23 2 0
11 85006195 A T T rs1016636 intronic 0.0388 0.0388 DLG2 0.06574 60 5 0 19 6 0
11 85024079 T C C rs185755081 intronic 0.0097 0.0097 DLG2 0.22343 59 6 1 26 0 0
11 85060360 C G G rs12794044 intronic 0.0157 0.0157 DLG2 0.72129 58 8 0 23 2 0
11 85086043 A T T rs35395221 intronic 0.0142 0.0142 DLG2 1.00000 59 7 0 23 2 0
11 85203814 C T T rs77687788 intronic 0.0399 0.0399 DLG2 0.02367 62 4 0 19 6 0
11 85203882 G A A rs75993784 intronic 0.0431 0.0431 DLG2 0.51888 57 9 0 20 5 0
11 85250747 G A A rs7939547 intronic 0.0393 0.0393 DLG2 0.01641 61 5 0 18 7 0
11 85262722 T C C rs7931722 intronic 0.0394 0.0394 DLG2 0.02002 62 4 0 18 6 0
11 85272815 T G G rs505238 intronic 0.0310 0.0310 DLG2 0.54181 53 13 0 22 3 0
11 85300458 G A A rs576722 intronic 0.0191 0.0191 DLG2 0.72218 57 9 0 24 2 0
15 47471564 A G G rs146546695 upstream 0.0428 0.0428 SEMA6D 0.59042 57 8 1 24 1 0
15 47472960 G A A rs79135353 upstream 0.0407 0.0407 SEMA6D 0.50649 58 8 0 21 5 0
15 47499732 G A A rs77819625 intronic 0.0189 0.0189 SEMA6D 0.00641 64 1 1 21 5 0
15 47524094 T C C rs80085470 intronic 0.0192 0.0192 SEMA6D 0.00553 64 1 1 20 5 0
15 47540002 A G G rs78106502 intronic 0.0408 0.0408 SEMA6D 0.00553 64 1 1 20 5 0
15 47540559 A G G rs11856688 intronic 0.0462 0.0462 SEMA6D 1.00000 58 8 0 22 3 0
15 47541152 C T T rs117884763 intronic 0.0211 0.0211 SEMA6D 0.00641 64 1 1 21 5 0
15 47541811 C T T rs76035674 intronic 0.0210 0.0210 SEMA6D 0.00553 64 1 1 20 5 0
15 47543232 T C C rs76999103 intronic 0.0192 0.0192 SEMA6D 0.00641 64 1 1 21 5 0
15 47552814 A G G rs78673643 intronic 0.0216 0.0216 SEMA6D 0.00641 64 1 1 21 5 0
15 47557518 C T T rs72731766 intronic 0.0276 0.0276 SEMA6D 1.00000 57 8 1 23 3 0
15 47580975 A G G rs7174561 intronic 0.0320 0.0320 SEMA6D 0.00641 64 1 1 21 5 0
15 47582288 C G G rs78142733 intronic 0.0217 0.0217 SEMA6D 0.00553 64 1 1 20 5 0
15 47589031 T G G rs17358151 intronic 0.0211 0.0211 SEMA6D 0.00553 64 1 1 20 5 0
15 47589185 G T T rs75474152 intronic 0.0259 0.0259 SEMA6D 0.00553 64 1 1 20 5 0
15 47630156 C T T rs77144407 intronic 0.0389 0.0389 SEMA6D 1.00000 58 8 0 23 3 0
15 47643236 C T T rs117401545 intronic 0.0375 0.0375 SEMA6D 1.00000 58 8 0 22 3 0
15 47697796 G C C rs61998609 intronic 0.0429 0.0429 SEMA6D 0.52276 53 12 1 24 2 0
15 47699041 T C C rs76187847 intronic 0.0220 0.0220 SEMA6D 0.01640 63 2 0 20 4 1
15 47704791 G A A rs79372522 intronic 0.0268 0.0268 SEMA6D 0.01558 64 2 0 20 4 1
15 47714563 C A A rs16959446 intronic 0.0437 0.0437 SEMA6D 0.51682 53 12 1 23 2 0
15 47722435 A G G rs111589399 intronic 0.0238 0.0238 SEMA6D 0.01558 64 2 0 20 4 1
15 47724040 G A A rs4775685 intronic 0.0437 0.0437 SEMA6D 0.51682 53 12 1 23 2 0
15 47727933 T C C rs74787996 intronic 0.0492 0.0492 SEMA6D 0.51682 53 12 1 23 2 0
15 47734225 T A A rs76552436 intronic 0.0498 0.0498 SEMA6D 0.51682 53 12 1 23 2 0
15 47775809 G A A rs61998616 intronic 0.0283 0.0283 SEMA6D 0.59042 57 8 1 24 1 0
15 47785052 T G G rs75701467 intronic 0.0200 0.0200 SEMA6D 1.00000 55 11 0 22 4 0
15 47839035 A G G rs72733864 intronic 0.0498 0.0498 SEMA6D 0.06460 61 5 0 19 6 0
15 47857783 G C C rs61998619 intronic 0.0297 0.0297 SEMA6D 0.75945 59 6 1 24 1 0
15 47887164 G A A rs117833852 intronic 0.0268 0.0268 SEMA6D 0.50269 55 11 0 23 2 0
15 47935535 T C C rs76732631 intronic 0.0290 0.0290 SEMA6D 0.76310 59 5 1 25 1 0
15 47944782 T C C rs1369639 intronic 0.0472 0.0472 SEMA6D 0.10353 54 12 0 24 1 0
15 47965075 A G G rs72735833 intronic 0.0394 0.0394 SEMA6D 0.00038 64 2 0 17 8 0
15 47967262 C T T rs17386817 intronic 0.0191 0.0191 SEMA6D 0.16733 54 11 0 24 1 0
15 47967971 C T T rs79207249 intronic 0.0329 0.0329 SEMA6D 0.59212 58 7 1 25 1 0
15 47979578 G A A rs17327778 intronic 0.0463 0.0463 SEMA6D 1.00000 58 7 0 22 3 0
15 47988326 G A A rs72735842 intronic 0.0386 0.0386 SEMA6D 0.00114 63 3 0 17 8 0
15 48008619 A G G rs72735850 upstream 0.0478 0.0478 SEMA6D 1.00000 60 5 1 23 2 0
15 48023229 A G G rs150484536 intronic 0.0274 0.0274 SEMA6D 0.27275 56 9 0 24 1 0
15 48050564 C T T rs56376571 intronic 0.0209 0.0209 SEMA6D 0.00141 64 2 0 18 7 0
15 48058769 T A A rs16960071 intronic 0.0263 0.0263 SEMA6D 0.61255 63 3 0 23 2 0
16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.47621 60 5 1 22 4 0
16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.00994 0 11 55 1 0 25
16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.00994 0 11 55 1 0 25
16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.00994 0 11 55 1 0 25
16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.00994 0 11 55 1 0 25
16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.00000 59 7 0 23 3 0
16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.00633 0 14 52 1 0 24
16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.00000 59 7 0 23 3 0
16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.00460 0 14 52 1 0 25
16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.00460 0 14 52 1 0 25
16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.00460 0 14 52 1 0 25
16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.00460 0 14 52 1 0 25
16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.00460 0 14 52 1 0 25
16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.00000 59 7 0 23 3 0
16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.34868 61 4 1 22 4 0
16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.00460 0 14 52 1 0 25
16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.00460 0 14 52 1 0 25
16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.00000 59 7 0 23 3 0
16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.00460 0 14 52 1 0 25
16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.00000 59 7 0 23 3 0
16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.00460 0 14 52 1 0 25
16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.00000 59 7 0 22 3 0
16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.00159 0 17 49 1 0 24
16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.00118 0 17 49 1 0 25
16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.00000 59 7 0 23 3 0
16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.00000 59 7 0 23 3 0
16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.00000 59 7 0 23 3 0
16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.00149 0 16 50 1 0 25
16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.00149 0 16 49 1 0 25
16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.00149 0 16 50 1 0 25
16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.00000 59 7 0 23 3 0
16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.00149 0 16 50 1 0 25
16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.00000 59 7 0 23 3 0
16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.00240 0 16 50 1 0 24
16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.00149 0 16 50 1 0 25
16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.00149 0 16 50 1 0 25
16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.00149 0 16 50 1 0 25
16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.00149 0 16 50 1 0 25
16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.00240 0 16 50 1 0 24
16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.00240 0 16 50 1 0 24
16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.00240 0 16 50 1 0 24
16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.73476 58 8 0 22 4 0
16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.00240 0 16 50 1 0 24
16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.00149 0 16 50 1 0 25
16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.00240 0 16 50 1 0 24
16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.00149 0 16 49 1 0 25
16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.00240 0 16 50 1 0 24
16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.00149 0 16 50 1 0 25
16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.50649 58 8 0 21 5 0
16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.00149 0 16 50 1 0 25
16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.00149 0 16 50 1 0 25
16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.00240 0 16 50 1 0 24
16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.30238 58 7 0 20 5 0
16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.00149 0 16 50 1 0 25
16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.00149 0 16 50 1 0 25
16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.03433 0 15 51 0 1 25
16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.00000 53 12 0 21 4 0
16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.16792 0 11 55 0 1 25
16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.16812 0 11 55 0 1 24
16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.33476 54 12 0 24 2 0
16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.75217 56 10 0 23 3 0
16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.00000 57 9 0 23 3 0
16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.75217 56 10 0 23 3 0
16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.69190 60 4 1 25 0 0
16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.72129 58 8 0 23 2 0
16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.71919 58 8 0 24 2 0
16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.72129 58 8 0 23 2 0
16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.72009 57 8 0 23 2 0
16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.72009 57 8 0 23 2 0
16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.18770 59 7 0 21 4 1
16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.85826 57 7 2 22 4 0
16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.46312 59 6 0 22 4 0
16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.46031 60 6 0 22 4 0
All p value < 0.05
Activation of NF-kappaB in B cells 264 74 4.89E-09 9.68E-06
WNT5A-dependent internalization of FZD4 187 49 1.31E-06 2.59E-03
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 190 48 1.33E-06 2.64E-03
Downstream signaling events of B Cell Receptor (BCR) 345 74 4.60E-06 9.05E-03
Depolymerisation of the Nuclear Lamina 191 48 5.88E-06 1.16E-02
Disinhibition of SNARE formation 177 48 6.89E-06 1.35E-02
Disassembly of the destruction complex and recruitment of AXIN to the membrane 123 43 3.67E-05 7.00E-02
# MUTATIONS P VALUE (P/WAY-BASED) FWERREACTOME PATHWAY
Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt
Activation of NF-kappaB in B cells 1 85738304 T G G rs141532778 intronic 0.0265 0.0265 BCL10 0.1949 59 7 0 24 1 1
Activation of NF-kappaB in B cells 1 85742155 G A A rs78416998 5_prime_UTR 0.0349 0.0349 BCL10 0.7734 60 5 1 23 3 0
Activation of NF-kappaB in B cells 1 109959684 G A A rs12119154 intronic 0.0463 0.0463 PSMA5 0.3842 59 7 0 22 3 1
Activation of NF-kappaB in B cells 2 54106726 G A A rs78542544 intronic 0.0466 0.0466 PSME4 0.0565 56 10 0 25 0 0
Activation of NF-kappaB in B cells 2 54109699 G A A rs75679248 intronic 0.0345 0.0345 PSME4 1.0000 57 9 0 22 3 0
Activation of NF-kappaB in B cells 2 54112612 T G G rs115678984 intronic 0.0340 0.0340 PSME4 0.7302 58 8 0 21 4 0
Activation of NF-kappaB in B cells 2 54116463 C T T rs805403 intronic 0.0376 0.0376 PSME4 0.2083 62 4 0 21 4 0
Activation of NF-kappaB in B cells 2 54119870 T C C rs77215245 intronic 0.0487 0.0487 PSME4 0.6362 55 10 1 23 2 0
Activation of NF-kappaB in B cells 2 54121956 T C C rs79436269 intronic 0.0498 0.0498 PSME4 0.6362 55 10 1 23 2 0
Activation of NF-kappaB in B cells 2 54131546 T C C rs78887562 intronic 0.0467 0.0467 PSME4 0.0565 56 10 0 25 0 0
Activation of NF-kappaB in B cells 2 54132737 G A A rs75125553 intronic 0.0493 0.0493 PSME4 0.6407 54 10 1 24 2 0
Activation of NF-kappaB in B cells 2 54148310 G C C rs74545963 intronic 0.0348 0.0348 PSME4 1.0000 57 9 0 23 3 0
Activation of NF-kappaB in B cells 2 54153284 A G G rs62139281 intronic 0.0226 0.0226 PSME4 0.0237 62 4 0 19 6 0
Activation of NF-kappaB in B cells 2 54161109 A C C rs74627832 intronic 0.0468 0.0468 PSME4 0.0565 56 10 0 25 0 0
Activation of NF-kappaB in B cells 2 54166671 C T T rs79435818 intronic 0.0317 0.0317 PSME4 1.0000 58 8 0 23 3 0
Activation of NF-kappaB in B cells 2 54166800 A G G rs76811723 intronic 0.0317 0.0317 PSME4 1.0000 58 8 0 22 3 0
Activation of NF-kappaB in B cells 2 54176733 C A A rs115660490 intronic 0.0366 0.0366 PSME4 0.7213 58 8 0 23 2 0
Activation of NF-kappaB in B cells 2 54182973 T A A rs114515761 intronic 0.0346 0.0346 PSME4 0.7192 58 8 0 24 2 0
Activation of NF-kappaB in B cells 2 54188394 T A A rs11692784 intronic 0.0346 0.0346 PSME4 0.7192 58 8 0 24 2 0
Activation of NF-kappaB in B cells 2 54198172 G A A rs141622297 upstream 0.0360 0.0360 PSME4 0.7192 58 8 0 24 2 0
Activation of NF-kappaB in B cells 2 54201823 G A A rs74336645 upstream 0.0362 0.0362 PSME4 0.7213 58 8 0 23 2 0
Activation of NF-kappaB in B cells 2 61155012 C G G rs79263888 3_prime_UTR 0.0229 0.0229 REL 0.7522 56 10 0 23 3 0
Activation of NF-kappaB in B cells 2 162169482 G A A rs7605885 intronic 0.0425 0.0425 PSMD14 0.8183 56 9 1 21 4 0
Activation of NF-kappaB in B cells 2 162215335 C T T rs6722186 intronic 0.0427 0.0427 PSMD14 1.0000 56 9 1 22 4 0
Activation of NF-kappaB in B cells 2 231921109 G A A rs3754982 upstream 0.0430 0.0430 PSMD1 0.0899 60 6 0 25 0 1
Activation of NF-kappaB in B cells 2 231926692 G A A rs80031661 intronic 0.0429 0.0429 PSMD1 0.0899 60 6 0 25 0 1
Activation of NF-kappaB in B cells 2 231932134 T C C rs78964764 intronic 0.0433 0.0433 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231933408 C T T rs13424110 intronic 0.0476 0.0476 PSMD1 0.1782 59 7 0 20 4 1
Activation of NF-kappaB in B cells 2 231937539 T C C rs2288148 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231939526 A G G rs12620983 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231947467 A G G rs11694724 intronic 0.0411 0.0411 PSMD1 0.2744 57 9 0 24 1 0
Activation of NF-kappaB in B cells 2 231949569 T C C rs2303354 intronic 0.0433 0.0433 PSMD1 0.0876 59 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231950847 T G G rs78363488 intronic 0.0407 0.0407 PSMD1 0.4353 57 8 0 24 1 0
Activation of NF-kappaB in B cells 2 231967886 T C C rs12616914 intronic 0.0436 0.0436 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231979258 A G G rs17586405 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231982950 T C C rs60707561 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 231983382 T G G rs17619636 intronic 0.0478 0.0478 PSMD1 0.0899 60 6 0 25 0 1
Activation of NF-kappaB in B cells 2 231998010 G A A rs77199363 intronic 0.0431 0.0431 PSMD1 0.0899 60 6 0 25 0 1
Activation of NF-kappaB in B cells 2 232003189 C T T rs80121410 intronic 0.0408 0.0408 PSMD1 0.2744 57 9 0 24 1 0
Activation of NF-kappaB in B cells 2 232021354 T C C rs115196328 intronic 0.0402 0.0402 PSMD1 0.5418 53 13 0 22 3 0
Activation of NF-kappaB in B cells 2 232025880 C T T rs76901853 intronic 0.0472 0.0472 PSMD1 0.0863 60 6 0 24 0 1
Activation of NF-kappaB in B cells 2 232036567 G A A rs11674175 intronic 0.0409 0.0409 PSMD1 0.2744 57 9 0 24 1 0
Activation of NF-kappaB in B cells 2 232041640 G A A rs111612792 downstream 0.0413 0.0413 PSMD1 0.2719 57 9 0 25 1 0
Activation of NF-kappaB in B cells 3 63994801 G A A rs62252370 downstream 0.0360 0.0360 PSMD6 1.0000 58 8 0 23 3 0
Activation of NF-kappaB in B cells 4 103436737 T C C rs79590323 intronic 0.0393 0.0393 NFKB1 0.4981 56 10 0 24 2 0
Activation of NF-kappaB in B cells 4 103441152 G A A rs74833382 intronic 0.0318 0.0318 NFKB1 0.7621 59 6 1 25 1 0
Activation of NF-kappaB in B cells 4 103441742 G A A rs78900265 intronic 0.0393 0.0393 NFKB1 0.4999 56 10 0 23 2 0
Activation of NF-kappaB in B cells 4 103465229 C T T rs76016852 intronic 0.0414 0.0414 NFKB1 0.4999 56 10 0 23 2 0
Activation of NF-kappaB in B cells 4 103534557 C T T rs4648117 intronic 0.0416 0.0416 NFKB1 0.7621 59 6 1 25 1 0
Activation of NF-kappaB in B cells 4 103535905 C T T rs4648127 intronic 0.0389 0.0389 NFKB1 0.4974 55 10 0 24 2 0
Activation of NF-kappaB in B cells 4 103542005 G T T rs997476 downstream 0.0397 0.0397 NFKB1 0.4981 56 10 0 24 2 0
Activation of NF-kappaB in B cells 5 133505097 T C C rs34751193 intronic 0.0303 0.0303 SKP1 0.7497 55 11 0 23 3 0
Activation of NF-kappaB in B cells 5 133512605 G T T rs11538030 5_prime_UTR 0.0356 0.0356 SKP1 0.6295 55 9 2 24 2 0
Activation of NF-kappaB in B cells 5 171287624 C G C rs702109 downstream 0.9605 0.0395 FBXW11 0.1356 0 13 52 1 2 22
Activation of NF-kappaB in B cells 5 171319929 T C C rs17569783 intronic 0.0456 0.0456 FBXW11 1.0000 59 6 1 23 2 0
Activation of NF-kappaB in B cells 5 171387634 G A A rs72835279 intronic 0.0450 0.0450 FBXW11 1.0000 59 6 1 24 2 0
Activation of NF-kappaB in B cells 5 171420105 G C C rs72835287 intronic 0.0441 0.0441 FBXW11 0.2719 57 9 0 25 1 0
Activation of NF-kappaB in B cells 5 171424137 T G G rs72835288 intronic 0.0465 0.0465 FBXW11 1.0000 59 6 1 24 2 0
Activation of NF-kappaB in B cells 6 32810147 G T T rs41270496 intronic 0.0323 0.0323 PSMB8 0.4984 59 7 0 22 4 0
MINOR ALLELEREACTOME PATHWAY CHROM POS REF ALT # RESPONDERS # NON-RESPONDERSID CONSEQUENCE AF MAF SYMBOL P VALUE
Activation of NF-kappaB in B cells 6 32811224 A T T rs72854938 intronic 0.0322 0.0322 PSMB8 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 6 32811366 G T T rs72854939 intronic 0.0322 0.0322 PSMB8 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 6 32826688 G T T rs115353581 intronic 0.0219 0.0219 PSMB9 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 6 32832218 A T T rs116481206 downstream 0.0219 0.0219 PSMB9 0.4862 59 7 0 21 4 0
Activation of NF-kappaB in B cells 6 44227224 C T T rs28362860 intronic 0.0269 0.0269 NFKBIE 0.4603 60 6 0 22 4 0
Activation of NF-kappaB in B cells 6 44233216 G C C rs28362857 missense 0.0296 0.0296 NFKBIE 0.0685 61 5 0 20 6 0
Activation of NF-kappaB in B cells 6 91239702 T A A rs62409064 intronic 0.0407 0.0407 MAP3K7 0.4940 58 7 1 20 5 0
Activation of NF-kappaB in B cells 6 91296810 C T T rs34016005 upstream 0.0303 0.0303 MAP3K7 0.4762 60 5 1 22 4 0
Activation of NF-kappaB in B cells 6 170851525 G A A rs12200064 intronic 0.0431 0.0431 PSMB1 0.3694 59 5 2 26 0 0
Activation of NF-kappaB in B cells 6 170858332 G A A rs17860779 intronic 0.0420 0.0420 PSMB1 1.0000 59 6 1 23 2 0
Activation of NF-kappaB in B cells 7 2955476 G C C rs41336352 intronic 0.0400 0.0400 CARD11 1.0000 58 8 0 22 3 0
Activation of NF-kappaB in B cells 7 2966334 G A A rs41448444 intronic 0.0454 0.0454 CARD11 0.7213 58 8 0 23 2 0
Activation of NF-kappaB in B cells 7 2968105 C A A rs71527417 intronic 0.0472 0.0472 CARD11 0.0436 49 16 1 25 1 0
Activation of NF-kappaB in B cells 7 2970297 C T T rs41386651 intronic 0.0410 0.0410 CARD11 0.7386 56 8 0 22 4 0
Activation of NF-kappaB in B cells 7 2970866 C T T rs9648301 intronic 0.0444 0.0444 CARD11 1.0000 57 9 0 22 4 0
Activation of NF-kappaB in B cells 7 3029796 G C C rs12700500 intronic 0.0454 0.0454 CARD11 1.0000 59 7 0 22 3 0
Activation of NF-kappaB in B cells 7 3042802 G A A rs35579453 intronic 0.0363 0.0363 CARD11 1.0000 57 9 0 22 4 0
Activation of NF-kappaB in B cells 7 3052087 G A A rs75468256 intronic 0.0407 0.0407 CARD11 0.2020 62 4 0 20 4 0
Activation of NF-kappaB in B cells 7 3072512 T C C rs6975176 intronic 0.0452 0.0452 CARD11 1.0000 61 4 1 25 1 0
Activation of NF-kappaB in B cells 7 3073243 G A A rs78353391 intronic 0.0427 0.0427 CARD11 0.0650 56 8 0 18 8 0
Activation of NF-kappaB in B cells 7 3079195 G T T rs62439353 intronic 0.0400 0.0400 CARD11 0.7348 58 8 0 22 4 0
Activation of NF-kappaB in B cells 7 42971385 G A A rs76256519 intronic 0.0432 0.0432 PSMA2 0.1923 61 5 0 21 3 1
Activation of NF-kappaB in B cells 7 148411091 C T T rs11764941 intronic 0.0416 0.0416 CUL1 0.0082 58 8 0 16 9 1
Activation of NF-kappaB in B cells 7 148422581 A G G rs11760399 intronic 0.0409 0.0409 CUL1 0.0158 57 9 0 16 9 1
Activation of NF-kappaB in B cells 7 148427470 A T T rs17625893 intronic 0.0188 0.0188 CUL1 0.3091 59 7 0 21 5 0
Activation of NF-kappaB in B cells 7 148453031 C G G rs4726991 intronic 0.0427 0.0427 CUL1 0.0164 61 5 0 18 7 0
Activation of NF-kappaB in B cells 7 148455710 A G G rs73158225 intronic 0.0426 0.0426 CUL1 0.0333 61 5 0 19 7 0
Activation of NF-kappaB in B cells 7 148456174 T G G rs17537343 intronic 0.0430 0.0430 CUL1 0.0164 61 5 0 18 7 0
Activation of NF-kappaB in B cells 7 148458141 C T T rs73158226 intronic 0.0426 0.0426 CUL1 0.0616 61 5 0 18 6 0
Activation of NF-kappaB in B cells 7 148470413 T C C rs73158234 intronic 0.0423 0.0423 CUL1 0.0333 61 5 0 19 7 0
Activation of NF-kappaB in B cells 7 148502252 T C C rs77948593 downstream 0.0395 0.0395 CUL1 1.0000 59 6 1 23 2 0
Activation of NF-kappaB in B cells 8 42125339 T C C rs76361874 upstream 0.0303 0.0303 IKBKB 0.0653 59 7 0 25 0 1
Activation of NF-kappaB in B cells 8 42127643 A C C rs17875739 upstream 0.0241 0.0241 IKBKB 0.0653 59 7 0 25 0 1
Activation of NF-kappaB in B cells 8 42128072 T A A rs62507976 upstream 0.0296 0.0296 IKBKB 0.4157 61 5 0 23 2 1
Activation of NF-kappaB in B cells 8 42135678 T G G rs17875740 intronic 0.0335 0.0335 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42138781 G C C rs80313154 intronic 0.0274 0.0274 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42142316 G A A rs79881854 intronic 0.0326 0.0326 IKBKB 0.0321 58 8 0 24 0 1
Activation of NF-kappaB in B cells 8 42145446 A G G rs17875744 intronic 0.0327 0.0327 IKBKB 0.0272 57 9 0 25 0 1
Activation of NF-kappaB in B cells 8 42150794 C T T rs79123247 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42154866 A G G rs78342373 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42155029 G A A rs112141582 intronic 0.0267 0.0267 IKBKB 0.0321 58 8 0 24 0 1
Activation of NF-kappaB in B cells 8 42158881 A G G rs75230171 intronic 0.0327 0.0327 IKBKB 0.0321 58 8 0 24 0 1
Activation of NF-kappaB in B cells 8 42159022 C T T rs79460550 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42161317 G A A rs113993388 intronic 0.0280 0.0280 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42162675 C T T rs17875700 intronic 0.0338 0.0338 IKBKB 0.0321 58 8 0 24 0 1
Activation of NF-kappaB in B cells 8 42170928 C T T rs76891399 intronic 0.0325 0.0325 IKBKB 0.0321 58 8 0 24 0 1
Activation of NF-kappaB in B cells 8 42173677 G T T rs17875746 intronic 0.0322 0.0322 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42180084 G A A rs17875721 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42180328 G T T rs17875751 intronic 0.0327 0.0327 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42180679 G A A rs78599265 intronic 0.0333 0.0333 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42186989 C T T rs17875731 intronic 0.0324 0.0324 IKBKB 0.0330 58 8 0 25 0 1
Activation of NF-kappaB in B cells 8 42188334 G T T rs79200457 intronic 0.0325 0.0325 IKBKB 0.0666 58 7 0 25 0 1
Activation of NF-kappaB in B cells 9 123578733 G A A rs10384 3_prime_UTR 0.0186 0.0186 PSMD5 0.3096 61 5 0 23 1 1
Activation of NF-kappaB in B cells 9 123598623 A G G rs62581704 intronic 0.0476 0.0476 PSMD5 0.3820 62 4 0 24 1 1
Activation of NF-kappaB in B cells 9 127118932 G A A rs117300833 intronic 0.0270 0.0270 PSMB7 0.3024 58 7 0 20 5 0
Activation of NF-kappaB in B cells 9 127119442 G A A rs16927388 intronic 0.0435 0.0435 PSMB7 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 9 127119799 G A A rs56058032 intronic 0.0172 0.0172 PSMB7 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 9 127141846 G C C rs79069085 intronic 0.0178 0.0178 PSMB7 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 9 127143001 T A A rs76699962 intronic 0.0448 0.0448 PSMB7 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 9 127144906 A C C rs79321634 intronic 0.0239 0.0239 PSMB7 0.2833 59 6 0 21 5 0
Activation of NF-kappaB in B cells 9 127145687 T C C rs77214542 intronic 0.0335 0.0335 PSMB7 1.0000 58 8 0 23 3 0
Activation of NF-kappaB in B cells 9 127145878 G C C rs41274376 intronic 0.0237 0.0237 PSMB7 0.3091 59 7 0 21 5 0
Activation of NF-kappaB in B cells 9 127151807 T G G rs114451602 intronic 0.0301 0.0301 PSMB7 0.5095 60 5 1 26 0 0
Activation of NF-kappaB in B cells 9 127172515 T C C rs140504275 intronic 0.0204 0.0204 PSMB7 0.1666 60 6 0 20 5 0
Activation of NF-kappaB in B cells 9 127177053 C T T rs73588260 intronic 0.0344 0.0344 PSMB7 0.7366 57 8 0 22 4 0
Activation of NF-kappaB in B cells 10 101958770 C T T rs12764732 intronic 0.0464 0.0464 CHUK 0.7209 57 9 0 23 2 0
Activation of NF-kappaB in B cells 10 101958858 T G G rs17883365 intronic 0.0229 0.0229 CHUK 1.0000 61 5 0 24 2 0
Activation of NF-kappaB in B cells 10 101961171 G A A rs17885986 intronic 0.0496 0.0496 CHUK 0.6322 57 8 1 21 4 1
Activation of NF-kappaB in B cells 10 101979482 T C C rs12764370 intronic 0.0302 0.0302 CHUK 0.7209 57 9 0 23 2 0
Activation of NF-kappaB in B cells 10 103121589 C T T rs11190960 intronic 0.0325 0.0325 BTRC 0.2234 59 6 1 26 0 0
Activation of NF-kappaB in B cells 10 103165858 G A A rs145847638 intronic 0.0278 0.0278 BTRC 0.4058 59 6 1 25 0 0
Activation of NF-kappaB in B cells 10 103180336 G A A rs11191003 intronic 0.0274 0.0274 BTRC 0.2234 59 6 1 26 0 0
Activation of NF-kappaB in B cells 10 103231195 T C C rs34711120 intronic 0.0435 0.0435 BTRC 0.7302 58 8 0 21 4 0
Activation of NF-kappaB in B cells 10 103272221 C T T rs12774622 intronic 0.0257 0.0257 BTRC 0.7970 57 8 1 23 2 0
Activation of NF-kappaB in B cells 10 103298099 G T T rs4151060 missense 0.0289 0.0289 BTRC 0.6362 55 10 1 23 2 0
Activation of NF-kappaB in B cells 11 242014 T A A rs17727753 intronic 0.0189 0.0189 PSMD13 1.0000 60 5 1 24 2 0
Activation of NF-kappaB in B cells 11 249105 G A A rs11601352 intronic 0.0465 0.0465 PSMD13 0.7522 56 10 0 23 3 0
Activation of NF-kappaB in B cells 11 14528592 T A A rs11023241 intronic 0.0417 0.0417 PSMA1 0.6117 57 8 1 23 2 1
Activation of NF-kappaB in B cells 11 14531031 C T T rs78398913 intronic 0.0273 0.0273 PSMA1 1.0000 56 9 0 22 4 0
Activation of NF-kappaB in B cells 11 14537004 A G G rs74589503 intronic 0.0418 0.0418 PSMA1 0.4981 56 10 0 24 2 0
Activation of NF-kappaB in B cells 11 14540827 C T T rs79966935 intronic 0.0233 0.0233 PSMA1 0.7222 57 9 0 24 2 0
Activation of NF-kappaB in B cells 11 14541179 A T T rs61883612 intronic 0.0441 0.0441 PSMA1 0.7666 55 11 0 21 5 0
Activation of NF-kappaB in B cells 11 14556220 C T T rs34162548 intronic 0.0376 0.0376 PSMA1 1.0000 55 11 0 21 4 0
Activation of NF-kappaB in B cells 11 14588324 G A A rs78854818 intronic 0.0413 0.0413 PSMA1 1.0000 59 6 1 24 2 0
Activation of NF-kappaB in B cells 11 14602698 T G G rs17567703 intronic 0.0418 0.0418 PSMA1 1.0000 58 8 0 23 3 0
Activation of NF-kappaB in B cells 11 14622982 G A A rs16930367 intronic 0.0250 0.0250 PSMA1 0.7192 58 8 0 24 2 0
Activation of NF-kappaB in B cells 11 14627135 G A A rs55760529 intronic 0.0485 0.0485 PSMA1 1.0000 56 9 1 23 3 0
Activation of NF-kappaB in B cells 11 14633490 G A A rs11023274 intronic 0.0317 0.0317 PSMA1 1.0000 56 9 1 23 3 0
Activation of NF-kappaB in B cells 11 14648387 G A A rs79123458 intronic 0.0412 0.0412 PSMA1 1.0000 59 6 1 24 2 0
Activation of NF-kappaB in B cells 11 47441683 C T T rs72903900 intronic 0.0375 0.0375 PSMC3 0.8389 59 5 2 23 3 0
Activation of NF-kappaB in B cells 11 47449591 G A A rs116930066 upstream 0.0311 0.0311 PSMC3 0.5028 56 9 0 24 2 0
Activation of NF-kappaB in B cells 12 122349404 T G G rs113810917 intronic 0.0229 0.0229 PSMD9 0.1282 57 8 1 25 0 0
Activation of NF-kappaB in B cells 12 122351293 A C C rs73229956 intronic 0.0288 0.0288 PSMD9 0.2597 54 11 1 24 1 0
Activation of NF-kappaB in B cells 12 125395161 G C C rs113660988 downstream 0.0428 0.0428 UBC 0.0064 64 1 1 21 5 0
Activation of NF-kappaB in B cells 12 125395728 C T T rs112205208 downstream 0.0429 0.0429 UBC 0.0064 64 1 1 21 5 0
Activation of NF-kappaB in B cells 12 125398911 C T T rs112043091 5_prime_UTR 0.0430 0.0430 UBC 0.0064 64 1 1 21 5 0
Activation of NF-kappaB in B cells 12 125399133 C T T rs41276688 5_prime_UTR 0.0434 0.0434 UBC 0.0064 64 1 1 21 5 0
Activation of NF-kappaB in B cells 14 23512430 C T T rs78162644 3_prime_UTR 0.0459 0.0459 PSMB11 1.0000 57 9 0 22 4 0
Activation of NF-kappaB in B cells 14 35787993 A T T rs12890150 downstream 0.0324 0.0324 PSMA6 0.5321 62 3 1 23 3 0
Activation of NF-kappaB in B cells 14 53178728 T C C rs117516552 intronic 0.0276 0.0276 PSMC6 0.7209 57 9 0 23 2 0
Activation of NF-kappaB in B cells 14 58710711 C G G rs117328560 upstream 0.0280 0.0280 PSMA3 0.4999 56 10 0 23 2 0
Activation of NF-kappaB in B cells 14 58729996 C G G rs111364917 intronic 0.0397 0.0397 PSMA3 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 14 58731398 T G G rs117955444 intronic 0.0210 0.0210 PSMA3 1.0000 59 7 0 22 3 0
Activation of NF-kappaB in B cells 15 78834476 A G G rs41280046 intronic 0.0393 0.0393 PSMA4 0.7087 60 6 0 23 3 0
Activation of NF-kappaB in B cells 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
Activation of NF-kappaB in B cells 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
Activation of NF-kappaB in B cells 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Activation of NF-kappaB in B cells 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Activation of NF-kappaB in B cells 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
Activation of NF-kappaB in B cells 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
Activation of NF-kappaB in B cells 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
Activation of NF-kappaB in B cells 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Activation of NF-kappaB in B cells 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
Activation of NF-kappaB in B cells 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
Activation of NF-kappaB in B cells 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
Activation of NF-kappaB in B cells 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
Activation of NF-kappaB in B cells 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
Activation of NF-kappaB in B cells 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
Activation of NF-kappaB in B cells 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
Activation of NF-kappaB in B cells 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
Activation of NF-kappaB in B cells 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
Activation of NF-kappaB in B cells 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
Activation of NF-kappaB in B cells 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
Activation of NF-kappaB in B cells 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
Activation of NF-kappaB in B cells 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
Activation of NF-kappaB in B cells 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
Activation of NF-kappaB in B cells 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
Activation of NF-kappaB in B cells 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
Activation of NF-kappaB in B cells 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
Activation of NF-kappaB in B cells 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
Activation of NF-kappaB in B cells 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
Activation of NF-kappaB in B cells 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
Activation of NF-kappaB in B cells 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
Activation of NF-kappaB in B cells 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
Activation of NF-kappaB in B cells 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
Activation of NF-kappaB in B cells 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Activation of NF-kappaB in B cells 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Activation of NF-kappaB in B cells 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
Activation of NF-kappaB in B cells 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
Activation of NF-kappaB in B cells 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
Activation of NF-kappaB in B cells 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
Activation of NF-kappaB in B cells 16 67973569 C T T rs17240392 upstream 0.0497 0.0497 PSMB10 0.4984 59 7 0 22 4 0
Activation of NF-kappaB in B cells 16 74334545 G T T rs149977784 intronic 0.0196 0.0196 PSMD7 1.0000 62 2 2 26 0 0
Activation of NF-kappaB in B cells 17 4702206 C A A rs71368518 downstream 0.0416 0.0416 PSMB6 1.0000 56 9 1 23 3 0
Activation of NF-kappaB in B cells 17 30778483 C T T rs117117721 intronic 0.0190 0.0190 PSMD11 1.0000 59 7 0 22 3 0
Activation of NF-kappaB in B cells 17 30791889 C T T rs35225085 intronic 0.0427 0.0427 PSMD11 0.4999 56 10 0 23 2 0
Activation of NF-kappaB in B cells 17 30794889 C G G rs35177842 intronic 0.0430 0.0430 PSMD11 0.4999 56 10 0 23 2 0
Activation of NF-kappaB in B cells 17 36920050 C T T rs118080693 intronic 0.0415 0.0415 PSMB3 0.1732 63 3 0 25 0 1
Activation of NF-kappaB in B cells 17 38144079 G T T rs118009374 intronic 0.0189 0.0189 PSMD3 0.8767 53 11 2 20 5 0
Activation of NF-kappaB in B cells 17 38154396 C T T rs118034841 downstream 0.0176 0.0176 PSMD3 0.0569 56 10 0 26 0 0
Activation of NF-kappaB in B cells 17 65334270 T A A rs146515782 3_prime_UTR 0.0418 0.0418 PSMD12 1.0000 58 8 0 23 3 0
Activation of NF-kappaB in B cells 18 23711373 G T T rs79820119 upstream 0.0407 0.0407 PSMA8 0.2218 53 13 0 23 2 0
Activation of NF-kappaB in B cells 18 23715815 T G G rs4800242 intronic 0.0460 0.0460 PSMA8 0.7043 59 6 0 22 3 0
Activation of NF-kappaB in B cells 18 23774138 C A A rs79452515 downstream 0.0424 0.0424 PSMA8 0.2993 59 7 0 20 5 0
Activation of NF-kappaB in B cells 18 56333866 G A A rs72958690 upstream 0.0368 0.0368 MALT1 0.8183 56 9 1 21 4 0
Activation of NF-kappaB in B cells 18 56338792 G A A rs56142402 5_prime_UTR 0.0327 0.0327 MALT1 0.8110 57 8 1 22 4 0
Activation of NF-kappaB in B cells 18 56363534 A C C rs55825071 intronic 0.0377 0.0377 MALT1 0.6531 56 9 1 20 5 0
Activation of NF-kappaB in B cells 19 40472450 A C C rs147915270 upstream 0.0382 0.0382 PSMC4 1.0000 58 7 1 22 3 0
Activation of NF-kappaB in B cells 19 40475070 T G G rs139876278 upstream 0.0147 0.0147 PSMC4 0.2725 63 2 1 23 3 0
Activation of NF-kappaB in B cells 20 1128622 T C C rs74871431 intronic 0.0320 0.0320 PSMF1 0.7087 60 6 0 23 3 0
Activation of NF-kappaB in B cells 20 1146048 C T T rs17716261 3_prime_UTR 0.0279 0.0279 PSMF1 0.4532 60 6 0 21 4 0
Activation of NF-kappaB in B cells 20 1149980 C T T rs77625408 downstream 0.0254 0.0254 PSMF1 0.7495 54 11 0 23 3 0
Activation of NF-kappaB in B cells 20 1152323 C T T rs34552580 downstream 0.0323 0.0323 PSMF1 1.0000 59 5 1 24 2 0
Activation of NF-kappaB in B cells 20 1155154 G A A rs78313102 intronic,non_coding_transcript 0.0258 0.0258 PSMF1 1.0000 58 7 0 23 3 0
WNT5A-dependent internalization of FZD4 3 183896966 G A A rs2231217 intronic 0.0406 0.0406 AP2M1 0.7980 57 8 1 24 2 0
WNT5A-dependent internalization of FZD4 5 175838749 T A A rs72807224 intronic 0.0466 0.0466 CLTB 0.0974 60 5 1 20 6 0
WNT5A-dependent internalization of FZD4 9 36189647 T C C rs3739608 upstream 0.0486 0.0486 CLTA 0.4858 59 6 1 21 5 0
WNT5A-dependent internalization of FZD4 9 36201064 G A A rs10972788 intronic 0.0274 0.0274 CLTA 0.2818 60 6 0 21 5 0
WNT5A-dependent internalization of FZD4 11 941844 C T T rs10902236 intronic 0.0339 0.0339 AP2A2 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 11 965671 C T T rs74045443 intronic 0.0489 0.0489 AP2A2 0.4662 58 6 0 22 4 0
WNT5A-dependent internalization of FZD4 11 966609 C T T rs7394613 intronic 0.0457 0.0457 AP2A2 0.0005 64 2 0 18 7 1
WNT5A-dependent internalization of FZD4 11 967822 C T T rs117367662 intronic 0.0338 0.0338 AP2A2 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 11 970818 C T T rs74045446 intronic 0.0491 0.0491 AP2A2 0.4474 60 6 0 20 4 0
WNT5A-dependent internalization of FZD4 11 971884 A G G rs7945582 intronic 0.0470 0.0470 AP2A2 0.6640 56 9 1 21 5 0
WNT5A-dependent internalization of FZD4 11 978921 C T T rs7122686 intronic 0.0468 0.0468 AP2A2 0.8183 56 9 1 21 4 0
WNT5A-dependent internalization of FZD4 11 986568 G C C rs112772664 intronic 0.0457 0.0457 AP2A2 0.4532 60 6 0 21 4 0
WNT5A-dependent internalization of FZD4 11 86653253 G A A rs79378895 downstream 0.0478 0.0478 FZD4 0.7222 57 9 0 24 2 0
WNT5A-dependent internalization of FZD4 11 86657419 A G G rs72963441 3_prime_UTR 0.0393 0.0393 FZD4 0.5065 58 8 0 21 5 0
WNT5A-dependent internalization of FZD4 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
WNT5A-dependent internalization of FZD4 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
WNT5A-dependent internalization of FZD4 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
WNT5A-dependent internalization of FZD4 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
WNT5A-dependent internalization of FZD4 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
WNT5A-dependent internalization of FZD4 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
WNT5A-dependent internalization of FZD4 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
WNT5A-dependent internalization of FZD4 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
WNT5A-dependent internalization of FZD4 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
WNT5A-dependent internalization of FZD4 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
WNT5A-dependent internalization of FZD4 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
WNT5A-dependent internalization of FZD4 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
WNT5A-dependent internalization of FZD4 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
WNT5A-dependent internalization of FZD4 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
WNT5A-dependent internalization of FZD4 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
WNT5A-dependent internalization of FZD4 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
WNT5A-dependent internalization of FZD4 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
WNT5A-dependent internalization of FZD4 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
WNT5A-dependent internalization of FZD4 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
WNT5A-dependent internalization of FZD4 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
WNT5A-dependent internalization of FZD4 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
WNT5A-dependent internalization of FZD4 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
WNT5A-dependent internalization of FZD4 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
WNT5A-dependent internalization of FZD4 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
WNT5A-dependent internalization of FZD4 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
WNT5A-dependent internalization of FZD4 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
WNT5A-dependent internalization of FZD4 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
WNT5A-dependent internalization of FZD4 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
WNT5A-dependent internalization of FZD4 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
WNT5A-dependent internalization of FZD4 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
WNT5A-dependent internalization of FZD4 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
WNT5A-dependent internalization of FZD4 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
WNT5A-dependent internalization of FZD4 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
WNT5A-dependent internalization of FZD4 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
WNT5A-dependent internalization of FZD4 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
WNT5A-dependent internalization of FZD4 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
WNT5A-dependent internalization of FZD4 17 4626173 A G G rs78082978 downstream 0.0315 0.0315 ARRB2 0.8212 55 10 1 23 3 0
WNT5A-dependent internalization of FZD4 17 33953109 G A A rs225253 intronic 0.0178 0.0178 AP2B1 0.2428 58 7 1 26 0 0
WNT5A-dependent internalization of FZD4 17 33990042 T C C rs75950451 intronic 0.0469 0.0469 AP2B1 0.8528 56 8 2 23 2 0
WNT5A-dependent internalization of FZD4 17 34003398 C T T rs79010821 intronic 0.0386 0.0386 AP2B1 0.1965 58 8 0 19 6 0
WNT5A-dependent internalization of FZD4 17 34006300 T A A rs79688427 intronic 0.0389 0.0389 AP2B1 0.2078 58 8 0 20 6 0
WNT5A-dependent internalization of FZD4 17 34051124 T G G rs11653803 3_prime_UTR 0.0341 0.0341 AP2B1 0.7192 58 8 0 24 2 0
WNT5A-dependent internalization of FZD4 17 57746013 C T T rs117419555 intronic 0.0437 0.0437 CLTC 1.0000 57 9 0 23 3 0
WNT5A-dependent internalization of FZD4 17 64305051 A G G rs78357146 intronic 0.0186 0.0186 PRKCA 0.7209 57 9 0 23 2 0
WNT5A-dependent internalization of FZD4 17 64315409 T C C rs80130647 intronic 0.0184 0.0184 PRKCA 0.7043 59 6 0 22 3 0
WNT5A-dependent internalization of FZD4 17 64318385 G A A rs12150623 intronic 0.0343 0.0343 PRKCA 0.7595 61 4 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64320040 C T T rs139317720 intronic 0.0229 0.0229 PRKCA 1.0000 62 3 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64326068 T G G rs12951126 intronic 0.0260 0.0260 PRKCA 1.0000 58 8 0 23 3 0
WNT5A-dependent internalization of FZD4 17 64343295 A C C rs72843901 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64344650 C T T rs72846606 intronic 0.0454 0.0454 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64344788 C T T rs72846607 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64346204 A G G rs12150367 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64349104 C T T rs72846609 intronic 0.0497 0.0497 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64351542 G C C rs28592028 intronic 0.0453 0.0453 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64352431 T G G rs544435459 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64354597 T C C rs72846612 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64358121 C G G rs72846614 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64359354 T C C rs72846615 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64365593 C T T rs72846677 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64367534 C T T rs72846678 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64369822 A G G rs72846681 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64375194 T C C rs72846695 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64377301 C A A rs113134992 intronic 0.0448 0.0448 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64382507 C G G rs79461368 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64389524 C T T rs77682324 intronic 0.0403 0.0403 PRKCA 0.7621 59 6 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64395773 T C C rs78584531 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64396570 T G G rs72838208 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64396695 A G G rs74329211 intronic 0.0432 0.0432 PRKCA 0.7302 58 8 0 21 4 0
WNT5A-dependent internalization of FZD4 17 64396883 G A A rs72838209 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64398013 G A A rs75125285 intronic 0.0295 0.0295 PRKCA 0.7632 60 5 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64400648 C T T rs72838214 intronic 0.0452 0.0452 PRKCA 0.4788 55 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64402141 G T T rs10221238 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64405430 T A A rs72838216 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64410564 C T T rs9972974 intronic 0.0390 0.0390 PRKCA 0.7632 60 5 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64412921 G A A rs62070391 intronic 0.0426 0.0426 PRKCA 0.7621 59 6 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64424382 C T T rs62070395 intronic 0.0425 0.0425 PRKCA 0.7595 59 6 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64429928 G A A rs117729211 intronic 0.0272 0.0272 PRKCA 0.0477 60 6 0 19 6 1
WNT5A-dependent internalization of FZD4 17 64431874 G A A rs72838278 intronic 0.0426 0.0426 PRKCA 0.7642 57 6 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64432202 A G G rs62070397 intronic 0.0427 0.0427 PRKCA 0.7621 59 6 1 25 1 0
WNT5A-dependent internalization of FZD4 17 64432881 A G G rs62070398 intronic 0.0426 0.0426 PRKCA 0.7595 59 6 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64438732 A T T rs113684166 intronic 0.0445 0.0445 PRKCA 0.2744 57 9 0 24 1 0
WNT5A-dependent internalization of FZD4 17 64441204 T C C rs75005068 intronic 0.0469 0.0469 PRKCA 0.2719 57 9 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64441759 C A A rs78330327 intronic 0.0465 0.0465 PRKCA 0.2710 56 9 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64445337 A C C rs118090701 intronic 0.0387 0.0387 PRKCA 1.0000 58 6 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64445856 A G G rs12451388 intronic 0.0449 0.0449 PRKCA 0.2744 57 9 0 24 1 0
WNT5A-dependent internalization of FZD4 17 64447721 G A A rs12452749 intronic 0.0462 0.0462 PRKCA 0.2786 57 9 0 23 1 0
WNT5A-dependent internalization of FZD4 17 64450113 G C C rs80162292 intronic 0.0461 0.0461 PRKCA 0.2710 56 9 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64453194 A G G rs111776777 intronic 0.0442 0.0442 PRKCA 0.8716 54 10 2 23 3 0
WNT5A-dependent internalization of FZD4 17 64458036 C T T rs113153197 intronic 0.0339 0.0339 PRKCA 0.1678 54 11 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64462111 T G G rs79239451 intronic 0.0464 0.0464 PRKCA 0.2744 57 9 0 24 1 0
WNT5A-dependent internalization of FZD4 17 64462288 G A A rs80080003 intronic 0.0305 0.0305 PRKCA 0.1706 56 10 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64483589 G T T rs79070174 intronic 0.0391 0.0391 PRKCA 1.0000 59 6 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64487077 T G G rs78149509 intronic 0.0200 0.0200 PRKCA 0.0381 63 3 0 21 4 1
WNT5A-dependent internalization of FZD4 17 64494906 A G G rs117168126 intronic 0.0300 0.0300 PRKCA 1.0000 59 6 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64501943 C T T rs7217954 intronic 0.0422 0.0422 PRKCA 1.0000 59 7 0 23 3 0
WNT5A-dependent internalization of FZD4 17 64519790 G A A rs11659067 intronic 0.0498 0.0498 PRKCA 0.0125 62 3 0 19 6 0
WNT5A-dependent internalization of FZD4 17 64525002 A T T rs77462363 intronic 0.0380 0.0380 PRKCA 1.0000 59 6 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64544723 C T T rs116879811 intronic 0.0274 0.0274 PRKCA 1.0000 60 6 0 24 2 0
WNT5A-dependent internalization of FZD4 17 64559535 A G G rs227907 intronic 0.0478 0.0478 PRKCA 0.2800 55 11 0 21 3 1
WNT5A-dependent internalization of FZD4 17 64561055 G A A rs62071706 intronic 0.0238 0.0238 PRKCA 0.1546 60 5 0 21 4 1
WNT5A-dependent internalization of FZD4 17 64590951 A T T rs11867591 intronic 0.0449 0.0449 PRKCA 0.2122 57 8 0 20 6 0
WNT5A-dependent internalization of FZD4 17 64604776 C T T rs117539643 intronic 0.0479 0.0479 PRKCA 0.6653 51 11 2 23 3 0
WNT5A-dependent internalization of FZD4 17 64608923 T C C rs72845947 intronic 0.0440 0.0440 PRKCA 0.7355 57 7 2 21 4 0
WNT5A-dependent internalization of FZD4 17 64610285 T C C rs72845948 intronic 0.0445 0.0445 PRKCA 0.8583 57 7 2 22 4 0
WNT5A-dependent internalization of FZD4 17 64610480 A C C rs17759657 intronic 0.0444 0.0444 PRKCA 0.8583 57 7 2 22 4 0
WNT5A-dependent internalization of FZD4 17 64612838 C T T rs16959714 intronic 0.0338 0.0338 PRKCA 0.4353 57 8 0 24 1 0
WNT5A-dependent internalization of FZD4 17 64614717 T C C rs17686540 intronic 0.0442 0.0442 PRKCA 0.7355 57 7 2 21 4 0
WNT5A-dependent internalization of FZD4 17 64626385 G A A rs74352723 intronic 0.0460 0.0460 PRKCA 0.2744 57 9 0 24 1 0
WNT5A-dependent internalization of FZD4 17 64628634 A G G rs117353888 intronic 0.0437 0.0437 PRKCA 0.2521 54 11 0 18 7 0
WNT5A-dependent internalization of FZD4 17 64660047 G C C rs146141011 intronic 0.0484 0.0484 PRKCA 1.0000 53 9 2 22 4 0
WNT5A-dependent internalization of FZD4 17 64671047 C T T rs16959942 intronic 0.0496 0.0496 PRKCA 0.1706 56 10 0 25 1 0
WNT5A-dependent internalization of FZD4 17 64712634 T C C rs78121420 intronic 0.0465 0.0465 PRKCA 1.0000 57 7 2 23 3 0
WNT5A-dependent internalization of FZD4 17 64713847 G T T rs112934229 intronic 0.0464 0.0464 PRKCA 1.0000 57 7 2 23 3 0
WNT5A-dependent internalization of FZD4 17 64723880 G A A rs79547774 intronic 0.0264 0.0264 PRKCA 1.0000 57 9 0 23 3 0
WNT5A-dependent internalization of FZD4 17 64738427 A C C rs117138620 intronic 0.0400 0.0400 PRKCA 0.3055 58 8 0 23 2 1
WNT5A-dependent internalization of FZD4 17 64748431 G T T rs141177250 intronic 0.0153 0.0153 PRKCA 0.7595 59 6 1 24 1 0
WNT5A-dependent internalization of FZD4 17 64755018 T C C rs74831470 intronic 0.0226 0.0226 PRKCA 0.7976 56 9 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64760870 A G G rs77904275 intronic 0.0307 0.0307 PRKCA 0.5233 53 11 1 24 2 0
WNT5A-dependent internalization of FZD4 17 64762410 C G G rs113025478 intronic 0.0307 0.0307 PRKCA 0.6398 54 11 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64763235 T C C rs77635068 intronic 0.0306 0.0306 PRKCA 0.6398 54 11 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64771614 C T T rs80238933 intronic 0.0297 0.0297 PRKCA 0.6398 54 11 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64776847 G A A rs113542727 intronic 0.0297 0.0297 PRKCA 0.5228 54 11 1 24 2 0
WNT5A-dependent internalization of FZD4 17 64791836 G C C rs56884788 intronic 0.0390 0.0390 PRKCA 0.6362 55 10 1 23 2 0
WNT5A-dependent internalization of FZD4 17 64792863 G C C rs72838636 intronic 0.0484 0.0484 PRKCA 0.6470 57 8 1 21 5 0
WNT5A-dependent internalization of FZD4 19 47342929 G A A rs17716171 intronic 0.0468 0.0468 AP2S1 0.3121 57 8 1 20 5 1
WNT5A-dependent internalization of FZD4 19 47352639 A G G rs78730097 intronic 0.0144 0.0144 AP2S1 1.0000 60 5 1 24 2 0
WNT5A-dependent internalization of FZD4 19 47353083 T A A rs117750880 intronic 0.0252 0.0252 AP2S1 0.7632 60 5 1 25 1 0
WNT5A-dependent internalization of FZD4 19 50279933 G T T rs79075745 intronic 0.0372 0.0372 AP2A1 0.7560 55 10 0 21 5 0
WNT5A-dependent internalization of FZD4 19 50282053 G A A rs62129179 intronic 0.0227 0.0227 AP2A1 0.2039 62 4 0 21 2 1
WNT5A-dependent internalization of FZD4 19 50297520 T C C rs62129182 intronic 0.0212 0.0212 AP2A1 0.3151 62 4 0 23 2 1
WNT5A-dependent internalization of FZD4 19 54401602 G C C rs41311973 intronic 0.0163 0.0163 PRKCG 0.7213 58 8 0 23 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 14 55593382 G A A rs149885215 upstream 0.0492 0.0492 LGALS3 1.0000 56 9 1 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 14 55598617 G T T rs78793419 intronic 0.0375 0.0375 LGALS3 0.4984 59 7 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3782471 G C C rs75401475 intronic 0.0208 0.0208 CREBBP 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3796252 T C C rs116481265 intronic 0.0390 0.0390 CREBBP 0.7549 56 10 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3857035 T G G rs130038 intronic 0.0341 0.0341 CREBBP 0.5065 58 8 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3876864 T C C rs77292571 intronic 0.0215 0.0215 CREBBP 0.7348 58 8 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3880659 A G G rs12447449 intronic 0.0347 0.0347 CREBBP 1.0000 57 8 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3881494 T C C rs113198082 intronic 0.0497 0.0497 CREBBP 0.2977 54 12 0 22 3 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3888283 A T T rs35581149 intronic 0.0268 0.0268 CREBBP 1.0000 57 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 3901493 T C C rs113653086 intronic 0.0332 0.0332 CREBBP 0.3346 58 8 0 20 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67058614 T G G rs116975210 upstream 0.0256 0.0256 CBFB 0.2078 58 8 0 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67059547 T C C rs118064296 upstream 0.0255 0.0255 CBFB 0.2078 58 8 0 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67060518 C A A rs78843766 upstream 0.0407 0.0407 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67064218 C T T rs115088567 intronic 0.0408 0.0408 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67065005 T G G rs60915579 intronic 0.0410 0.0410 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67077985 A T T rs16957128 intronic 0.0410 0.0410 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67081133 C A A rs116271212 intronic 0.0409 0.0409 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67087645 T C C rs34968486 intronic 0.0413 0.0413 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67089554 C T T rs115947495 intronic 0.0409 0.0409 CBFB 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67092389 T C C rs58448340 intronic 0.0410 0.0410 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67097563 C G G rs146692508 intronic 0.0409 0.0409 CBFB 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67110174 G A A rs115775129 intronic 0.0409 0.0409 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67113178 A G G rs78817904 intronic 0.0407 0.0407 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67121057 G C C rs114556591 intronic 0.0408 0.0408 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67121931 C G G rs80188152 intronic 0.0408 0.0408 CBFB 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67122543 A G G rs2204708 intronic 0.0407 0.0407 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67127104 C T T rs116154207 intronic 0.0408 0.0408 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67128349 G C C rs115375898 intronic 0.0408 0.0408 CBFB 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 16 67138195 C G G rs76658185 downstream 0.0409 0.0409 CBFB 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36161662 G C C rs75192893 3_prime_UTR 0.0252 0.0252 RUNX1 1.0000 61 4 1 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36258223 T C C rs2734472 intronic 0.0207 0.0207 RUNX1 0.0718 55 11 0 24 1 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36279730 T C C rs79087516 intronic 0.0328 0.0328 RUNX1 0.7285 62 3 1 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36298914 T C C rs2051392 intronic 0.0378 0.0378 RUNX1 0.0576 28 30 8 6 19 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36360816 C T T rs118131631 intronic 0.0328 0.0328 RUNX1 1.0000 58 8 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36385772 G A A rs78097430 intronic 0.0312 0.0312 RUNX1 1.0000 60 5 1 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36389539 C T T rs77728098 intronic 0.0493 0.0493 RUNX1 1.0000 58 7 1 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36392564 A G G rs71329093 intronic 0.0314 0.0314 RUNX1 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36400441 C G G rs75967349 intronic 0.0294 0.0294 RUNX1 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36405472 C G G rs75102343 intronic 0.0365 0.0365 RUNX1 0.0087 52 14 0 26 0 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36420012 T C C rs55800826 intronic 0.0435 0.0435 RUNX1 0.7065 51 14 1 19 7 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36420200 T G G rs77398576 intronic 0.0289 0.0289 RUNX1 0.2818 60 6 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36445895 T C C rs78203858 intronic 0.0402 0.0402 RUNX1 1.0000 57 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36481863 C A A rs9305560 intronic 0.0454 0.0454 RUNX1 0.8770 56 8 2 22 2 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36525063 G T T rs79134632 intronic 0.0303 0.0303 RUNX1 0.0320 54 12 0 25 0 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36525900 T C C rs62216988 intronic 0.0414 0.0414 RUNX1 0.1174 57 9 0 23 1 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36531645 A C C rs2834807 intronic 0.0357 0.0357 RUNX1 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36540870 T C C rs9984209 intronic 0.0153 0.0153 RUNX1 0.7929 59 6 1 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36549995 T C C rs76673048 intronic 0.0153 0.0153 RUNX1 0.7855 59 6 1 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36554527 C T T rs80172635 intronic 0.0341 0.0341 RUNX1 0.1028 53 13 0 25 1 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36578831 T A T rs8132151 intronic 0.9516 0.0484 RUNX1 0.2734 1 7 58 0 6 20
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36600490 G A A rs113393734 intronic 0.0338 0.0338 RUNX1 0.5316 56 9 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36615789 T G G rs76608041 intronic 0.0356 0.0356 RUNX1 0.4862 59 7 0 21 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36644806 C T T rs73192907 intronic 0.0329 0.0329 RUNX1 0.7549 56 10 0 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36651166 C T T rs78150243 intronic 0.0348 0.0348 RUNX1 0.4984 59 7 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36678254 G A A rs77468602 intronic 0.0288 0.0288 RUNX1 1.0000 56 10 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36679979 A G G rs75531812 intronic 0.0486 0.0486 RUNX1 0.4353 58 8 0 24 1 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36682912 T A A rs66699816 intronic 0.0476 0.0476 RUNX1 0.3666 4 34 28 0 11 14
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36714201 C A A rs2242721 intronic 0.0422 0.0422 RUNX1 1.0000 57 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36741936 A G G rs2242724 intronic 0.0446 0.0446 RUNX1 0.5457 56 10 0 20 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36777301 C T T rs113799213 intronic 0.0482 0.0482 RUNX1 0.7348 58 8 0 22 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36790637 C T T rs73197362 intronic 0.0471 0.0471 RUNX1 0.1026 56 9 0 18 6 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36817202 G T T rs76384559 intronic 0.0472 0.0472 RUNX1 0.7302 58 8 0 21 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36827331 G C C rs62217064 intronic 0.0304 0.0304 RUNX1 0.4532 60 6 0 21 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36887862 G A A rs73201472 intronic 0.0285 0.0285 RUNX1 0.0370 61 4 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36904158 A G G rs78159534 intronic 0.0382 0.0382 RUNX1 1.0000 58 7 1 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36978701 C T T rs141048458 intronic 0.0137 0.0137 RUNX1 0.7043 59 6 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 36988765 A G G rs117334794 intronic 0.0137 0.0137 RUNX1 1.0000 59 7 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37001252 G A A rs147475775 intronic 0.0133 0.0133 RUNX1 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37041204 A T T rs9978750 intronic 0.0430 0.0430 RUNX1 1.0000 58 8 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37111438 C T T rs2835112 intronic 0.0109 0.0109 RUNX1 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37145469 A G G rs78766167 intronic 0.0338 0.0338 RUNX1 0.8583 57 8 1 22 3 1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37146205 T C C rs2835139 intronic 0.0440 0.0440 RUNX1 1.0000 56 10 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37165262 T G G rs79838028 intronic 0.0208 0.0208 RUNX1 0.7681 60 5 1 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37168627 C A A rs9976429 intronic 0.0381 0.0381 RUNX1 1.0000 59 7 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37201847 G A A rs2835146 intronic 0.0109 0.0109 RUNX1 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37220269 T A A rs141274106 intronic 0.0109 0.0109 RUNX1 1.0000 58 8 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37276929 C T T rs75561514 intronic 0.0138 0.0138 RUNX1 1.0000 61 4 1 24 2 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37283402 C T T rs79437318 intronic 0.0284 0.0284 RUNX1 0.7681 60 5 1 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37314583 C T T rs35256126 intronic 0.0349 0.0349 RUNX1 0.1421 59 6 1 19 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37316253 T C C rs35676489 intronic 0.0484 0.0484 RUNX1 1.0000 57 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37318065 G A A rs112248952 intronic 0.0352 0.0352 RUNX1 1.0000 58 8 0 22 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37323869 A G G rs17813817 intronic 0.0353 0.0353 RUNX1 0.1603 57 6 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37325386 A G G rs74524623 intronic 0.0186 0.0186 RUNX1 0.3387 61 4 1 21 4 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37327434 G C C rs35296624 intronic 0.0356 0.0356 RUNX1 0.2734 58 7 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37327713 G C C rs35137377 intronic 0.0355 0.0355 RUNX1 0.2734 58 7 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37331245 G C C rs13049450 intronic 0.0354 0.0354 RUNX1 0.1521 59 6 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37332139 G T T rs75887851 intronic 0.0458 0.0458 RUNX1 0.4799 58 6 1 20 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37332988 C T T rs79662622 intronic 0.0372 0.0372 RUNX1 0.2734 58 7 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37333615 C T T rs34303222 intronic 0.0353 0.0353 RUNX1 0.2734 58 7 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37335408 T A A rs35338421 intronic 0.0354 0.0354 RUNX1 0.2734 58 7 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37342778 C T T rs13047609 intronic 0.0320 0.0320 RUNX1 0.6499 56 8 1 21 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37343254 G T T rs13048435 intronic 0.0319 0.0319 RUNX1 0.4348 57 8 1 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37345637 G A A rs13052673 intronic 0.0474 0.0474 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37346157 A G G rs915742 intronic 0.0473 0.0473 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37347057 C T T rs2835194 intronic 0.0475 0.0475 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37348386 A G G rs34544538 intronic 0.0472 0.0472 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37350173 C T T rs71330629 intronic 0.0472 0.0472 RUNX1 0.1227 55 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37351306 C T T rs2835205 intronic 0.0476 0.0476 RUNX1 0.1139 55 9 1 17 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37351459 T C C rs56317271 intronic 0.0472 0.0472 RUNX1 0.1117 56 9 1 17 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37351802 C T T rs13048310 intronic 0.0473 0.0473 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37352953 T C C rs13046307 intronic 0.0473 0.0473 RUNX1 0.1117 56 9 1 17 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37353681 T C C rs71330630 intronic 0.0473 0.0473 RUNX1 0.1227 55 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37357051 C T T rs28665789 5_prime_UTR 0.0498 0.0498 RUNX1 1.0000 56 9 0 23 3 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37361832 A C C rs36028697 intronic 0.0476 0.0476 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37362718 C A A rs2835215 intronic 0.0476 0.0476 RUNX1 0.1117 56 9 1 17 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37363385 A G G rs2835216 intronic 0.0477 0.0477 RUNX1 0.1196 56 9 1 18 8 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37364473 A G G rs13047560 intronic 0.0432 0.0432 RUNX1 0.3739 56 10 0 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37366389 A T T rs34327189 intronic 0.0459 0.0459 RUNX1 0.7528 55 10 0 20 5 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37368100 C G G rs55824509 intronic 0.0431 0.0431 RUNX1 0.3739 56 10 0 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37369628 C T T rs13049536 intronic 0.0431 0.0431 RUNX1 0.3612 56 10 0 19 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37370442 G A A rs13050761 intronic 0.0430 0.0430 RUNX1 0.3739 56 10 0 20 6 0
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 21 37371181 C T T rs71330631 intronic 0.0433 0.0433 RUNX1 0.3788 55 10 0 20 6 0
Downstream signaling events of B Cell Receptor (BCR) 1 85738304 T G G rs141532778 intronic 0.0265 0.0265 BCL10 0.1949 59 7 0 24 1 1
Downstream signaling events of B Cell Receptor (BCR) 1 85742155 G A A rs78416998 5_prime_UTR 0.0349 0.0349 BCL10 0.7734 60 5 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 1 109959684 G A A rs12119154 intronic 0.0463 0.0463 PSMA5 0.3842 59 7 0 22 3 1
Downstream signaling events of B Cell Receptor (BCR) 1 115255717 T C C rs9724630 intronic 0.0490 0.0490 NRAS 0.0910 60 6 0 20 6 0
Downstream signaling events of B Cell Receptor (BCR) 2 33674504 A G G rs17013001 intronic 0.0406 0.0406 RASGRP3 0.2744 57 9 0 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 33707486 A G G rs17648515 intronic 0.0454 0.0454 RASGRP3 0.7549 56 10 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 2 33715019 A C C rs17595032 intronic 0.0422 0.0422 RASGRP3 0.7549 56 10 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 2 33717791 T A A rs12470632 intronic 0.0329 0.0329 RASGRP3 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 33718749 G A A rs72804240 intronic 0.0274 0.0274 RASGRP3 0.3739 56 10 0 20 6 0
Downstream signaling events of B Cell Receptor (BCR) 2 33723194 T C C rs34719322 intronic 0.0204 0.0204 RASGRP3 0.5590 61 4 1 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 33725279 T C C rs34958143 intronic 0.0231 0.0231 RASGRP3 0.7348 58 8 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 33725706 A T T rs72785908 intronic 0.0406 0.0406 RASGRP3 0.1706 56 10 0 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 33732446 A G G rs80205916 intronic 0.0361 0.0361 RASGRP3 0.7632 60 5 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 33758737 C T T rs56197103 intronic 0.0426 0.0426 RASGRP3 0.7384 55 9 1 21 3 1
Downstream signaling events of B Cell Receptor (BCR) 2 33760191 A G G rs148641284 intronic 0.0360 0.0360 RASGRP3 0.7469 57 9 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 54106726 G A A rs78542544 intronic 0.0466 0.0466 PSME4 0.0565 56 10 0 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 2 54109699 G A A rs75679248 intronic 0.0345 0.0345 PSME4 1.0000 57 9 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 54112612 T G G rs115678984 intronic 0.0340 0.0340 PSME4 0.7302 58 8 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 54116463 C T T rs805403 intronic 0.0376 0.0376 PSME4 0.2083 62 4 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 54119870 T C C rs77215245 intronic 0.0487 0.0487 PSME4 0.6362 55 10 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54121956 T C C rs79436269 intronic 0.0498 0.0498 PSME4 0.6362 55 10 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54131546 T C C rs78887562 intronic 0.0467 0.0467 PSME4 0.0565 56 10 0 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 2 54132737 G A A rs75125553 intronic 0.0493 0.0493 PSME4 0.6407 54 10 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54148310 G C C rs74545963 intronic 0.0348 0.0348 PSME4 1.0000 57 9 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 54153284 A G G rs62139281 intronic 0.0226 0.0226 PSME4 0.0237 62 4 0 19 6 0
Downstream signaling events of B Cell Receptor (BCR) 2 54161109 A C C rs74627832 intronic 0.0468 0.0468 PSME4 0.0565 56 10 0 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 2 54166671 C T T rs79435818 intronic 0.0317 0.0317 PSME4 1.0000 58 8 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 54166800 A G G rs76811723 intronic 0.0317 0.0317 PSME4 1.0000 58 8 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 54176733 C A A rs115660490 intronic 0.0366 0.0366 PSME4 0.7213 58 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54182973 T A A rs114515761 intronic 0.0346 0.0346 PSME4 0.7192 58 8 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54188394 T A A rs11692784 intronic 0.0346 0.0346 PSME4 0.7192 58 8 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54198172 G A A rs141622297 upstream 0.0360 0.0360 PSME4 0.7192 58 8 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 54201823 G A A rs74336645 upstream 0.0362 0.0362 PSME4 0.7213 58 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 2 61155012 C G G rs79263888 3_prime_UTR 0.0229 0.0229 REL 0.7522 56 10 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 68411185 T C C rs72832011 intronic 0.0451 0.0451 PPP3R1 0.0653 59 7 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 68413244 T A A rs72832013 intronic 0.0455 0.0455 PPP3R1 0.0621 59 7 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 162169482 G A A rs7605885 intronic 0.0425 0.0425 PSMD14 0.8183 56 9 1 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 162215335 C T T rs6722186 intronic 0.0427 0.0427 PSMD14 1.0000 56 9 1 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 2 231921109 G A A rs3754982 upstream 0.0430 0.0430 PSMD1 0.0899 60 6 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231926692 G A A rs80031661 intronic 0.0429 0.0429 PSMD1 0.0899 60 6 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231932134 T C C rs78964764 intronic 0.0433 0.0433 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231933408 C T T rs13424110 intronic 0.0476 0.0476 PSMD1 0.1782 59 7 0 20 4 1
Downstream signaling events of B Cell Receptor (BCR) 2 231937539 T C C rs2288148 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231939526 A G G rs12620983 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231947467 A G G rs11694724 intronic 0.0411 0.0411 PSMD1 0.2744 57 9 0 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 231949569 T C C rs2303354 intronic 0.0433 0.0433 PSMD1 0.0876 59 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231950847 T G G rs78363488 intronic 0.0407 0.0407 PSMD1 0.4353 57 8 0 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 231967886 T C C rs12616914 intronic 0.0436 0.0436 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231979258 A G G rs17586405 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231982950 T C C rs60707561 intronic 0.0434 0.0434 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231983382 T G G rs17619636 intronic 0.0478 0.0478 PSMD1 0.0899 60 6 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 231998010 G A A rs77199363 intronic 0.0431 0.0431 PSMD1 0.0899 60 6 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 232003189 C T T rs80121410 intronic 0.0408 0.0408 PSMD1 0.2744 57 9 0 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 232021354 T C C rs115196328 intronic 0.0402 0.0402 PSMD1 0.5418 53 13 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 2 232025880 C T T rs76901853 intronic 0.0472 0.0472 PSMD1 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 2 232036567 G A A rs11674175 intronic 0.0409 0.0409 PSMD1 0.2744 57 9 0 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 2 232041640 G A A rs111612792 downstream 0.0413 0.0413 PSMD1 0.2719 57 9 0 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 3 63994801 G A A rs62252370 downstream 0.0360 0.0360 PSMD6 1.0000 58 8 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 4 102027455 C T T rs78657301 intronic 0.0019 0.0019 PPP3CA 0.7980 57 8 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102030909 T C C rs143246322 intronic 0.0331 0.0331 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102046408 C T T rs79507245 intronic 0.0394 0.0394 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102046629 C T T rs74675949 intronic 0.0393 0.0393 PPP3CA 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102047770 T C C rs78209620 intronic 0.0395 0.0395 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102047812 A G G rs78888749 intronic 0.0394 0.0394 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102049484 A G G rs113609659 intronic 0.0394 0.0394 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102059408 A G G rs111885453 intronic 0.0393 0.0393 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102060085 C A A rs150119589 intronic 0.0392 0.0392 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102061144 C T T rs113496555 intronic 0.0392 0.0392 PPP3CA 0.4985 55 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102061766 T C C rs116229517 intronic 0.0392 0.0392 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102061822 C T T rs112122964 intronic 0.0393 0.0393 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102062069 G A A rs74631130 intronic 0.0392 0.0392 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102063270 T C C rs111752790 intronic 0.0421 0.0421 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102064126 A T T rs113744576 intronic 0.0439 0.0439 PPP3CA 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102064899 T C C rs112973280 intronic 0.0500 0.0500 PPP3CA 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102065144 G A A rs112695279 intronic 0.0497 0.0497 PPP3CA 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102065533 G A A rs75372805 intronic 0.0392 0.0392 PPP3CA 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102065719 T C C rs17240082 intronic 0.0496 0.0496 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102071777 C T T rs112522326 intronic 0.0439 0.0439 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102073273 G A A rs111792710 intronic 0.0391 0.0391 PPP3CA 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102105924 C T T rs80191143 intronic 0.0153 0.0153 PPP3CA 1.0000 60 5 1 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 4 102128007 A C C rs75423137 intronic 0.0447 0.0447 PPP3CA 0.6398 54 11 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 102158097 G A A rs116097940 intronic 0.0226 0.0226 PPP3CA 0.3171 60 6 0 23 1 1
Downstream signaling events of B Cell Receptor (BCR) 4 102159289 C T T rs13133951 intronic 0.0215 0.0215 PPP3CA 0.3221 60 6 0 24 1 1
Downstream signaling events of B Cell Receptor (BCR) 4 102174349 T C C rs114543570 intronic 0.0466 0.0466 PPP3CA 0.7621 59 6 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 4 103436737 T C C rs79590323 intronic 0.0393 0.0393 NFKB1 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 103441152 G A A rs74833382 intronic 0.0318 0.0318 NFKB1 0.7621 59 6 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 4 103441742 G A A rs78900265 intronic 0.0393 0.0393 NFKB1 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 103465229 C T T rs76016852 intronic 0.0414 0.0414 NFKB1 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 103534557 C T T rs4648117 intronic 0.0416 0.0416 NFKB1 0.7621 59 6 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 4 103535905 C T T rs4648127 intronic 0.0389 0.0389 NFKB1 0.4974 55 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 4 103542005 G T T rs997476 downstream 0.0397 0.0397 NFKB1 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 5 133505097 T C C rs34751193 intronic 0.0303 0.0303 SKP1 0.7497 55 11 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 5 133512605 G T T rs11538030 5_prime_UTR 0.0356 0.0356 SKP1 0.6295 55 9 2 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 5 171287624 C G C rs702109 downstream 0.9605 0.0395 FBXW11 0.1356 0 13 52 1 2 22
Downstream signaling events of B Cell Receptor (BCR) 5 171319929 T C C rs17569783 intronic 0.0456 0.0456 FBXW11 1.0000 59 6 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 5 171387634 G A A rs72835279 intronic 0.0450 0.0450 FBXW11 1.0000 59 6 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 5 171420105 G C C rs72835287 intronic 0.0441 0.0441 FBXW11 0.2719 57 9 0 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 5 171424137 T G G rs72835288 intronic 0.0465 0.0465 FBXW11 1.0000 59 6 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 6 32810147 G T T rs41270496 intronic 0.0323 0.0323 PSMB8 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 32811224 A T T rs72854938 intronic 0.0322 0.0322 PSMB8 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 32811366 G T T rs72854939 intronic 0.0322 0.0322 PSMB8 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 32826688 G T T rs115353581 intronic 0.0219 0.0219 PSMB9 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 32832218 A T T rs116481206 downstream 0.0219 0.0219 PSMB9 0.4862 59 7 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 44227224 C T T rs28362860 intronic 0.0269 0.0269 NFKBIE 0.4603 60 6 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 44233216 G C C rs28362857 missense 0.0296 0.0296 NFKBIE 0.0685 61 5 0 20 6 0
Downstream signaling events of B Cell Receptor (BCR) 6 91239702 T A A rs62409064 intronic 0.0407 0.0407 MAP3K7 0.4940 58 7 1 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 6 91296810 C T T rs34016005 upstream 0.0303 0.0303 MAP3K7 0.4762 60 5 1 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 6 170851525 G A A rs12200064 intronic 0.0431 0.0431 PSMB1 0.3694 59 5 2 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 6 170858332 G A A rs17860779 intronic 0.0420 0.0420 PSMB1 1.0000 59 6 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 7 2955476 G C C rs41336352 intronic 0.0400 0.0400 CARD11 1.0000 58 8 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 7 2966334 G A A rs41448444 intronic 0.0454 0.0454 CARD11 0.7213 58 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 7 2968105 C A A rs71527417 intronic 0.0472 0.0472 CARD11 0.0436 49 16 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 7 2970297 C T T rs41386651 intronic 0.0410 0.0410 CARD11 0.7386 56 8 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 7 2970866 C T T rs9648301 intronic 0.0444 0.0444 CARD11 1.0000 57 9 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 7 3029796 G C C rs12700500 intronic 0.0454 0.0454 CARD11 1.0000 59 7 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 7 3042802 G A A rs35579453 intronic 0.0363 0.0363 CARD11 1.0000 57 9 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 7 3052087 G A A rs75468256 intronic 0.0407 0.0407 CARD11 0.2020 62 4 0 20 4 0
Downstream signaling events of B Cell Receptor (BCR) 7 3072512 T C C rs6975176 intronic 0.0452 0.0452 CARD11 1.0000 61 4 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 7 3073243 G A A rs78353391 intronic 0.0427 0.0427 CARD11 0.0650 56 8 0 18 8 0
Downstream signaling events of B Cell Receptor (BCR) 7 3079195 G T T rs62439353 intronic 0.0400 0.0400 CARD11 0.7348 58 8 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 7 42971385 G A A rs76256519 intronic 0.0432 0.0432 PSMA2 0.1923 61 5 0 21 3 1
Downstream signaling events of B Cell Receptor (BCR) 7 148411091 C T T rs11764941 intronic 0.0416 0.0416 CUL1 0.0082 58 8 0 16 9 1
Downstream signaling events of B Cell Receptor (BCR) 7 148422581 A G G rs11760399 intronic 0.0409 0.0409 CUL1 0.0158 57 9 0 16 9 1
Downstream signaling events of B Cell Receptor (BCR) 7 148427470 A T T rs17625893 intronic 0.0188 0.0188 CUL1 0.3091 59 7 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 7 148453031 C G G rs4726991 intronic 0.0427 0.0427 CUL1 0.0164 61 5 0 18 7 0
Downstream signaling events of B Cell Receptor (BCR) 7 148455710 A G G rs73158225 intronic 0.0426 0.0426 CUL1 0.0333 61 5 0 19 7 0
Downstream signaling events of B Cell Receptor (BCR) 7 148456174 T G G rs17537343 intronic 0.0430 0.0430 CUL1 0.0164 61 5 0 18 7 0
Downstream signaling events of B Cell Receptor (BCR) 7 148458141 C T T rs73158226 intronic 0.0426 0.0426 CUL1 0.0616 61 5 0 18 6 0
Downstream signaling events of B Cell Receptor (BCR) 7 148470413 T C C rs73158234 intronic 0.0423 0.0423 CUL1 0.0333 61 5 0 19 7 0
Downstream signaling events of B Cell Receptor (BCR) 7 148502252 T C C rs77948593 downstream 0.0395 0.0395 CUL1 1.0000 59 6 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 8 42125339 T C C rs76361874 upstream 0.0303 0.0303 IKBKB 0.0653 59 7 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42127643 A C C rs17875739 upstream 0.0241 0.0241 IKBKB 0.0653 59 7 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42128072 T A A rs62507976 upstream 0.0296 0.0296 IKBKB 0.4157 61 5 0 23 2 1
Downstream signaling events of B Cell Receptor (BCR) 8 42135678 T G G rs17875740 intronic 0.0335 0.0335 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42138781 G C C rs80313154 intronic 0.0274 0.0274 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42142316 G A A rs79881854 intronic 0.0326 0.0326 IKBKB 0.0321 58 8 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42145446 A G G rs17875744 intronic 0.0327 0.0327 IKBKB 0.0272 57 9 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42150794 C T T rs79123247 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42154866 A G G rs78342373 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42155029 G A A rs112141582 intronic 0.0267 0.0267 IKBKB 0.0321 58 8 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42158881 A G G rs75230171 intronic 0.0327 0.0327 IKBKB 0.0321 58 8 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42159022 C T T rs79460550 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42161317 G A A rs113993388 intronic 0.0280 0.0280 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42162675 C T T rs17875700 intronic 0.0338 0.0338 IKBKB 0.0321 58 8 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42170928 C T T rs76891399 intronic 0.0325 0.0325 IKBKB 0.0321 58 8 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42173677 G T T rs17875746 intronic 0.0322 0.0322 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42180084 G A A rs17875721 intronic 0.0326 0.0326 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42180328 G T T rs17875751 intronic 0.0327 0.0327 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42180679 G A A rs78599265 intronic 0.0333 0.0333 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42186989 C T T rs17875731 intronic 0.0324 0.0324 IKBKB 0.0330 58 8 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 8 42188334 G T T rs79200457 intronic 0.0325 0.0325 IKBKB 0.0666 58 7 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 9 123578733 G A A rs10384 3_prime_UTR 0.0186 0.0186 PSMD5 0.3096 61 5 0 23 1 1
Downstream signaling events of B Cell Receptor (BCR) 9 123598623 A G G rs62581704 intronic 0.0476 0.0476 PSMD5 0.3820 62 4 0 24 1 1
Downstream signaling events of B Cell Receptor (BCR) 9 127118932 G A A rs117300833 intronic 0.0270 0.0270 PSMB7 0.3024 58 7 0 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 9 127119442 G A A rs16927388 intronic 0.0435 0.0435 PSMB7 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 9 127119799 G A A rs56058032 intronic 0.0172 0.0172 PSMB7 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 9 127141846 G C C rs79069085 intronic 0.0178 0.0178 PSMB7 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 9 127143001 T A A rs76699962 intronic 0.0448 0.0448 PSMB7 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 9 127144906 A C C rs79321634 intronic 0.0239 0.0239 PSMB7 0.2833 59 6 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 9 127145687 T C C rs77214542 intronic 0.0335 0.0335 PSMB7 1.0000 58 8 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 9 127145878 G C C rs41274376 intronic 0.0237 0.0237 PSMB7 0.3091 59 7 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 9 127151807 T G G rs114451602 intronic 0.0301 0.0301 PSMB7 0.5095 60 5 1 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 9 127172515 T C C rs140504275 intronic 0.0204 0.0204 PSMB7 0.1666 60 6 0 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 9 127177053 C T T rs73588260 intronic 0.0344 0.0344 PSMB7 0.7366 57 8 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 10 75203331 A T T rs12775630 intronic 0.0464 0.0464 PPP3CB 0.8528 56 8 2 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 10 75243476 G A A rs72814306 intronic 0.0163 0.0163 PPP3CB 0.2725 63 2 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 10 101958770 C T T rs12764732 intronic 0.0464 0.0464 CHUK 0.7209 57 9 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 10 101958858 T G G rs17883365 intronic 0.0229 0.0229 CHUK 1.0000 61 5 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 10 101961171 G A A rs17885986 intronic 0.0496 0.0496 CHUK 0.6322 57 8 1 21 4 1
Downstream signaling events of B Cell Receptor (BCR) 10 101979482 T C C rs12764370 intronic 0.0302 0.0302 CHUK 0.7209 57 9 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 10 103121589 C T T rs11190960 intronic 0.0325 0.0325 BTRC 0.2234 59 6 1 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 10 103165858 G A A rs145847638 intronic 0.0278 0.0278 BTRC 0.4058 59 6 1 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 10 103180336 G A A rs11191003 intronic 0.0274 0.0274 BTRC 0.2234 59 6 1 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 10 103231195 T C C rs34711120 intronic 0.0435 0.0435 BTRC 0.7302 58 8 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 10 103272221 C T T rs12774622 intronic 0.0257 0.0257 BTRC 0.7970 57 8 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 10 103298099 G T T rs4151060 missense 0.0289 0.0289 BTRC 0.6362 55 10 1 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 242014 T A A rs17727753 intronic 0.0189 0.0189 PSMD13 1.0000 60 5 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 249105 G A A rs11601352 intronic 0.0465 0.0465 PSMD13 0.7522 56 10 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 11 527311 T G G rs117011293 downstream 0.0497 0.0497 HRAS 0.4157 61 5 0 23 2 1
Downstream signaling events of B Cell Receptor (BCR) 11 14528592 T A A rs11023241 intronic 0.0417 0.0417 PSMA1 0.6117 57 8 1 23 2 1
Downstream signaling events of B Cell Receptor (BCR) 11 14531031 C T T rs78398913 intronic 0.0273 0.0273 PSMA1 1.0000 56 9 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 11 14537004 A G G rs74589503 intronic 0.0418 0.0418 PSMA1 0.4981 56 10 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 14540827 C T T rs79966935 intronic 0.0233 0.0233 PSMA1 0.7222 57 9 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 14541179 A T T rs61883612 intronic 0.0441 0.0441 PSMA1 0.7666 55 11 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 11 14556220 C T T rs34162548 intronic 0.0376 0.0376 PSMA1 1.0000 55 11 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 11 14588324 G A A rs78854818 intronic 0.0413 0.0413 PSMA1 1.0000 59 6 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 14602698 T G G rs17567703 intronic 0.0418 0.0418 PSMA1 1.0000 58 8 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 11 14622982 G A A rs16930367 intronic 0.0250 0.0250 PSMA1 0.7192 58 8 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 14627135 G A A rs55760529 intronic 0.0485 0.0485 PSMA1 1.0000 56 9 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 11 14633490 G A A rs11023274 intronic 0.0317 0.0317 PSMA1 1.0000 56 9 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 11 14648387 G A A rs79123458 intronic 0.0412 0.0412 PSMA1 1.0000 59 6 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 11 47441683 C T T rs72903900 intronic 0.0375 0.0375 PSMC3 0.8389 59 5 2 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 11 47449591 G A A rs116930066 upstream 0.0311 0.0311 PSMC3 0.5028 56 9 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 12 25374046 T C C rs117991169 intronic 0.0070 0.0070 KRAS 1.0000 63 2 1 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 12 25384938 C T T rs187995827 intronic 0.0218 0.0218 KRAS 0.6900 61 4 1 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 12 25389886 T C C rs61761102 intronic 0.0354 0.0354 KRAS 1.0000 57 7 2 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 12 25393865 A C C rs17388893 intronic 0.0338 0.0338 KRAS 1.0000 57 7 2 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 12 25395953 T C C rs61761078 intronic 0.0309 0.0309 KRAS 0.5904 57 8 1 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 12 25397593 A C C rs61761074 intronic 0.0336 0.0336 KRAS 0.3096 61 5 0 23 1 1
Downstream signaling events of B Cell Receptor (BCR) 12 25398972 C T T rs17329975 intronic 0.0340 0.0340 KRAS 1.0000 57 7 2 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 12 122349404 T G G rs113810917 intronic 0.0229 0.0229 PSMD9 0.1282 57 8 1 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 12 122351293 A C C rs73229956 intronic 0.0288 0.0288 PSMD9 0.2597 54 11 1 24 1 0
Downstream signaling events of B Cell Receptor (BCR) 12 125395161 G C C rs113660988 downstream 0.0428 0.0428 UBC 0.0064 64 1 1 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 12 125395728 C T T rs112205208 downstream 0.0429 0.0429 UBC 0.0064 64 1 1 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 12 125398911 C T T rs112043091 5_prime_UTR 0.0430 0.0430 UBC 0.0064 64 1 1 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 12 125399133 C T T rs41276688 5_prime_UTR 0.0434 0.0434 UBC 0.0064 64 1 1 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 14 23512430 C T T rs78162644 3_prime_UTR 0.0459 0.0459 PSMB11 1.0000 57 9 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 14 35787993 A T T rs12890150 downstream 0.0324 0.0324 PSMA6 0.5321 62 3 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 14 53178728 T C C rs117516552 intronic 0.0276 0.0276 PSMC6 0.7209 57 9 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 14 58710711 C G G rs117328560 upstream 0.0280 0.0280 PSMA3 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 14 58729996 C G G rs111364917 intronic 0.0397 0.0397 PSMA3 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 14 58731398 T G G rs117955444 intronic 0.0210 0.0210 PSMA3 1.0000 59 7 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 14 90868665 A G G rs34825576 intronic 0.0382 0.0382 CALM1 0.5425 53 13 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 15 38801129 C T T rs12901652 intronic 0.0478 0.0478 RASGRP1 0.0703 56 9 1 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 15 38803689 G A A rs28710819 intronic 0.0461 0.0461 RASGRP1 0.7703 53 13 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 15 38805185 A C C rs55888286 intronic 0.0498 0.0498 RASGRP1 0.7632 60 5 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 15 38816519 G A A rs35925499 intronic 0.0463 0.0463 RASGRP1 0.7302 58 8 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 15 78834476 A G G rs41280046 intronic 0.0393 0.0393 PSMA4 0.7087 60 6 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
Downstream signaling events of B Cell Receptor (BCR) 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
Downstream signaling events of B Cell Receptor (BCR) 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
Downstream signaling events of B Cell Receptor (BCR) 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
Downstream signaling events of B Cell Receptor (BCR) 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
Downstream signaling events of B Cell Receptor (BCR) 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
Downstream signaling events of B Cell Receptor (BCR) 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
Downstream signaling events of B Cell Receptor (BCR) 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 67973569 C T T rs17240392 upstream 0.0497 0.0497 PSMB10 0.4984 59 7 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 16 68137486 G T T rs78479045 intronic 0.0183 0.0183 NFATC3 0.7734 60 5 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 68165961 G C C rs75914405 intronic 0.0183 0.0183 NFATC3 0.7734 60 5 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 16 68170298 C T T rs117300105 intronic 0.0352 0.0352 NFATC3 0.1078 62 4 0 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 16 74334545 G T T rs149977784 intronic 0.0196 0.0196 PSMD7 1.0000 62 2 2 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 17 4702206 C A A rs71368518 downstream 0.0416 0.0416 PSMB6 1.0000 56 9 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 17 30778483 C T T rs117117721 intronic 0.0190 0.0190 PSMD11 1.0000 59 7 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 17 30791889 C T T rs35225085 intronic 0.0427 0.0427 PSMD11 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 17 30794889 C G G rs35177842 intronic 0.0430 0.0430 PSMD11 0.4999 56 10 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 17 36920050 C T T rs118080693 intronic 0.0415 0.0415 PSMB3 0.1732 63 3 0 25 0 1
Downstream signaling events of B Cell Receptor (BCR) 17 38144079 G T T rs118009374 intronic 0.0189 0.0189 PSMD3 0.8767 53 11 2 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 17 38154396 C T T rs118034841 downstream 0.0176 0.0176 PSMD3 0.0569 56 10 0 26 0 0
Downstream signaling events of B Cell Receptor (BCR) 17 65334270 T A A rs146515782 3_prime_UTR 0.0418 0.0418 PSMD12 1.0000 58 8 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 23711373 G T T rs79820119 upstream 0.0407 0.0407 PSMA8 0.2218 53 13 0 23 2 0
Downstream signaling events of B Cell Receptor (BCR) 18 23715815 T G G rs4800242 intronic 0.0460 0.0460 PSMA8 0.7043 59 6 0 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 23774138 C A A rs79452515 downstream 0.0424 0.0424 PSMA8 0.2993 59 7 0 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 18 56333866 G A A rs72958690 upstream 0.0368 0.0368 MALT1 0.8183 56 9 1 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 18 56338792 G A A rs56142402 5_prime_UTR 0.0327 0.0327 MALT1 0.8110 57 8 1 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 18 56363534 A C C rs55825071 intronic 0.0377 0.0377 MALT1 0.6531 56 9 1 20 5 0
Downstream signaling events of B Cell Receptor (BCR) 18 77161434 C T T rs73007652 intronic 0.0439 0.0439 NFATC1 1.0000 54 12 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 18 77181200 C T T rs4799054 intronic 0.0312 0.0312 NFATC1 0.3820 62 4 0 24 1 1
Downstream signaling events of B Cell Receptor (BCR) 18 77193040 G A A rs142796661 intronic 0.0417 0.0417 NFATC1 0.4442 53 12 0 21 4 1
Downstream signaling events of B Cell Receptor (BCR) 18 77197508 G A A rs117121680 intronic 0.0416 0.0416 NFATC1 0.3172 52 13 0 21 4 1
Downstream signaling events of B Cell Receptor (BCR) 18 77199322 C T T rs75588847 intronic 0.0455 0.0455 NFATC1 0.3091 59 7 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 18 77199460 G A A rs62096887 intronic 0.0211 0.0211 NFATC1 1.0000 60 6 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 18 77211908 G A A rs55953864 intronic 0.0480 0.0480 NFATC1 0.3091 59 7 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 18 77212989 G T T rs73007700 intronic 0.0438 0.0438 NFATC1 0.5065 58 8 0 21 5 0
Downstream signaling events of B Cell Receptor (BCR) 18 77239775 G A A rs117383241 intronic 0.0246 0.0246 NFATC1 0.7113 59 6 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 77241715 G A A rs117246954 intronic 0.0175 0.0175 NFATC1 0.7222 57 9 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 18 77256499 A G G rs62096906 intronic 0.0466 0.0466 NFATC1 1.0000 53 12 0 22 4 0
Downstream signaling events of B Cell Receptor (BCR) 18 77275049 A G G rs113507668 intronic 0.0393 0.0393 NFATC1 1.0000 58 7 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 77278071 G A A rs116844899 intronic 0.0231 0.0231 NFATC1 1.0000 59 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 77279921 G A A rs79426764 intronic 0.0497 0.0497 NFATC1 0.2606 51 15 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 18 77279961 A G G rs76389821 intronic 0.0306 0.0306 NFATC1 0.2710 56 9 0 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 19 40472450 A C C rs147915270 upstream 0.0382 0.0382 PSMC4 1.0000 58 7 1 22 3 0
Downstream signaling events of B Cell Receptor (BCR) 19 40475070 T G G rs139876278 upstream 0.0147 0.0147 PSMC4 0.2725 63 2 1 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 20 1128622 T C C rs74871431 intronic 0.0320 0.0320 PSMF1 0.7087 60 6 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 20 1146048 C T T rs17716261 3_prime_UTR 0.0279 0.0279 PSMF1 0.4532 60 6 0 21 4 0
Downstream signaling events of B Cell Receptor (BCR) 20 1149980 C T T rs77625408 downstream 0.0254 0.0254 PSMF1 0.7495 54 11 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 20 1152323 C T T rs34552580 downstream 0.0323 0.0323 PSMF1 1.0000 59 5 1 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 20 1155154 G A A rs78313102 intronic,non_coding_transcript 0.0258 0.0258 PSMF1 1.0000 58 7 0 23 3 0
Downstream signaling events of B Cell Receptor (BCR) 20 50001132 C T T rs75343958 downstream 0.0191 0.0191 NFATC2 0.0863 60 6 0 24 0 1
Downstream signaling events of B Cell Receptor (BCR) 20 50014957 G A A rs77379100 intronic 0.0207 0.0207 NFATC2 0.7222 57 9 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 20 50113131 A C C rs73128899 intronic 0.0467 0.0467 NFATC2 0.7632 60 5 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 20 50113240 A G G rs73128900 intronic 0.0466 0.0466 NFATC2 0.7632 60 5 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 20 50124126 C T T rs6013204 intronic 0.0473 0.0473 NFATC2 1.0000 60 6 0 24 2 0
Downstream signaling events of B Cell Receptor (BCR) 20 50129716 T C C rs17728960 intronic 0.0477 0.0477 NFATC2 0.7621 59 6 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 20 50143470 C T T rs77042341 intronic 0.0367 0.0367 NFATC2 0.7631 59 5 1 25 1 0
Downstream signaling events of B Cell Receptor (BCR) 20 50170376 T G G rs80208372 intronic 0.0480 0.0480 NFATC2 1.0000 55 10 0 22 4 0
Depolymerisation of the Nuclear Lamina 2 11819328 G A A rs140904588 intronic 0.0333 0.0333 LPIN1 0.1086 59 5 0 25 0 1
Depolymerisation of the Nuclear Lamina 2 11848161 C G G rs77534915 intronic 0.0360 0.0360 LPIN1 0.6828 61 5 0 23 3 0
Depolymerisation of the Nuclear Lamina 2 11882703 A C C rs80102993 intronic 0.0434 0.0434 LPIN1 0.4984 59 7 0 22 4 0
Depolymerisation of the Nuclear Lamina 2 11885139 C T T rs74899248 intronic 0.0444 0.0444 LPIN1 0.4984 59 7 0 22 4 0
Depolymerisation of the Nuclear Lamina 2 11885972 C G G rs78733123 intronic 0.0354 0.0354 LPIN1 0.4393 60 6 0 23 2 1
Depolymerisation of the Nuclear Lamina 2 11894527 C G G rs75421235 intronic 0.0416 0.0416 LPIN1 0.7222 57 9 0 24 2 0
Depolymerisation of the Nuclear Lamina 2 11895388 C T T rs11694928 intronic 0.0498 0.0498 LPIN1 0.5065 58 8 0 21 5 0
Depolymerisation of the Nuclear Lamina 2 11911946 G A A rs111726318 intronic 0.0471 0.0471 LPIN1 0.2818 60 6 0 21 5 0
Depolymerisation of the Nuclear Lamina 2 11943082 C T T rs4669781 missense 0.0342 0.0342 LPIN1 0.1706 56 10 0 25 1 0
Depolymerisation of the Nuclear Lamina 2 11945495 A C C rs79025286 intronic 0.0282 0.0282 LPIN1 0.2744 57 9 0 24 1 0
Depolymerisation of the Nuclear Lamina 2 11955603 C T T rs75560733 intronic 0.0410 0.0410 LPIN1 0.5425 53 13 0 23 3 0
Depolymerisation of the Nuclear Lamina 2 11963271 A C C rs56163146 intronic 0.0449 0.0449 LPIN1 0.4984 59 7 0 22 4 0
Depolymerisation of the Nuclear Lamina 2 11968029 A G G rs34857485 downstream 0.0304 0.0304 LPIN1 0.4098 61 5 0 24 1 1
Depolymerisation of the Nuclear Lamina 5 68462801 C G G rs8192259 upstream 0.0444 0.0444 CCNB1 0.7688 54 11 0 21 5 0
Depolymerisation of the Nuclear Lamina 5 126143504 C T C rs2973605 intronic 0.9641 0.0359 LMNB1 1.0000 1 8 57 0 3 22
Depolymerisation of the Nuclear Lamina 6 33746837 C T T rs151266730 intronic 0.0122 0.0122 LEMD2 0.5321 62 3 1 23 3 0
Depolymerisation of the Nuclear Lamina 10 62548390 G A A rs3213056 intronic 0.0326 0.0326 CDK1 0.7469 57 9 0 21 4 0
Depolymerisation of the Nuclear Lamina 12 65578819 T G G rs75563741 intronic 0.0221 0.0221 LEMD3 0.4862 59 7 0 21 4 0
Depolymerisation of the Nuclear Lamina 12 65586630 A G G rs78691095 intronic 0.0389 0.0389 LEMD3 0.8053 57 8 1 21 4 0
Depolymerisation of the Nuclear Lamina 12 65594504 A G G rs74809372 intronic 0.0234 0.0234 LEMD3 0.2781 56 10 0 24 1 0
Depolymerisation of the Nuclear Lamina 12 98930771 G A A rs57467331 downstream 0.0354 0.0354 TMPO 0.4862 59 7 0 21 4 0
Depolymerisation of the Nuclear Lamina 12 98932013 G C C rs76069997 downstream 0.0352 0.0352 TMPO 0.4984 59 7 0 22 4 0
Depolymerisation of the Nuclear Lamina 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
Depolymerisation of the Nuclear Lamina 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
Depolymerisation of the Nuclear Lamina 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Depolymerisation of the Nuclear Lamina 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Depolymerisation of the Nuclear Lamina 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
Depolymerisation of the Nuclear Lamina 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
Depolymerisation of the Nuclear Lamina 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
Depolymerisation of the Nuclear Lamina 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Depolymerisation of the Nuclear Lamina 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
Depolymerisation of the Nuclear Lamina 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
Depolymerisation of the Nuclear Lamina 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
Depolymerisation of the Nuclear Lamina 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
Depolymerisation of the Nuclear Lamina 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
Depolymerisation of the Nuclear Lamina 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
Depolymerisation of the Nuclear Lamina 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
Depolymerisation of the Nuclear Lamina 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
Depolymerisation of the Nuclear Lamina 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
Depolymerisation of the Nuclear Lamina 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
Depolymerisation of the Nuclear Lamina 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
Depolymerisation of the Nuclear Lamina 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
Depolymerisation of the Nuclear Lamina 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
Depolymerisation of the Nuclear Lamina 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
Depolymerisation of the Nuclear Lamina 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
Depolymerisation of the Nuclear Lamina 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
Depolymerisation of the Nuclear Lamina 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
Depolymerisation of the Nuclear Lamina 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
Depolymerisation of the Nuclear Lamina 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
Depolymerisation of the Nuclear Lamina 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
Depolymerisation of the Nuclear Lamina 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Depolymerisation of the Nuclear Lamina 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Depolymerisation of the Nuclear Lamina 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
Depolymerisation of the Nuclear Lamina 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
Depolymerisation of the Nuclear Lamina 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
Depolymerisation of the Nuclear Lamina 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
Depolymerisation of the Nuclear Lamina 16 50058523 C T T rs111253683 5_prime_UTR 0.0302 0.0302 CNEP1R1 0.5717 61 4 1 23 3 0
Depolymerisation of the Nuclear Lamina 17 64305051 A G G rs78357146 intronic 0.0186 0.0186 PRKCA 0.7209 57 9 0 23 2 0
Depolymerisation of the Nuclear Lamina 17 64315409 T C C rs80130647 intronic 0.0184 0.0184 PRKCA 0.7043 59 6 0 22 3 0
Depolymerisation of the Nuclear Lamina 17 64318385 G A A rs12150623 intronic 0.0343 0.0343 PRKCA 0.7595 61 4 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64320040 C T T rs139317720 intronic 0.0229 0.0229 PRKCA 1.0000 62 3 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64326068 T G G rs12951126 intronic 0.0260 0.0260 PRKCA 1.0000 58 8 0 23 3 0
Depolymerisation of the Nuclear Lamina 17 64343295 A C C rs72843901 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64344650 C T T rs72846606 intronic 0.0454 0.0454 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64344788 C T T rs72846607 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64346204 A G G rs12150367 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64349104 C T T rs72846609 intronic 0.0497 0.0497 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64351542 G C C rs28592028 intronic 0.0453 0.0453 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64352431 T G G rs544435459 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64354597 T C C rs72846612 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64358121 C G G rs72846614 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64359354 T C C rs72846615 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64365593 C T T rs72846677 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64367534 C T T rs72846678 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64369822 A G G rs72846681 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64375194 T C C rs72846695 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64377301 C A A rs113134992 intronic 0.0448 0.0448 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64382507 C G G rs79461368 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64389524 C T T rs77682324 intronic 0.0403 0.0403 PRKCA 0.7621 59 6 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64395773 T C C rs78584531 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64396570 T G G rs72838208 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64396695 A G G rs74329211 intronic 0.0432 0.0432 PRKCA 0.7302 58 8 0 21 4 0
Depolymerisation of the Nuclear Lamina 17 64396883 G A A rs72838209 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64398013 G A A rs75125285 intronic 0.0295 0.0295 PRKCA 0.7632 60 5 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64400648 C T T rs72838214 intronic 0.0452 0.0452 PRKCA 0.4788 55 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64402141 G T T rs10221238 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64405430 T A A rs72838216 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64410564 C T T rs9972974 intronic 0.0390 0.0390 PRKCA 0.7632 60 5 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64412921 G A A rs62070391 intronic 0.0426 0.0426 PRKCA 0.7621 59 6 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64424382 C T T rs62070395 intronic 0.0425 0.0425 PRKCA 0.7595 59 6 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64429928 G A A rs117729211 intronic 0.0272 0.0272 PRKCA 0.0477 60 6 0 19 6 1
Depolymerisation of the Nuclear Lamina 17 64431874 G A A rs72838278 intronic 0.0426 0.0426 PRKCA 0.7642 57 6 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64432202 A G G rs62070397 intronic 0.0427 0.0427 PRKCA 0.7621 59 6 1 25 1 0
Depolymerisation of the Nuclear Lamina 17 64432881 A G G rs62070398 intronic 0.0426 0.0426 PRKCA 0.7595 59 6 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64438732 A T T rs113684166 intronic 0.0445 0.0445 PRKCA 0.2744 57 9 0 24 1 0
Depolymerisation of the Nuclear Lamina 17 64441204 T C C rs75005068 intronic 0.0469 0.0469 PRKCA 0.2719 57 9 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64441759 C A A rs78330327 intronic 0.0465 0.0465 PRKCA 0.2710 56 9 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64445337 A C C rs118090701 intronic 0.0387 0.0387 PRKCA 1.0000 58 6 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64445856 A G G rs12451388 intronic 0.0449 0.0449 PRKCA 0.2744 57 9 0 24 1 0
Depolymerisation of the Nuclear Lamina 17 64447721 G A A rs12452749 intronic 0.0462 0.0462 PRKCA 0.2786 57 9 0 23 1 0
Depolymerisation of the Nuclear Lamina 17 64450113 G C C rs80162292 intronic 0.0461 0.0461 PRKCA 0.2710 56 9 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64453194 A G G rs111776777 intronic 0.0442 0.0442 PRKCA 0.8716 54 10 2 23 3 0
Depolymerisation of the Nuclear Lamina 17 64458036 C T T rs113153197 intronic 0.0339 0.0339 PRKCA 0.1678 54 11 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64462111 T G G rs79239451 intronic 0.0464 0.0464 PRKCA 0.2744 57 9 0 24 1 0
Depolymerisation of the Nuclear Lamina 17 64462288 G A A rs80080003 intronic 0.0305 0.0305 PRKCA 0.1706 56 10 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64483589 G T T rs79070174 intronic 0.0391 0.0391 PRKCA 1.0000 59 6 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64487077 T G G rs78149509 intronic 0.0200 0.0200 PRKCA 0.0381 63 3 0 21 4 1
Depolymerisation of the Nuclear Lamina 17 64494906 A G G rs117168126 intronic 0.0300 0.0300 PRKCA 1.0000 59 6 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64501943 C T T rs7217954 intronic 0.0422 0.0422 PRKCA 1.0000 59 7 0 23 3 0
Depolymerisation of the Nuclear Lamina 17 64519790 G A A rs11659067 intronic 0.0498 0.0498 PRKCA 0.0125 62 3 0 19 6 0
Depolymerisation of the Nuclear Lamina 17 64525002 A T T rs77462363 intronic 0.0380 0.0380 PRKCA 1.0000 59 6 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64544723 C T T rs116879811 intronic 0.0274 0.0274 PRKCA 1.0000 60 6 0 24 2 0
Depolymerisation of the Nuclear Lamina 17 64559535 A G G rs227907 intronic 0.0478 0.0478 PRKCA 0.2800 55 11 0 21 3 1
Depolymerisation of the Nuclear Lamina 17 64561055 G A A rs62071706 intronic 0.0238 0.0238 PRKCA 0.1546 60 5 0 21 4 1
Depolymerisation of the Nuclear Lamina 17 64590951 A T T rs11867591 intronic 0.0449 0.0449 PRKCA 0.2122 57 8 0 20 6 0
Depolymerisation of the Nuclear Lamina 17 64604776 C T T rs117539643 intronic 0.0479 0.0479 PRKCA 0.6653 51 11 2 23 3 0
Depolymerisation of the Nuclear Lamina 17 64608923 T C C rs72845947 intronic 0.0440 0.0440 PRKCA 0.7355 57 7 2 21 4 0
Depolymerisation of the Nuclear Lamina 17 64610285 T C C rs72845948 intronic 0.0445 0.0445 PRKCA 0.8583 57 7 2 22 4 0
Depolymerisation of the Nuclear Lamina 17 64610480 A C C rs17759657 intronic 0.0444 0.0444 PRKCA 0.8583 57 7 2 22 4 0
Depolymerisation of the Nuclear Lamina 17 64612838 C T T rs16959714 intronic 0.0338 0.0338 PRKCA 0.4353 57 8 0 24 1 0
Depolymerisation of the Nuclear Lamina 17 64614717 T C C rs17686540 intronic 0.0442 0.0442 PRKCA 0.7355 57 7 2 21 4 0
Depolymerisation of the Nuclear Lamina 17 64626385 G A A rs74352723 intronic 0.0460 0.0460 PRKCA 0.2744 57 9 0 24 1 0
Depolymerisation of the Nuclear Lamina 17 64628634 A G G rs117353888 intronic 0.0437 0.0437 PRKCA 0.2521 54 11 0 18 7 0
Depolymerisation of the Nuclear Lamina 17 64660047 G C C rs146141011 intronic 0.0484 0.0484 PRKCA 1.0000 53 9 2 22 4 0
Depolymerisation of the Nuclear Lamina 17 64671047 C T T rs16959942 intronic 0.0496 0.0496 PRKCA 0.1706 56 10 0 25 1 0
Depolymerisation of the Nuclear Lamina 17 64712634 T C C rs78121420 intronic 0.0465 0.0465 PRKCA 1.0000 57 7 2 23 3 0
Depolymerisation of the Nuclear Lamina 17 64713847 G T T rs112934229 intronic 0.0464 0.0464 PRKCA 1.0000 57 7 2 23 3 0
Depolymerisation of the Nuclear Lamina 17 64723880 G A A rs79547774 intronic 0.0264 0.0264 PRKCA 1.0000 57 9 0 23 3 0
Depolymerisation of the Nuclear Lamina 17 64738427 A C C rs117138620 intronic 0.0400 0.0400 PRKCA 0.3055 58 8 0 23 2 1
Depolymerisation of the Nuclear Lamina 17 64748431 G T T rs141177250 intronic 0.0153 0.0153 PRKCA 0.7595 59 6 1 24 1 0
Depolymerisation of the Nuclear Lamina 17 64755018 T C C rs74831470 intronic 0.0226 0.0226 PRKCA 0.7976 56 9 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64760870 A G G rs77904275 intronic 0.0307 0.0307 PRKCA 0.5233 53 11 1 24 2 0
Depolymerisation of the Nuclear Lamina 17 64762410 C G G rs113025478 intronic 0.0307 0.0307 PRKCA 0.6398 54 11 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64763235 T C C rs77635068 intronic 0.0306 0.0306 PRKCA 0.6398 54 11 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64771614 C T T rs80238933 intronic 0.0297 0.0297 PRKCA 0.6398 54 11 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64776847 G A A rs113542727 intronic 0.0297 0.0297 PRKCA 0.5228 54 11 1 24 2 0
Depolymerisation of the Nuclear Lamina 17 64791836 G C C rs56884788 intronic 0.0390 0.0390 PRKCA 0.6362 55 10 1 23 2 0
Depolymerisation of the Nuclear Lamina 17 64792863 G C C rs72838636 intronic 0.0484 0.0484 PRKCA 0.6470 57 8 1 21 5 0
Depolymerisation of the Nuclear Lamina 18 2967168 A T T rs145394193 intronic 0.0160 0.0160 LPIN2 0.7192 58 8 0 24 2 0
Depolymerisation of the Nuclear Lamina 18 3015946 A G G rs77361064 upstream 0.0479 0.0479 LPIN2 1.0000 57 9 0 22 4 0
Depolymerisation of the Nuclear Lamina 18 3016562 T C C rs76840312 upstream 0.0473 0.0473 LPIN2 1.0000 57 9 0 22 4 0
Depolymerisation of the Nuclear Lamina 20 39968020 A T T rs117029881 upstream 0.0108 0.0108 LPIN3 0.7632 60 5 1 25 1 0
Depolymerisation of the Nuclear Lamina 20 39971848 T C C rs79070826 intronic 0.0382 0.0382 LPIN3 1.0000 61 4 1 25 1 0
Depolymerisation of the Nuclear Lamina 20 39977650 C T T rs78339899 intronic 0.0345 0.0345 LPIN3 1.0000 61 4 1 25 1 0
Depolymerisation of the Nuclear Lamina 20 39982743 C T T rs7269761 intronic 0.0405 0.0405 LPIN3 1.0000 60 4 1 25 1 0
Depolymerisation of the Nuclear Lamina 20 39984988 G A A rs79649817 intronic 0.0295 0.0295 LPIN3 1.0000 61 4 1 25 1 0
Depolymerisation of the Nuclear Lamina 20 39989181 C T T rs2235594 3_prime_UTR 0.0462 0.0462 LPIN3 1.0000 60 4 1 25 1 0
Disinhibition of SNARE formation 1 109285777 G A A rs61797290 upstream 0.0453 0.0453 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109290893 C T T rs1004424 intronic 0.0414 0.0414 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109291952 G T T rs61797292 intronic 0.0458 0.0458 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109292062 G A A rs61797293 intronic 0.0417 0.0417 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109293596 T C C rs61797294 intronic 0.0465 0.0465 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109295260 C G G rs41299559 intronic 0.0458 0.0458 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109300874 A G G rs61797297 intronic 0.0444 0.0444 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109308400 C G G rs61797304 intronic 0.0450 0.0450 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109310759 A G G rs76989906 intronic 0.0458 0.0458 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109311501 T G G rs74406644 intronic 0.0458 0.0458 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 1 109316394 A C C rs61797328 intronic 0.0458 0.0458 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109317182 C T T rs74727654 intronic 0.0459 0.0459 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109324694 A G G rs61797330 intronic 0.0413 0.0413 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109334327 A C C rs61797332 intronic 0.0415 0.0415 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109341648 T G G rs61797348 intronic 0.0458 0.0458 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109347906 G C C rs61797351 intronic 0.0415 0.0415 STXBP3 0.2699 60 6 0 21 3 1
Disinhibition of SNARE formation 1 109351109 A G G rs61797354 intronic 0.0419 0.0419 STXBP3 0.2789 60 6 0 22 3 1
Disinhibition of SNARE formation 16 23845860 G T T rs72777910 upstream 0.0300 0.0300 PRKCB 0.4762 60 5 1 22 4 0
Disinhibition of SNARE formation 16 23849482 T C T rs2023670 intronic 0.9513 0.0487 PRKCB 0.0099 0 11 55 1 0 25
Disinhibition of SNARE formation 16 23850240 A G A rs11074581 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Disinhibition of SNARE formation 16 23851956 T C T rs7189210 intronic 0.9663 0.0337 PRKCB 0.0099 0 11 55 1 0 25
Disinhibition of SNARE formation 16 23852415 A T A rs2188359 intronic 0.9528 0.0472 PRKCB 0.0099 0 11 55 1 0 25
Disinhibition of SNARE formation 16 23859391 A G G rs62030647 intronic 0.0226 0.0226 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23874933 A C A rs6497691 intronic 0.9663 0.0337 PRKCB 0.0063 0 14 52 1 0 24
Disinhibition of SNARE formation 16 23876099 C T T rs79131874 intronic 0.0303 0.0303 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23877500 A G A rs8059885 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23877606 A G A rs8060048 intronic 0.9644 0.0356 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23877781 G A G rs8060718 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23878470 C T C rs12935004 intronic 0.9657 0.0343 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23880851 C T C rs8061523 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23881930 G A G rs8047121 intronic 0.9662 0.0338 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23882469 T C T rs1468129 intronic 0.9663 0.0337 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23885608 A T A rs8044732 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23885751 A G G rs62031692 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23887574 G T T rs79034087 intronic 0.0290 0.0290 PRKCB 0.3487 61 4 1 22 4 0
Disinhibition of SNARE formation 16 23888354 C T C rs7404417 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23889896 T C T rs8063823 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23893893 G A G rs11647359 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23895034 A G A rs6497695 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23895443 A G G rs62028075 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23895884 T C T rs9944348 intronic 0.9665 0.0335 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23896089 T C C rs74572166 intronic 0.0245 0.0245 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23896209 C A C rs9302418 intronic 0.9664 0.0336 PRKCB 0.0046 0 14 52 1 0 25
Disinhibition of SNARE formation 16 23896438 G T T rs62028076 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 22 3 0
Disinhibition of SNARE formation 16 23898605 A T A rs933290 intronic 0.9632 0.0368 PRKCB 0.0016 0 17 49 1 0 24
Disinhibition of SNARE formation 16 23899211 A T A rs12926245 intronic 0.9632 0.0368 PRKCB 0.0012 0 17 49 1 0 25
Disinhibition of SNARE formation 16 23899610 G A A rs17753246 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23899951 G A A rs62028077 intronic 0.0254 0.0254 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23900716 T C C rs62028078 intronic 0.0252 0.0252 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23901896 C T C rs6497696 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23901948 A C A rs6497697 intronic 0.9630 0.0370 PRKCB 0.0015 0 16 49 1 0 25
Disinhibition of SNARE formation 16 23904058 A G A rs886115 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23904781 G A A rs17753509 intronic 0.0253 0.0253 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23905676 C T C rs7200610 intronic 0.9631 0.0369 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23907177 A C C rs17810011 intronic 0.0251 0.0251 PRKCB 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 16 23907765 C T C rs9925890 intronic 0.9632 0.0368 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23912174 A G A rs12448249 intronic 0.9519 0.0481 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23914915 C A C rs1004186 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23916258 G A G rs1004187 intronic 0.9632 0.0368 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23916521 G C G rs1008654 intronic 0.9633 0.0367 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23917335 G A G rs6497699 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23917465 C G C rs7186538 intronic 0.9645 0.0355 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23917700 C A C rs7187091 intronic 0.9646 0.0354 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23919088 C T T rs78322646 intronic 0.0278 0.0278 PRKCB 0.7348 58 8 0 22 4 0
Disinhibition of SNARE formation 16 23921083 C T C rs6497702 intronic 0.9647 0.0353 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23925936 C G C rs11074588 intronic 0.9649 0.0351 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23939212 G A G rs11074590 intronic 0.9650 0.0350 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23941628 C A C rs2005671 intronic 0.9647 0.0353 PRKCB 0.0015 0 16 49 1 0 25
Disinhibition of SNARE formation 16 23943749 T C T rs9302420 intronic 0.9649 0.0351 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23945985 T G T rs195989 intronic 0.9651 0.0349 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23946157 G A A rs76973283 intronic 0.0302 0.0302 PRKCB 0.5065 58 8 0 21 5 0
Disinhibition of SNARE formation 16 23949175 G C G rs2560403 intronic 0.9657 0.0343 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23949438 A G A rs195985 intronic 0.9658 0.0342 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23953265 T C T rs2560404 intronic 0.9656 0.0344 PRKCB 0.0024 0 16 50 1 0 24
Disinhibition of SNARE formation 16 23954128 T C C rs17810486 intronic 0.0308 0.0308 PRKCB 0.3024 58 7 0 20 5 0
Disinhibition of SNARE formation 16 23954253 G A G rs195994 intronic 0.9653 0.0347 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23962258 G C G rs196000 intronic 0.9659 0.0341 PRKCB 0.0015 0 16 50 1 0 25
Disinhibition of SNARE formation 16 23964858 T A T rs196003 intronic 0.9647 0.0353 PRKCB 0.0343 0 15 51 0 1 25
Disinhibition of SNARE formation 16 23985814 C T T rs72779914 intronic 0.0487 0.0487 PRKCB 1.0000 53 12 0 21 4 0
Disinhibition of SNARE formation 16 23987552 A G A rs169030 intronic 0.9709 0.0291 PRKCB 0.1679 0 11 55 0 1 25
Disinhibition of SNARE formation 16 23988755 T C T rs196013 intronic 0.9681 0.0319 PRKCB 0.1681 0 11 55 0 1 24
Disinhibition of SNARE formation 16 24009919 A G G rs75622923 intronic 0.0319 0.0319 PRKCB 0.3348 54 12 0 24 2 0
Disinhibition of SNARE formation 16 24022944 C T T rs111746132 intronic 0.0229 0.0229 PRKCB 0.7522 56 10 0 23 3 0
Disinhibition of SNARE formation 16 24066378 G A A rs113426570 intronic 0.0216 0.0216 PRKCB 1.0000 57 9 0 23 3 0
Disinhibition of SNARE formation 16 24100759 T A A rs11643939 intronic 0.0294 0.0294 PRKCB 0.7522 56 10 0 23 3 0
Disinhibition of SNARE formation 16 24105816 G A A rs56316329 intronic 0.0251 0.0251 PRKCB 0.6919 60 4 1 25 0 0
Disinhibition of SNARE formation 16 24111853 T C C rs55959083 intronic 0.0431 0.0431 PRKCB 0.7213 58 8 0 23 2 0
Disinhibition of SNARE formation 16 24112768 G A A rs117056307 intronic 0.0430 0.0430 PRKCB 0.7192 58 8 0 24 2 0
Disinhibition of SNARE formation 16 24122052 G A A rs117467859 intronic 0.0433 0.0433 PRKCB 0.7213 58 8 0 23 2 0
Disinhibition of SNARE formation 16 24122492 C T T rs72779977 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Disinhibition of SNARE formation 16 24123560 G A A rs60261043 intronic 0.0457 0.0457 PRKCB 0.7201 57 8 0 23 2 0
Disinhibition of SNARE formation 16 24132273 G A A rs62027458 intronic 0.0232 0.0232 PRKCB 0.1877 59 7 0 21 4 1
Disinhibition of SNARE formation 16 24164042 G T T rs72779989 intronic 0.0487 0.0487 PRKCB 0.8583 57 7 2 22 4 0
Disinhibition of SNARE formation 16 24197496 A T T rs79699525 intronic 0.0261 0.0261 PRKCB 0.4631 59 6 0 22 4 0
Disinhibition of SNARE formation 16 24199852 C T T rs78424166 intronic 0.0359 0.0359 PRKCB 0.4603 60 6 0 22 4 0
Disinhibition of SNARE formation 17 64305051 A G G rs78357146 intronic 0.0186 0.0186 PRKCA 0.7209 57 9 0 23 2 0
Disinhibition of SNARE formation 17 64315409 T C C rs80130647 intronic 0.0184 0.0184 PRKCA 0.7043 59 6 0 22 3 0
Disinhibition of SNARE formation 17 64318385 G A A rs12150623 intronic 0.0343 0.0343 PRKCA 0.7595 61 4 1 23 2 0
Disinhibition of SNARE formation 17 64320040 C T T rs139317720 intronic 0.0229 0.0229 PRKCA 1.0000 62 3 1 24 1 0
Disinhibition of SNARE formation 17 64326068 T G G rs12951126 intronic 0.0260 0.0260 PRKCA 1.0000 58 8 0 23 3 0
Disinhibition of SNARE formation 17 64343295 A C C rs72843901 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64344650 C T T rs72846606 intronic 0.0454 0.0454 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64344788 C T T rs72846607 intronic 0.0457 0.0457 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64346204 A G G rs12150367 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64349104 C T T rs72846609 intronic 0.0497 0.0497 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64351542 G C C rs28592028 intronic 0.0453 0.0453 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64352431 T G G rs544435459 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64354597 T C C rs72846612 intronic 0.0451 0.0451 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64358121 C G G rs72846614 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64359354 T C C rs72846615 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64365593 C T T rs72846677 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64367534 C T T rs72846678 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64369822 A G G rs72846681 intronic 0.0451 0.0451 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64375194 T C C rs72846695 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64377301 C A A rs113134992 intronic 0.0448 0.0448 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64382507 C G G rs79461368 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64389524 C T T rs77682324 intronic 0.0403 0.0403 PRKCA 0.7621 59 6 1 25 1 0
Disinhibition of SNARE formation 17 64395773 T C C rs78584531 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64396570 T G G rs72838208 intronic 0.0452 0.0452 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64396695 A G G rs74329211 intronic 0.0432 0.0432 PRKCA 0.7302 58 8 0 21 4 0
Disinhibition of SNARE formation 17 64396883 G A A rs72838209 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64398013 G A A rs75125285 intronic 0.0295 0.0295 PRKCA 0.7632 60 5 1 25 1 0
Disinhibition of SNARE formation 17 64400648 C T T rs72838214 intronic 0.0452 0.0452 PRKCA 0.4788 55 9 1 25 1 0
Disinhibition of SNARE formation 17 64402141 G T T rs10221238 intronic 0.0452 0.0452 PRKCA 0.4770 56 9 1 25 1 0
Disinhibition of SNARE formation 17 64405430 T A A rs72838216 intronic 0.0453 0.0453 PRKCA 0.4725 56 9 1 24 1 0
Disinhibition of SNARE formation 17 64410564 C T T rs9972974 intronic 0.0390 0.0390 PRKCA 0.7632 60 5 1 25 1 0
Disinhibition of SNARE formation 17 64412921 G A A rs62070391 intronic 0.0426 0.0426 PRKCA 0.7621 59 6 1 25 1 0
Disinhibition of SNARE formation 17 64424382 C T T rs62070395 intronic 0.0425 0.0425 PRKCA 0.7595 59 6 1 24 1 0
Disinhibition of SNARE formation 17 64429928 G A A rs117729211 intronic 0.0272 0.0272 PRKCA 0.0477 60 6 0 19 6 1
Disinhibition of SNARE formation 17 64431874 G A A rs72838278 intronic 0.0426 0.0426 PRKCA 0.7642 57 6 1 25 1 0
Disinhibition of SNARE formation 17 64432202 A G G rs62070397 intronic 0.0427 0.0427 PRKCA 0.7621 59 6 1 25 1 0
Disinhibition of SNARE formation 17 64432881 A G G rs62070398 intronic 0.0426 0.0426 PRKCA 0.7595 59 6 1 24 1 0
Disinhibition of SNARE formation 17 64438732 A T T rs113684166 intronic 0.0445 0.0445 PRKCA 0.2744 57 9 0 24 1 0
Disinhibition of SNARE formation 17 64441204 T C C rs75005068 intronic 0.0469 0.0469 PRKCA 0.2719 57 9 0 25 1 0
Disinhibition of SNARE formation 17 64441759 C A A rs78330327 intronic 0.0465 0.0465 PRKCA 0.2710 56 9 0 25 1 0
Disinhibition of SNARE formation 17 64445337 A C C rs118090701 intronic 0.0387 0.0387 PRKCA 1.0000 58 6 1 23 2 0
Disinhibition of SNARE formation 17 64445856 A G G rs12451388 intronic 0.0449 0.0449 PRKCA 0.2744 57 9 0 24 1 0
Disinhibition of SNARE formation 17 64447721 G A A rs12452749 intronic 0.0462 0.0462 PRKCA 0.2786 57 9 0 23 1 0
Disinhibition of SNARE formation 17 64450113 G C C rs80162292 intronic 0.0461 0.0461 PRKCA 0.2710 56 9 0 25 1 0
Disinhibition of SNARE formation 17 64453194 A G G rs111776777 intronic 0.0442 0.0442 PRKCA 0.8716 54 10 2 23 3 0
Disinhibition of SNARE formation 17 64458036 C T T rs113153197 intronic 0.0339 0.0339 PRKCA 0.1678 54 11 0 25 1 0
Disinhibition of SNARE formation 17 64462111 T G G rs79239451 intronic 0.0464 0.0464 PRKCA 0.2744 57 9 0 24 1 0
Disinhibition of SNARE formation 17 64462288 G A A rs80080003 intronic 0.0305 0.0305 PRKCA 0.1706 56 10 0 25 1 0
Disinhibition of SNARE formation 17 64483589 G T T rs79070174 intronic 0.0391 0.0391 PRKCA 1.0000 59 6 1 23 2 0
Disinhibition of SNARE formation 17 64487077 T G G rs78149509 intronic 0.0200 0.0200 PRKCA 0.0381 63 3 0 21 4 1
Disinhibition of SNARE formation 17 64494906 A G G rs117168126 intronic 0.0300 0.0300 PRKCA 1.0000 59 6 1 23 2 0
Disinhibition of SNARE formation 17 64501943 C T T rs7217954 intronic 0.0422 0.0422 PRKCA 1.0000 59 7 0 23 3 0
Disinhibition of SNARE formation 17 64519790 G A A rs11659067 intronic 0.0498 0.0498 PRKCA 0.0125 62 3 0 19 6 0
Disinhibition of SNARE formation 17 64525002 A T T rs77462363 intronic 0.0380 0.0380 PRKCA 1.0000 59 6 1 23 2 0
Disinhibition of SNARE formation 17 64544723 C T T rs116879811 intronic 0.0274 0.0274 PRKCA 1.0000 60 6 0 24 2 0
Disinhibition of SNARE formation 17 64559535 A G G rs227907 intronic 0.0478 0.0478 PRKCA 0.2800 55 11 0 21 3 1
Disinhibition of SNARE formation 17 64561055 G A A rs62071706 intronic 0.0238 0.0238 PRKCA 0.1546 60 5 0 21 4 1
Disinhibition of SNARE formation 17 64590951 A T T rs11867591 intronic 0.0449 0.0449 PRKCA 0.2122 57 8 0 20 6 0
Disinhibition of SNARE formation 17 64604776 C T T rs117539643 intronic 0.0479 0.0479 PRKCA 0.6653 51 11 2 23 3 0
Disinhibition of SNARE formation 17 64608923 T C C rs72845947 intronic 0.0440 0.0440 PRKCA 0.7355 57 7 2 21 4 0
Disinhibition of SNARE formation 17 64610285 T C C rs72845948 intronic 0.0445 0.0445 PRKCA 0.8583 57 7 2 22 4 0
Disinhibition of SNARE formation 17 64610480 A C C rs17759657 intronic 0.0444 0.0444 PRKCA 0.8583 57 7 2 22 4 0
Disinhibition of SNARE formation 17 64612838 C T T rs16959714 intronic 0.0338 0.0338 PRKCA 0.4353 57 8 0 24 1 0
Disinhibition of SNARE formation 17 64614717 T C C rs17686540 intronic 0.0442 0.0442 PRKCA 0.7355 57 7 2 21 4 0
Disinhibition of SNARE formation 17 64626385 G A A rs74352723 intronic 0.0460 0.0460 PRKCA 0.2744 57 9 0 24 1 0
Disinhibition of SNARE formation 17 64628634 A G G rs117353888 intronic 0.0437 0.0437 PRKCA 0.2521 54 11 0 18 7 0
Disinhibition of SNARE formation 17 64660047 G C C rs146141011 intronic 0.0484 0.0484 PRKCA 1.0000 53 9 2 22 4 0
Disinhibition of SNARE formation 17 64671047 C T T rs16959942 intronic 0.0496 0.0496 PRKCA 0.1706 56 10 0 25 1 0
Disinhibition of SNARE formation 17 64712634 T C C rs78121420 intronic 0.0465 0.0465 PRKCA 1.0000 57 7 2 23 3 0
Disinhibition of SNARE formation 17 64713847 G T T rs112934229 intronic 0.0464 0.0464 PRKCA 1.0000 57 7 2 23 3 0
Disinhibition of SNARE formation 17 64723880 G A A rs79547774 intronic 0.0264 0.0264 PRKCA 1.0000 57 9 0 23 3 0
Disinhibition of SNARE formation 17 64738427 A C C rs117138620 intronic 0.0400 0.0400 PRKCA 0.3055 58 8 0 23 2 1
Disinhibition of SNARE formation 17 64748431 G T T rs141177250 intronic 0.0153 0.0153 PRKCA 0.7595 59 6 1 24 1 0
Disinhibition of SNARE formation 17 64755018 T C C rs74831470 intronic 0.0226 0.0226 PRKCA 0.7976 56 9 1 23 2 0
Disinhibition of SNARE formation 17 64760870 A G G rs77904275 intronic 0.0307 0.0307 PRKCA 0.5233 53 11 1 24 2 0
Disinhibition of SNARE formation 17 64762410 C G G rs113025478 intronic 0.0307 0.0307 PRKCA 0.6398 54 11 1 23 2 0
Disinhibition of SNARE formation 17 64763235 T C C rs77635068 intronic 0.0306 0.0306 PRKCA 0.6398 54 11 1 23 2 0
Disinhibition of SNARE formation 17 64771614 C T T rs80238933 intronic 0.0297 0.0297 PRKCA 0.6398 54 11 1 23 2 0
Disinhibition of SNARE formation 17 64776847 G A A rs113542727 intronic 0.0297 0.0297 PRKCA 0.5228 54 11 1 24 2 0
Disinhibition of SNARE formation 17 64791836 G C C rs56884788 intronic 0.0390 0.0390 PRKCA 0.6362 55 10 1 23 2 0
Disinhibition of SNARE formation 17 64792863 G C C rs72838636 intronic 0.0484 0.0484 PRKCA 0.6470 57 8 1 21 5 0
Disinhibition of SNARE formation 19 54401602 G C C rs41311973 intronic 0.0163 0.0163 PRKCG 0.7213 58 8 0 23 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 1 212485607 A T A rs351381 intronic 0.9528 0.0472 PPP2R5A 0.2993 0 7 59 0 5 20
Disassembly of the destruction complex and recruitment of AXIN to the membrane 1 212505662 A G G rs17665257 intronic 0.0348 0.0348 PPP2R5A 0.6148 59 6 1 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 1 212507249 C T T rs61828730 intronic 0.0408 0.0408 PPP2R5A 0.8011 58 7 1 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 1 228204651 G A A rs12747212 intronic 0.0465 0.0465 WNT3A 0.1984 58 8 0 23 1 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 2 208631211 A T T rs74471859 3_prime_UTR 0.0420 0.0420 FZD5 0.2352 56 10 0 19 7 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 2 208632817 G A A rs35994626 missense 0.0418 0.0418 FZD5 0.2352 56 10 0 19 7 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 41241993 A G G rs11564437 intronic 0.0255 0.0255 CTNNB1 0.2725 63 2 1 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119663780 G A A rs114872182 intronic 0.0222 0.0222 GSK3B 0.8074 61 4 1 24 1 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119674978 G C C rs115950158 intronic 0.0384 0.0384 GSK3B 0.2761 56 10 0 23 1 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119734170 T C C rs116755725 intronic 0.0237 0.0237 GSK3B 0.0397 54 11 1 26 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119736734 T C C rs78796384 intronic 0.0177 0.0177 GSK3B 0.1282 57 8 1 25 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119752368 T A A rs78883820 intronic 0.0403 0.0403 GSK3B 1.0000 52 13 1 20 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119785723 C T T rs75142045 intronic 0.0236 0.0236 GSK3B 0.0391 54 11 1 25 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119795926 C T T rs75192446 intronic 0.0409 0.0409 GSK3B 1.0000 52 13 1 20 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 3 119816610 G A A rs114798987 upstream 0.0229 0.0229 GSK3B 0.0646 61 5 0 19 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 112077680 T C C rs62363988 intronic 0.0273 0.0273 APC 0.7207 62 3 1 23 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 112124405 C T T rs62364020 intronic 0.0266 0.0266 APC 0.7207 62 3 1 23 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 112141114 C G G rs62364022 intronic 0.0270 0.0270 APC 0.7207 62 3 1 23 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 112164747 A G G rs62364023 intronic 0.0271 0.0271 APC 0.7285 62 3 1 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 133551516 A G G rs75368011 intronic 0.0484 0.0484 PPP2CA 0.0685 61 5 0 20 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 133553213 T A A rs79758263 intronic 0.0483 0.0483 PPP2CA 0.0646 61 5 0 19 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 133554676 A G G rs71587522 intronic 0.0288 0.0288 PPP2CA 0.7497 55 11 0 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 137417081 A G G rs60251892 upstream 0.0479 0.0479 WNT8A 0.4762 60 5 1 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 137429148 C T T rs146145625 downstream 0.0305 0.0305 WNT8A 1.0000 57 8 0 22 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 148887275 C A A rs114967510 intronic 0.0299 0.0299 CSNK1A1 1.0000 56 10 0 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 5 148921266 C T T rs114031822 intronic 0.0172 0.0172 CSNK1A1 1.0000 58 7 0 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42955700 G A A rs150318932 intronic 0.0184 0.0184 PPP2R5D 0.0188 62 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42956855 C G G rs139678883 intronic 0.0185 0.0185 PPP2R5D 0.0179 63 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42956915 G A A rs116911410 intronic 0.0185 0.0185 PPP2R5D 0.0179 63 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42958019 T C C rs9462861 intronic 0.0181 0.0181 PPP2R5D 0.1111 62 4 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42958084 A G G rs114754270 intronic 0.0185 0.0185 PPP2R5D 0.0179 63 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42967569 G A A rs143336223 intronic 0.0182 0.0182 PPP2R5D 0.0179 63 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42970465 A G G rs78833196 intronic 0.0403 0.0403 PPP2R5D 0.2977 54 12 0 22 3 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 6 42978824 C T T rs41274902 intronic 0.0182 0.0182 PPP2R5D 0.0179 63 2 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 90892588 C T T rs78521924 upstream 0.0215 0.0215 FZD1 0.7469 57 9 0 21 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 116165233 C T T rs45498702 intronic 0.0462 0.0462 CAV1 0.2078 58 8 0 20 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 116187330 G A A rs1474511 intronic 0.0342 0.0342 CAV1 0.0534 59 7 0 18 7 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 116192330 C T T rs75022895 intronic 0.0478 0.0478 CAV1 0.0150 58 8 0 16 9 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 116193508 A T T rs117052851 intronic 0.0304 0.0304 CAV1 1.0000 56 10 0 21 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 7 116197908 C T T rs35902398 intronic 0.0348 0.0348 CAV1 0.2428 58 7 1 26 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 10 99076980 G C C rs11189125 upstream 0.0428 0.0428 FRAT1 1.0000 60 5 1 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 10 99081117 G A A rs11189129 3_prime_UTR 0.0422 0.0422 FRAT1 1.0000 60 5 1 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 10 99097398 T C C rs35502594 upstream 0.0344 0.0344 FRAT2 0.4762 60 5 1 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64690070 G A A rs147029783 upstream 0.0444 0.0444 PPP2R5B 0.3373 55 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64691910 T G G rs76436719 upstream 0.0440 0.0440 PPP2R5B 0.3373 55 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64692312 A G G rs60798873 5_prime_UTR 0.0441 0.0441 PPP2R5B 0.3373 55 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64692356 C T T rs61024397 5_prime_UTR 0.0441 0.0441 PPP2R5B 0.3373 55 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64694023 A T T rs57393537 intronic 0.0442 0.0442 PPP2R5B 0.3373 55 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64695020 T G G rs885999 intronic 0.0443 0.0443 PPP2R5B 0.3348 54 11 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64697950 C T T rs111934356 splice_region,intronic 0.0384 0.0384 PPP2R5B 0.5002 55 9 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 64700976 T C C rs10488702 intronic 0.0458 0.0458 PPP2R5B 0.7222 57 9 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68105602 G A A rs74968229 intronic 0.0413 0.0413 LRP5 1.0000 57 9 0 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68109822 T C C rs4988311 intronic 0.0434 0.0434 LRP5 0.8249 55 10 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68111672 A G G rs314756 intronic 0.0470 0.0470 LRP5 0.5316 56 9 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68176016 C T T rs76884287 intronic 0.0481 0.0481 LRP5 0.7302 58 8 0 21 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68192362 C G G rs75776943 intronic 0.0486 0.0486 LRP5 0.3091 59 7 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68205117 T C C rs137864217 intronic 0.0205 0.0205 LRP5 0.4984 59 7 0 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68214505 C G G rs78471927 intronic 0.0482 0.0482 LRP5 0.7227 58 7 0 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 68214890 G A A rs79320300 intronic 0.0441 0.0441 LRP5 0.4984 59 7 0 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 11 111624412 A G A rs4322429 intronic 0.9540 0.0460 PPP2R1B 0.2775 2 13 51 0 2 24
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12267520 G A A rs12826332 downstream 0.0468 0.0468 LRP6 0.0422 61 4 0 20 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12267823 T C C rs34372334 downstream 0.0471 0.0471 LRP6 0.0410 62 4 0 20 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12269960 G A A rs3741792 3_prime_UTR 0.0471 0.0471 LRP6 0.0237 62 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12270560 A G G rs71457129 3_prime_UTR 0.0470 0.0470 LRP6 0.0250 61 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12271574 C T T rs71457130 3_prime_UTR 0.0469 0.0469 LRP6 0.0237 62 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12275297 A G G rs71457131 intronic 0.0317 0.0317 LRP6 0.2078 58 8 0 20 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12287013 T A A rs12819810 intronic 0.0495 0.0495 LRP6 0.0237 62 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12287589 C T T rs12819916 intronic 0.0496 0.0496 LRP6 0.0237 62 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12295552 T G G rs34694539 intronic 0.0496 0.0496 LRP6 0.0250 61 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12297091 A G G rs71457134 intronic 0.0496 0.0496 LRP6 0.0410 62 4 0 20 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12315857 T C C rs2300230 intronic 0.0496 0.0496 LRP6 0.0237 62 4 0 19 5 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12321526 G A A rs11054719 intronic 0.0210 0.0210 LRP6 1.0000 58 8 0 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12324058 G A A rs113794654 intronic 0.0315 0.0315 LRP6 1.0000 60 5 1 24 1 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12324841 A G G rs12833575 intronic 0.0327 0.0327 LRP6 0.3477 57 9 0 20 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12325932 C G G rs76038196 intronic 0.0382 0.0382 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12326027 C G G rs75049047 intronic 0.0381 0.0381 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12326128 C T T rs76299027 intronic 0.0380 0.0380 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12328826 T C C rs78024436 intronic 0.0382 0.0382 LRP6 0.0351 62 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12337956 C T T rs77595426 intronic 0.0383 0.0383 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12346016 G A A rs79359989 intronic 0.0383 0.0383 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12350029 A G G rs187847468 intronic 0.0383 0.0383 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12357470 T A A rs75431901 intronic 0.0382 0.0382 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12364411 T C C rs17374170 intronic 0.0382 0.0382 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12369072 C A A rs75798211 intronic 0.0468 0.0468 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12370932 C T T rs77970482 intronic 0.0381 0.0381 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12372047 T G G rs117001679 intronic 0.0383 0.0383 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12374101 A G G rs75253855 intronic 0.0383 0.0383 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12378128 C T T rs11054733 intronic 0.0209 0.0209 LRP6 1.0000 57 8 0 23 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12378158 C T T rs78815657 intronic 0.0383 0.0383 LRP6 0.0400 62 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12378767 T C C rs117299638 intronic 0.0379 0.0379 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12378920 C T T rs80214149 intronic 0.0383 0.0383 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12384668 G A A rs77157509 intronic 0.0376 0.0376 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12388356 A C C rs77588531 intronic 0.0383 0.0383 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12391576 T C C rs75155789 intronic 0.0380 0.0380 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12398849 T G G rs116946061 intronic 0.0380 0.0380 LRP6 0.0335 63 3 0 20 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12404270 C T T rs78533154 intronic 0.0384 0.0384 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12414109 G T T rs149872900 intronic 0.0383 0.0383 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12414920 T C C rs147798710 intronic 0.0383 0.0383 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 12 12416595 A C C rs117775212 intronic 0.0383 0.0383 LRP6 0.0381 63 3 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 63877780 T G G rs76445028 intronic 0.0431 0.0431 PPP2R5E 0.3158 53 13 0 21 4 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 63977051 C A A rs17766076 intronic 0.0436 0.0436 PPP2R5E 0.6433 56 9 1 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102253838 T C C rs151299721 intronic 0.0229 0.0229 PPP2R5C 0.4981 56 10 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102274571 A T T rs76294435 intronic 0.0481 0.0481 PPP2R5C 0.2818 60 6 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102287985 G A A rs80152381 intronic 0.0425 0.0425 PPP2R5C 1.0000 54 11 0 21 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102326654 C T T rs80319248 intronic 0.0269 0.0269 PPP2R5C 0.7348 58 8 0 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102338112 A G G rs2476521 intronic 0.0458 0.0458 PPP2R5C 0.0565 56 10 0 25 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102339600 T C C rs116995481 intronic 0.0294 0.0294 PPP2R5C 0.0569 56 10 0 26 0 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102344254 C T T rs8012434 intronic 0.0449 0.0449 PPP2R5C 0.7192 58 8 0 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 14 102395021 T C T rs1741145 downstream 0.9636 0.0364 PPP2R5C 0.7522 0 10 56 0 3 23
Disassembly of the destruction complex and recruitment of AXIN to the membrane 16 337655 A G G rs45530432 3_prime_UTR 0.0218 0.0218 AXIN1 0.5928 57 7 1 25 1 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 16 350846 A G A rs214245 intronic 0.9604 0.0396 AXIN1 0.2078 0 8 58 0 6 20
Disassembly of the destruction complex and recruitment of AXIN to the membrane 16 351517 A G A rs214242 intronic 0.9533 0.0467 AXIN1 0.2078 0 8 58 0 6 20
Disassembly of the destruction complex and recruitment of AXIN to the membrane 16 392392 C G G rs118100148 intronic 0.0492 0.0492 AXIN1 1.0000 51 14 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 17 42641345 G C C rs75575961 downstream 0.0180 0.0180 FZD2 0.6957 60 6 0 21 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 1948218 C T T rs117285549 intronic 0.0293 0.0293 CSNK1G2 0.6148 59 6 1 22 4 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 1952808 G A A rs74415283 intronic 0.0236 0.0236 CSNK1G2 0.3091 59 7 0 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 1957031 G T T rs34956563 intronic 0.0245 0.0245 CSNK1G2 0.7980 57 8 1 24 2 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 52710886 A G G rs62109206 intronic 0.0217 0.0217 PPP2R1A 0.8074 61 4 1 24 1 1
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 52716143 G A A rs74536039 intronic 0.0445 0.0445 PPP2R1A 0.8249 55 10 1 21 5 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 52720738 C T T rs77810569 intronic 0.0478 0.0478 PPP2R1A 0.5544 55 10 1 20 6 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 52726288 G A A rs77891912 intronic 0.0456 0.0456 PPP2R1A 0.5418 53 13 0 22 3 0
Disassembly of the destruction complex and recruitment of AXIN to the membrane 19 52729981 C T T rs111484780 3_prime_UTR 0.0455 0.0455 PPP2R1A 0.5425 53 13 0 23 3 0









Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Dominant model Recessive model
4 4345379 T C C rs7695197 upstream 0.31 0.31 NSG1 3.55E-06 0.013 0.021 0.022 0.14 34 31 1 7 8 11 50.72 46.38 2.90 27.59 31.03 41.38 2.70 23.65
4 4346427 G A A rs3981 upstream 0.32 0.32 NSG1 3.84E-06 0.014 0.023 0.023 0.15 34 30 1 7 8 11 51.47 45.59 2.94 27.59 31.03 41.38 2.78 23.29
4 4346465 T C C rs12641832 upstream 0.33 0.33 NSG1 3.84E-06 0.014 0.023 0.023 0.15 34 30 1 7 8 11 51.47 45.59 2.94 27.59 31.03 41.38 2.78 23.29
4 4351540 G A A rs34402391 intronic 0.34 0.34 NSG1 1.10E-05 0.040 0.065 0.066 0.38 33 30 2 6 8 11 50.00 45.59 4.41 25.00 32.14 42.86 3.00 16.25
17 11348500 A G G rs9900468 intronic 0.21 0.21 SHISA6 4.92E-05 0.167 0.258 0.262 0.88 43 14 9 8 18 0 63.77 21.74 14.49 31.03 65.52 3.45 3.91 0.21
5 75425227 T G G rs10514059 intronic 0.22 0.22 SV2C 1.34E-04 0.391 0.556 0.562 1.00 41 24 1 5 17 4 60.87 36.23 2.90 20.69 62.07 17.24 5.96 6.98
19 15900659 A G G rs7249737 upstream 0.08 0.08 OR10H5 2.14E-04 0.548 0.728 0.734 1.00 53 12 1 10 15 0 78.26 18.84 2.90 39.29 57.14 3.57 5.56 1.24
4 4357296 A G A rs10937867 intronic 0.62 0.38 NSG1 3.37E-04 0.713 0.871 0.875 1.00 9 33 24 2 3 21 14.49 49.28 36.23 10.34 13.79 75.86 1.47 5.53
10 50815871 T C C rs75287762 upstream 0.08 0.08 SLC18A3 3.74E-04 0.750 0.897 0.901 1.00 59 7 0 14 12 0 86.96 11.59 1.45 51.72 44.83 3.45 6.22 2.43
19 15906476 G C C rs62106069 downstream 0.08 0.08 OR10H5 3.90E-04 0.764 0.906 0.910 1.00 52 11 1 11 15 0 79.10 17.91 2.99 41.38 55.17 3.45 5.36 1.16
13 47440800 T C C rs9567743 intronic 0.18 0.18 HTR2A 3.92E-04 0.766 0.908 0.911 1.00 28 31 7 21 2 1 42.03 46.38 11.59 81.48 11.11 7.41 0.16 0.61
11 84340842 T G G rs17807944 intronic 0.22 0.22 DLG2 4.15E-04 0.785 0.920 0.923 1.00 30 32 4 21 2 3 44.93 47.83 7.25 75.86 10.34 13.79 0.26 2.05
7 157825498 C T C rs6953551 intronic 0.70 0.30 PTPRN2 4.37E-04 0.802 0.930 0.932 1.00 1 26 38 2 1 22 2.94 39.71 57.35 10.71 7.14 82.14 0.25 3.42
19 15855434 C A A rs56108924 downstream 0.10 0.10 OR10H3 5.33E-04 0.861 0.961 0.963 1.00 52 13 1 10 15 1 76.81 20.29 2.90 37.93 55.17 6.90 5.42 2.48
6 34036642 G T T rs1906954 intronic 0.06 0.06 GRM4 5.86E-04 0.886 0.972 0.973 1.00 62 2 0 18 8 0 94.03 4.48 1.49 65.52 31.03 3.45 8.29 2.36
19 15910817 T C C rs55908984 downstream 0.07 0.07 OR10H5 6.49E-04 0.910 0.981 0.982 1.00 53 12 1 11 15 0 78.26 18.84 2.90 41.38 55.17 3.45 5.10 1.20
19 15907908 C T T rs62106071 downstream 0.08 0.08 OR10H5 6.54E-04 0.911 0.981 0.982 1.00 52 12 1 11 15 0 77.94 19.12 2.94 41.38 55.17 3.45 5.01 1.18
19 15908978 C T T rs72995365 downstream 0.07 0.07 OR10H5 6.54E-04 0.911 0.981 0.982 1.00 52 12 1 11 15 0 77.94 19.12 2.94 41.38 55.17 3.45 5.01 1.18
6 44192158 T C C rs1886884 intronic 0.47 0.47 SLC29A1 6.72E-04 0.917 0.983 0.984 1.00 9 33 23 14 8 4 14.71 50.00 35.29 51.72 31.03 17.24 0.16 0.38
2 50882657 C T C rs9752732 intronic 0.82 0.18 NRXN1 7.31E-04 0.933 0.988 0.989 1.00 2 11 53 2 13 10 4.35 17.39 78.26 10.71 50.00 39.29 0.38 0.18
P VALUE
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SYMBOL # MUTATIONS P VALUE FWER
DLG2 208 6.25E-07 0.000137
SLC6A4 2 1.86E-03 0.336693
DAGLA 5 8.14E-03 0.834428
SHISA9 15 3.74E-02 0.999771
SCRIB 2 4.25E-02 0.999928
SV2B 17 6.11E-02 0.999999
PPFIA4 3 6.33E-02 0.999999
PRKCZ 5 6.61E-02 1.000000
NAAA 1 7.03E-02 1.000000
SYT17 4 7.47E-02 1.000000
USP46 3 7.60E-02 1.000000
GRIA1 38 8.74E-02 1.000000
FNTA 2 9.10E-02 1.000000
HRH2 7 9.10E-02 1.000000
GRM1 17 9.16E-02 1.000000
AP3D1 3 9.35E-02 1.000000
LYPD6B 7 9.43E-02 1.000000
DTNBP1 16 9.86E-02 1.000000
RAP1A 16 9.99E-02 1.000000
SLC6A7 1 1.04E-01 1.000000
SRC 1 1.20E-01 1.000000
APBA1 3 1.22E-01 1.000000
DNM3 36 1.29E-01 1.000000
STX3 5 1.29E-01 1.000000
KIF17 4 1.49E-01 1.000000
OR56A4 2 1.62E-01 1.000000
ATP1A2 2 1.62E-01 1.000000
DOC2B 8 1.63E-01 1.000000
SV2C 12 1.71E-01 1.000000
DAG1 4 1.72E-01 1.000000
SNCG 1 1.75E-01 1.000000
FRRS1L 4 1.76E-01 1.000000
BRSK1 2 1.78E-01 1.000000
GLUL 2 1.80E-01 1.000000
RAB11A 2 1.92E-01 1.000000
WNT7A 3 1.93E-01 1.000000
HTR1D 2 2.01E-01 1.000000
GABBR1 30 2.02E-01 1.000000
STXBP1 10 2.02E-01 1.000000
SLC6A15 4 2.10E-01 1.000000
SHISA6 15 2.18E-01 1.000000
DNM2 12 2.25E-01 1.000000
DDC 6 2.28E-01 1.000000
HTR1E 29 2.32E-01 1.000000
FLOT1 2 2.37E-01 1.000000
RPH3A 13 2.58E-01 1.000000
KCNC4 3 2.62E-01 1.000000
EFNB2 2 2.67E-01 1.000000
COLQ 7 2.83E-01 1.000000
SLC1A7 8 2.87E-01 1.000000
CTNND1 4 2.88E-01 1.000000
SYN3 46 2.88E-01 1.000000
NUMB 10 2.90E-01 1.000000
GRM4 2 2.92E-01 1.000000
SLC6A9 3 3.00E-01 1.000000
KIF5C 5 3.01E-01 1.000000
UNC13A 7 3.15E-01 1.000000
SNAPIN 1 3.22E-01 1.000000
SLC18A1 3 3.27E-01 1.000000
SYT1 41 3.29E-01 1.000000
ALDH5A1 6 3.29E-01 1.000000
HTR4 12 3.93E-01 1.000000
PDE1B 2 3.97E-01 1.000000
HTR5A 3 4.00E-01 1.000000
HSPA8 3 4.05E-01 1.000000
AP2B1 5 4.14E-01 1.000000
HRAS 1 4.16E-01 1.000000
CNIH2 2 4.16E-01 1.000000
ICA1 32 4.20E-01 1.000000
CPLX2 8 4.25E-01 1.000000
CACNA1B 5 4.45E-01 1.000000
CLSTN1 5 4.64E-01 1.000000
NPTXR 2 4.68E-01 1.000000
CHRM5 5 4.74E-01 1.000000
AKAP9 1 4.86E-01 1.000000
BAIAP3 1 4.86E-01 1.000000
CACNG2 14 4.89E-01 1.000000
SLC6A13 3 4.93E-01 1.000000
CHRM3 37 4.97E-01 1.000000
ADRB1 1 4.98E-01 1.000000
CHRM1 1 4.98E-01 1.000000
CHAT 1 5.03E-01 1.000000
LRTOMT 1 5.06E-01 1.000000
HRH1 6 5.09E-01 1.000000
SYT2 3 5.09E-01 1.000000
SLC6A18 2 5.11E-01 1.000000
NF1 6 5.13E-01 1.000000
GAD1 6 5.25E-01 1.000000
SLC30A1 2 5.50E-01 1.000000
SLC17A6 3 5.69E-01 1.000000
SLC6A20 10 5.75E-01 1.000000
SNCA 3 5.80E-01 1.000000
STX1A 3 5.83E-01 1.000000
SLC6A12 3 5.83E-01 1.000000
CACNG7 2 5.83E-01 1.000000
NRG1 103 5.83E-01 1.000000
UNC13B 5 5.85E-01 1.000000
NPTX1 2 5.90E-01 1.000000
SLC1A2 12 6.06E-01 1.000000
LYNX1 4 6.33E-01 1.000000
DOC2A 1 6.47E-01 1.000000
EPS8 7 6.54E-01 1.000000
ATP2A2 2 6.58E-01 1.000000
ARHGAP44 47 6.59E-01 1.000000
SLC22A1 2 6.72E-01 1.000000
SLC38A1 7 6.81E-01 1.000000
RHOT1 8 6.95E-01 1.000000
NRXN1 77 6.98E-01 1.000000
SLC32A1 1 7.19E-01 1.000000
SLC5A7 2 7.23E-01 1.000000
OR5T3 1 7.30E-01 1.000000
SYT12 3 7.31E-01 1.000000
SYT7 4 7.36E-01 1.000000
PRKCI 2 7.44E-01 1.000000
SLC6A17 7 7.51E-01 1.000000
CALY 1 7.52E-01 1.000000
HTR6 2 7.52E-01 1.000000
PPFIA1 2 7.55E-01 1.000000
GABRA2 18 7.59E-01 1.000000
PPP1R9A 15 7.60E-01 1.000000
ALDH9A1 3 7.65E-01 1.000000
DRD3 1 7.68E-01 1.000000
SLC18A2 2 7.74E-01 1.000000
NRXN2 5 7.79E-01 1.000000
SLC1A3 14 7.88E-01 1.000000
HOMER1 5 7.88E-01 1.000000
CHRM2 12 7.88E-01 1.000000
SLC6A2 6 7.92E-01 1.000000
SLC1A6 3 7.94E-01 1.000000
DRD4 1 7.96E-01 1.000000
AP2M1 1 7.98E-01 1.000000
HIP1 17 7.99E-01 1.000000
PATE1 4 8.06E-01 1.000000
CPLX1 5 8.09E-01 1.000000
CACNG4 3 8.09E-01 1.000000
LYPD6 4 8.11E-01 1.000000
CHRNB4 2 8.17E-01 1.000000
PPFIA3 3 8.17E-01 1.000000
GPER1 4 8.18E-01 1.000000
GSG1L 19 8.23E-01 1.000000
NPTX2 2 8.24E-01 1.000000
DAGLB 1 8.25E-01 1.000000
ADAM10 12 8.30E-01 1.000000
KIF5A 3 8.38E-01 1.000000
SLC6A16 2 8.45E-01 1.000000
MCTP1 45 8.46E-01 1.000000
PRIMA1 7 8.48E-01 1.000000
DRD2 7 8.50E-01 1.000000
NIPSNAP1 2 8.58E-01 1.000000
SLC6A6 7 8.61E-01 1.000000
RAB8A 2 8.65E-01 1.000000
GAD2 2 8.78E-01 1.000000
LIN7A 12 8.80E-01 1.000000
GPHN 62 8.92E-01 1.000000
GRIP1 24 8.98E-01 1.000000
YWHAE 23 9.12E-01 1.000000
SYT11 3 9.16E-01 1.000000
PATE4 7 9.24E-01 1.000000
RIMS1 17 9.24E-01 1.000000
CACNA1A 19 9.26E-01 1.000000
SYNJ1 3 9.27E-01 1.000000
GRIN1 5 9.29E-01 1.000000
SLC6A3 4 9.32E-01 1.000000
SNAP25 8 9.33E-01 1.000000
CAMK2A 5 9.38E-01 1.000000
SLC6A5 6 9.38E-01 1.000000
RIMS2 39 9.39E-01 1.000000
SLC17A8 6 9.41E-01 1.000000
SNCAIP 5 9.43E-01 1.000000
CACNG3 7 9.48E-01 1.000000
SLC22A2 3 9.50E-01 1.000000
HTR7 5 9.51E-01 1.000000
SLC6A19 2 9.53E-01 1.000000
ITGB3 9 9.55E-01 1.000000
NSG1 6 9.61E-01 1.000000
RIMS4 6 9.62E-01 1.000000
MAPK10 19 9.70E-01 1.000000
SYN2 56 9.79E-01 1.000000
SYT5 3 9.82E-01 1.000000
EPS15 8 9.84E-01 1.000000
PAH 4 9.85E-01 1.000000
NRXN3 187 9.90E-01 1.000000
DGKI 40 9.90E-01 1.000000
AGTPBP1 6 9.93E-01 1.000000
HTR2A 26 9.94E-01 1.000000
LRRC7 34 9.95E-01 1.000000
GPC6 98 9.97E-01 1.000000
ADORA1 12 9.98E-01 1.000000
COMT 5 9.98E-01 1.000000
NAALAD2 23 9.98E-01 1.000000
PPFIA2 47 9.98E-01 1.000000
MEF2C 39 9.99E-01 1.000000
SLC6A11 21 9.99E-01 1.000000
PTPRN2 90 1.00E+00 1.000000
SNPH 4 1.00E+00 1.000000
NOS1 11 1.00E+00 1.000000
GRM5 13 1.00E+00 1.000000
DLG1 72 1.00E+00 1.000000
CACNG5 12 1.00E+00 1.000000
ABAT 14 1.00E+00 1.000000
CPT1C 1 1.00E+00 1.000000
DLG4 1 1.00E+00 1.000000
DNM1 1 1.00E+00 1.000000
GRASP 1 1.00E+00 1.000000
GRIP2 4 1.00E+00 1.000000
HRH3 1 1.00E+00 1.000000
HRH4 1 1.00E+00 1.000000
HTR1F 1 1.00E+00 1.000000
KCNMB4 3 1.00E+00 1.000000
LGI1 1 1.00E+00 1.000000
OR11H4 1 1.00E+00 1.000000
PPT1 1 1.00E+00 1.000000
PSCA 1 1.00E+00 1.000000
RAB3A 1 1.00E+00 1.000000
RIMS3 2 1.00E+00 1.000000
SHISA7 1 1.00E+00 1.000000
SLC29A1 1 1.00E+00 1.000000
SLC6A1 4 1.00E+00 1.000000
SNAP47 2 1.00E+00 1.000000









Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Ref/Ref Ref/Alt Alt/Alt Dominant model Recessive model
7 75690988 A C C rs10216079 intronic 0.20 0.20 MDH2 2.65E-05 0.105 0.165 0.172 0.770 37 26 2 26 0 0 55.88 39.71 4.41 93.10 3.45 3.45 0.09 0.77
7 75677578 G T T rs2286828 intronic 0.21 0.21 MDH2 2.66E-05 0.106 0.165 0.173 0.771 38 26 2 26 0 0 56.52 39.13 4.35 93.10 3.45 3.45 0.10 0.79
7 75677739 G A A rs2286829 intronic 0.21 0.21 MDH2 2.66E-05 0.106 0.165 0.173 0.771 38 26 2 26 0 0 56.52 39.13 4.35 93.10 3.45 3.45 0.10 0.79
7 75686007 G A A rs867973 intronic 0.18 0.18 MDH2 2.66E-05 0.106 0.165 0.173 0.771 38 26 2 26 0 0 56.52 39.13 4.35 93.10 3.45 3.45 0.10 0.79
7 75688672 G A A rs78587454 intronic 0.18 0.18 MDH2 2.66E-05 0.106 0.165 0.173 0.771 38 26 2 26 0 0 56.52 39.13 4.35 93.10 3.45 3.45 0.10 0.79
7 75695081 G A A rs3779419 intronic 0.23 0.23 MDH2 2.66E-05 0.106 0.165 0.173 0.771 38 26 2 26 0 0 56.52 39.13 4.35 93.10 3.45 3.45 0.10 0.79
16 90008296 T C C rs11644157 downstream 0.06 0.06 TUBB3 1.30E-04 0.420 0.586 0.604 0.999 62 3 0 16 10 0 92.65 5.88 1.47 58.62 37.93 3.45 8.89 2.39
9 87388848 G A G rs4877288 intronic 0.63 0.37 NTRK2 2.36E-04 0.629 0.799 0.814 1.000 16 36 14 1 7 16 24.64 53.62 21.74 7.41 29.63 62.96 4.09 6.12
16 90003359 G A A rs4534840 downstream 0.11 0.11 TUBB3 2.41E-04 0.637 0.805 0.821 1.000 62 4 0 15 10 0 91.30 7.25 1.45 57.14 39.29 3.57 7.88 2.52
16 78331490 A G G rs73574528 intronic 0.14 0.14 WWOX 2.80E-04 0.692 0.851 0.865 1.000 31 29 6 23 2 0 46.38 43.48 10.14 85.71 10.71 3.57 0.14 0.33
16 89991963 C T T rs62052213 intronic 0.08 0.08 TUBB3 3.05E-04 0.723 0.874 0.887 1.000 59 5 0 15 11 0 89.55 8.96 1.49 55.17 41.38 3.45 6.96 2.36
16 89998157 G A A rs62052214 intronic 0.06 0.06 TUBB3 3.34E-04 0.754 0.896 0.908 1.000 62 4 0 16 10 0 91.30 7.25 1.45 58.62 37.93 3.45 7.41 2.43
16 90007025 A G G rs11640500 downstream 0.06 0.06 TUBB3 3.34E-04 0.754 0.896 0.908 1.000 62 4 0 16 10 0 91.30 7.25 1.45 58.62 37.93 3.45 7.41 2.43
16 90008896 G A A rs74251586 downstream 0.06 0.06 TUBB3 3.34E-04 0.754 0.896 0.908 1.000 62 4 0 16 10 0 91.30 7.25 1.45 58.62 37.93 3.45 7.41 2.43
16 90008928 C A A rs79886664 downstream 0.06 0.06 TUBB3 3.34E-04 0.754 0.896 0.908 1.000 62 4 0 16 10 0 91.30 7.25 1.45 58.62 37.93 3.45 7.41 2.43
9 87382724 T C T rs2378671 intronic 0.53 0.47 NTRK2 4.61E-04 0.856 0.956 0.963 1.000 16 36 14 1 8 16 24.64 53.62 21.74 7.14 32.14 60.71 4.25 5.56
9 87384534 G A G rs10746750 intronic 0.59 0.41 NTRK2 4.61E-04 0.856 0.956 0.963 1.000 16 36 14 1 8 16 24.64 53.62 21.74 7.14 32.14 60.71 4.25 5.56
9 87392582 C T C rs10465180 intronic 0.63 0.37 NTRK2 4.61E-04 0.856 0.956 0.963 1.000 16 36 14 1 8 16 24.64 53.62 21.74 7.14 32.14 60.71 4.25 5.56
9 87394720 G C G rs1778971 intronic 0.59 0.41 NTRK2 4.61E-04 0.856 0.956 0.963 1.000 16 36 14 1 8 16 24.64 53.62 21.74 7.14 32.14 60.71 4.25 5.56
9 87395810 A G A rs1778970 intronic 0.59 0.41 NTRK2 4.61E-04 0.856 0.956 0.963 1.000 16 36 14 1 8 16 24.64 53.62 21.74 7.14 32.14 60.71 4.25 5.56
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RTN4IP1 19 0.0056 0.7923
DYRK1A 30 0.0069 0.8579
PEX6 4 0.0150 0.9856
KCNB1 35 0.0210 0.9974
TBC1D24 2 0.0212 0.9976
PRRT2 1 0.0303 0.9998
SLC13A5 3 0.0343 0.9999
PRICKLE1 8 0.0420 1.0000
GALC 8 0.0475 1.0000
ALG6 4 0.0541 1.0000
SETD5 5 0.0563 1.0000
MDH2 2 0.0597 1.0000
SURF1 2 0.0683 1.0000
CHRNB2 1 0.0685 1.0000
PIGO 1 0.0697 1.0000
PSAP 1 0.0701 1.0000
SYNGAP1 3 0.0712 1.0000
NHLRC1 6 0.0723 1.0000
PAFAH1B1 4 0.0857 1.0000
GRIN2B 55 0.0901 1.0000
PCDH12 1 0.0941 1.0000
IDH2 2 0.0960 1.0000
RNASEH2C 1 0.1006 1.0000
EPM2A 11 0.1089 1.0000
KCNJ10 2 0.1098 1.0000
ALG8 2 0.1136 1.0000
CLN8 1 0.1162 1.0000
COQ9 2 0.1162 1.0000
GABRB2 95 0.1235 1.0000
ARFGEF2 2 0.1289 1.0000
NDUFV1 3 0.1289 1.0000
NTRK2 111 0.1497 1.0000
PEX7 2 0.1528 1.0000
DYNC1H1 7 0.1535 1.0000
DHX30 1 0.1630 1.0000
SCN2A 8 0.1671 1.0000
FRRS1L 4 0.1757 1.0000
GLUL 2 0.1796 1.0000
TBCK 10 0.1802 1.0000
FAR1 1 0.1809 1.0000
LYST 3 0.1836 1.0000
SLC12A5 2 0.1890 1.0000
COL4A2 21 0.1898 1.0000
STXBP1 10 0.2022 1.0000
AKT1 2 0.2033 1.0000
CIC 2 0.2096 1.0000
OCLN 4 0.2120 1.0000
MFF 2 0.2171 1.0000
KCNK4 1 0.2176 1.0000
HLCS 26 0.2329 1.0000
TRPM6 6 0.2398 1.0000
PCCB 5 0.2403 1.0000
TRAK1 4 0.2448 1.0000
GOSR2 2 0.2558 1.0000
AP3B2 5 0.2578 1.0000
HACE1 6 0.2670 1.0000
GTPBP2 1 0.2672 1.0000
RMND1 2 0.2780 1.0000
MOCS2 1 0.2781 1.0000
SMARCC2 1 0.2818 1.0000
LIAS 1 0.2834 1.0000
SETBP1 35 0.2839 1.0000
AIMP1 2 0.2845 1.0000
NAGA 4 0.2919 1.0000
DENND5A 2 0.2945 1.0000
ASPA 2 0.2947 1.0000
EIF3F 4 0.2955 1.0000
KIF5C 5 0.3007 1.0000
SCN3A 2 0.3009 1.0000
AKT3 36 0.3086 1.0000
EEF1A2 3 0.3161 1.0000
TUBB3 1 0.3163 1.0000
ALDH5A1 6 0.3294 1.0000
EPG5 9 0.3296 1.0000
ARID1B 52 0.3372 1.0000
CNNM2 6 0.3418 1.0000
GNB1 4 0.3438 1.0000
DNM1L 6 0.3441 1.0000
SLC25A12 2 0.3477 1.0000
NSD1 6 0.3554 1.0000
STAG1 22 0.3685 1.0000
COQ4 1 0.3739 1.0000
TANGO2 1 0.3842 1.0000
EIF2B5 15 0.3876 1.0000
HSD17B4 7 0.3885 1.0000
SLC25A22 2 0.4034 1.0000
COL4A1 36 0.4116 1.0000
SCN8A 10 0.4148 1.0000
AMT 1 0.4157 1.0000
HRAS 1 0.4157 1.0000
NDE1 2 0.4209 1.0000
NPRL3 3 0.4213 1.0000
PIK3R2 10 0.4223 1.0000
RORB 6 0.4236 1.0000
HCN2 6 0.4346 1.0000
TSEN2 3 0.4435 1.0000
IFIH1 6 0.4476 1.0000
POMT1 1 0.4554 1.0000
CACNA1E 41 0.4576 1.0000
ADAR 2 0.4603 1.0000
DEAF1 3 0.4644 1.0000
KARS 2 0.4671 1.0000
FBXO11 3 0.4680 1.0000
RHOBTB2 1 0.4762 1.0000
PDHX 1 0.4770 1.0000
PHACTR1 13 0.4879 1.0000
ATP1A1 4 0.4892 1.0000
D2HGDH 2 0.4905 1.0000
PEX19 4 0.4909 1.0000
ALG11 1 0.4981 1.0000
WDR62 1 0.4984 1.0000
ZBTB18 1 0.4999 1.0000
CAD 1 0.5027 1.0000
GABRA1 6 0.5037 1.0000
PTS 1 0.5065 1.0000
ROGDI 2 0.5065 1.0000
TSC2 2 0.5134 1.0000
BOLA3 2 0.5275 1.0000
MTHFR 1 0.5316 1.0000
PRMT7 1 0.5321 1.0000
TREX1 1 0.5357 1.0000
RTTN 6 0.5359 1.0000
RNASET2 4 0.5373 1.0000
KCTD3 2 0.5374 1.0000
TSC1 1 0.5425 1.0000
SCARB2 5 0.5434 1.0000
MFSD8 2 0.5449 1.0000
TSEN54 2 0.5494 1.0000
PACS1 10 0.5497 1.0000
CPA6 14 0.5516 1.0000
NDUFAF2 17 0.5585 1.0000
STRADA 3 0.5586 1.0000
MTOR 4 0.5639 1.0000
FARS2 41 0.5675 1.0000
SZT2 6 0.5676 1.0000
CHRNA2 3 0.5718 1.0000
SEPSECS 2 0.5833 1.0000
ALDH7A1 6 0.5897 1.0000
KCNJ11 2 0.5934 1.0000
NACC1 4 0.5977 1.0000
GABRG2 4 0.6056 1.0000
SLC1A2 12 0.6065 1.0000
PACS2 7 0.6074 1.0000
RORA 44 0.6079 1.0000
STAMBP 5 0.6188 1.0000
BTD 8 0.6306 1.0000
SUCLA2 5 0.6335 1.0000
GM2A 3 0.6363 1.0000
SCN9A 10 0.6665 1.0000
NARS2 8 0.6707 1.0000
TBCD 13 0.6804 1.0000
PLAA 18 0.6829 1.0000
NRXN1 77 0.6977 1.0000
EHMT1 13 0.7075 1.0000
CHRNA4 14 0.7080 1.0000
PHGDH 4 0.7089 1.0000
CTNNA2 104 0.7096 1.0000
KCNQ2 9 0.7130 1.0000
PPP3CA 26 0.7133 1.0000
PEX10 1 0.7184 1.0000
MMADHC 1 0.7209 1.0000
FGF12 40 0.7212 1.0000
PEX2 7 0.7237 1.0000
ARG1 1 0.7302 1.0000
ARV1 1 0.7302 1.0000
GRIN2D 1 0.7302 1.0000
MOGS 1 0.7348 1.0000
GABBR2 52 0.7352 1.0000
ALG9 3 0.7375 1.0000
MOCS1 3 0.7376 1.0000
WDR45B 2 0.7491 1.0000
COG7 1 0.7495 1.0000
BCKDHB 6 0.7555 1.0000
NGLY1 7 0.7558 1.0000
PNPO 1 0.7632 1.0000
KCNQ5 73 0.7653 1.0000
UBA5 3 0.7681 1.0000
PEX13 1 0.7700 1.0000
ST3GAL5 21 0.7868 1.0000
RELN 35 0.7913 1.0000
MAP2K2 1 0.7929 1.0000
UBE3A 13 0.7931 1.0000
BRAT1 8 0.7952 1.0000
CC2D2A 1 0.8053 1.0000
PEX1 3 0.8154 1.0000
FUT8 10 0.8211 1.0000
ALPL 6 0.8235 1.0000
ATP6V1A 1 0.8279 1.0000
BRAF 8 0.8333 1.0000
PCCA 10 0.8353 1.0000
EML1 17 0.8395 1.0000
PMM2 2 0.8427 1.0000
CACNA1D 18 0.8588 1.0000
MACF1 10 0.8590 1.0000
KCNQ3 42 0.8659 1.0000
GNAO1 2 0.8733 1.0000
PIGN 6 0.8744 1.0000
EMX2 2 0.8790 1.0000
TBL1XR1 11 0.8817 1.0000
RARS2 3 0.8826 1.0000
MAP2K1 4 0.8827 1.0000
KCNC1 2 0.8856 1.0000
NDUFS4 3 0.8906 1.0000
GPHN 62 0.8916 1.0000
MLC1 4 0.8939 1.0000
RALA 9 0.8992 1.0000
ZEB2 2 0.9072 1.0000
ACOX1 27 0.9095 1.0000
PIGG 5 0.9100 1.0000
MTR 9 0.9148 1.0000
NBEA 114 0.9155 1.0000
DOCK7 10 0.9209 1.0000
GRIN2A 15 0.9219 1.0000
CACNA1A 19 0.9256 1.0000
SYNJ1 3 0.9266 1.0000
GRIN1 5 0.9294 1.0000
SPTAN1 3 0.9369 1.0000
KCNT1 2 0.9374 1.0000
UNC80 6 0.9424 1.0000
CREBBP 8 0.9467 1.0000
PIK3CA 21 0.9479 1.0000
GLDC 6 0.9496 1.0000
SLC6A19 2 0.9526 1.0000
KCNA2 15 0.9546 1.0000
SLC2A1 3 0.9552 1.0000
CACNA1G 2 0.9572 1.0000
NDUFAF5 18 0.9579 1.0000
KRAS 7 0.9583 1.0000
FBXL4 13 0.9583 1.0000
RNASEH2B 4 0.9592 1.0000
SMARCA2 15 0.9601 1.0000
QDPR 8 0.9604 1.0000
WASF1 6 0.9627 1.0000
FKTN 3 0.9627 1.0000
WWOX 224 0.9631 1.0000
CHD2 7 0.9687 1.0000
GCH1 4 0.9728 1.0000
TCF4 27 0.9782 1.0000
DIAPH1 10 0.9782 1.0000
DEPDC5 103 0.9810 1.0000
DPYD 46 0.9836 1.0000
CYFIP2 8 0.9836 1.0000
PAH 4 0.9849 1.0000
NDUFA10 4 0.9886 1.0000
KIF1A 13 0.9888 1.0000
MBD5 56 0.9889 1.0000
GLB1 8 0.9929 1.0000
PTEN 6 0.9957 1.0000
HECW2 55 0.9965 1.0000
PLCB1 55 0.9971 1.0000
GRIA4 14 0.9984 1.0000
HCN1 14 0.9985 1.0000
MEF2C 39 0.9991 1.0000
KIF2A 7 0.9994 1.0000
GNAQ 16 0.9996 1.0000
MAGI2 175 0.9998 1.0000
GABRB3 20 0.9999 1.0000
GNB5 33 0.9999 1.0000
CNTNAP2 372 1.0000 1.0000
ABAT 14 1.0000 1.0000
AMPD2 1 1.0000 1.0000
CLTC 1 1.0000 1.0000
DNM1 1 1.0000 1.0000
EFTUD2 1 1.0000 1.0000
FGFR3 1 1.0000 1.0000
GSS 1 1.0000 1.0000
HEPACAM 3 1.0000 1.0000
HEXA 2 1.0000 1.0000
ITPA 1 1.0000 1.0000
LGI1 1 1.0000 1.0000
MBOAT7 1 1.0000 1.0000
OTUD6B 1 1.0000 1.0000
POMGNT1 1 1.0000 1.0000
PPT1 1 1.0000 1.0000
RAB18 1 1.0000 1.0000
RFT1 3 1.0000 1.0000
SLC35A1 2 1.0000 1.0000
SLC6A1 4 1.0000 1.0000
TUBB2A 1 1.0000 1.0000
VARS 1 1.0000 1.0000




























































































































































































































































































































































































































(Nyholt/Cheverud) π=1e-4 π=1e-5 π=1e-6 π=1e-4 π=1e-5 π=1e-6
17 4350407 G C G rs2047231 intronic 0.82 0.18 SPNS3 1.60E-07 0.026 0.041 0.056 0.437 0.80 0.29 0.04 0.97 0.78 0.26
15 50553000 G A A rs7182203 intronic 0.26 0.26 HDC 2.43E-07 0.038 0.061 0.083 0.581 0.96 0.73 0.21 0.98 0.84 0.35
4 8291102 C T T rs7683388 intronic 0.39 0.39 HTRA3 1.52E-06 0.217 0.326 0.420 0.996 0.74 0.22 0.03 0.95 0.65 0.16
17 4350182 T C T rs2047233 intronic 0.88 0.12 SPNS3 1.58E-06 0.224 0.335 0.431 0.996 0.25 0.03 0.00 0.77 0.25 0.03
5 179619074 T C C rs34570575 intronic 0.10 0.10 RASGEF1C 2.87E-06 0.370 0.524 0.642 1.000 0.22 0.03 0.00 0.64 0.15 0.02
3 37604012 T G G rs9825420 intronic 0.18 0.18 ITGA9 3.32E-06 0.414 0.577 0.695 1.000 0.23 0.03 0.00 0.68 0.17 0.02
4 4345379 T C C rs7695197 upstream 0.31 0.31 NSG1 3.55E-06 0.436 0.601 0.720 1.000 0.63 0.15 0.02 0.60 0.13 0.01
4 4346427 G A A rs3981 upstream 0.32 0.32 NSG1 3.84E-06 0.461 0.630 0.747 1.000 0.61 0.14 0.02 0.57 0.12 0.01
4 4346465 T C C rs12641832 upstream 0.33 0.33 NSG1 3.84E-06 0.461 0.630 0.747 1.000 0.61 0.14 0.02 0.57 0.12 0.01
4 113961039 G T G rs10015551 intronic, non-coding transcript 0.57 0.43 RP11-650J17.1 4.72E-06 0.532 0.705 0.815 1.000 0.46 0.08 0.01 0.69 0.19 0.02
15 99100580 A G A rs2311753 intergenic 0.79 0.21 5.49E-06 0.587 0.758 0.860 1.000 0.47 0.08 0.01 0.84 0.34 0.05
15 99101462 A G A rs2871859 intergenic 0.79 0.21 5.49E-06 0.587 0.758 0.860 1.000 0.47 0.08 0.01 0.84 0.34 0.05
17 4350367 A G A rs2047232 intronic 0.88 0.12 SPNS3 5.64E-06 0.597 0.768 0.867 1.000 0.09 0.01 0.00 0.45 0.08 0.01
2 156765630 T C C rs16839725 intergenic 0.29 0.29 5.90E-06 0.613 0.783 0.879 1.000 0.48 0.08 0.01 0.29 0.04 0.00
14 47620548 C T C rs1952220 intronic 0.87 0.13 MDGA2 6.25E-06 0.634 0.801 0.893 1.000 0.19 0.02 0.00 0.09 0.01 0.00
15 99102128 A G A rs11853887 intergenic 0.76 0.24 6.52E-06 0.650 0.815 0.903 1.000 0.45 0.08 0.01 0.83 0.32 0.05
4 113961811 C T C rs10433900 intronic, non-coding transcript 0.52 0.48 RP11-650J17.1 6.81E-06 0.666 0.828 0.912 1.000 0.44 0.07 0.01 0.66 0.16 0.02
3 37603952 T A A rs9825270 intronic 0.19 0.19 ITGA9 7.07E-06 0.679 0.839 0.920 1.000 0.08 0.01 0.00 0.39 0.06 0.01
4 16428073 G A A rs73224601 intronic, non-coding transcript 0.10 0.10 RP11-446J8.1 7.46E-06 0.699 0.855 0.931 1.000 0.07 0.01 0.00 0.55 0.11 0.01
3 72015276 C A A rs2036594 intergenic 0.17 0.17 8.48E-06 0.745 0.889 0.952 1.000 0.11 0.01 0.00 0.57 0.12 0.01
19 46569619 A G A rs713409 intronic 0.53 0.47 IGFL4 8.91E-06 0.762 0.900 0.959 1.000 0.37 0.06 0.01 0.70 0.19 0.02
19 46569630 A G A rs713411 intronic 0.53 0.47 IGFL4 8.91E-06 0.762 0.900 0.959 1.000 0.37 0.06 0.01 0.70 0.19 0.02
1 156486009 G A G rs6685228 downstream 0.76 0.24 RP11-284F21.8 9.82E-06 0.794 0.921 0.970 1.000 0.06 0.01 0.00 0.31 0.04 0.00
CHROM POS REF ALT MINOR ALLELE
rPPA (empirical prior)
P VALUEID CONSEQUENCE AF MAF SYMBOL
FWER rPPA (flat prior)
